conference logo
 
Programme  Titles  Presenters  Topics 
,LAB-Experimental (pre-clinical) Therapeutics and Pharmacology
Combined inhibition of HER1/EGFR and RAC1 yields cytostasis and induces apoptosis in a caspase-independent manner by down-regulation of survivin
Georg Karpel-Massler*, Mike-Andrew Westhoff, Richard Eric Kast, Annika Dwucet, Christian Rainer Wirtz, Klaus-Michael Debatin, Marc-Eric Halatsch
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines
Georg Karpel-Massler*, Richard Eric Kast, Mike-Andrew Westhoff, Nathalie Merkur, Annika Dwucet, Christian Rainer Wirtz, Klaus-Michael Debatin, Marc-Eric Halatsch
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
^Top
 
 
CLIN-Radiation Therapy
A phase II trial of primary or adjuvant stereotactic intensity modulated radiotherapy in the treatment of patients with one to three newly diagnosed symptomatic brain metastases
Mario Ammirati*, Varun Kshettry, Tariq Lamki, Lai Wei, John Grecula
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A review of total radiation dosages with whole brain radiation and radiosurgery in patients treated for metastatic cancer to the brain
Andrew Graff*, Patrick Clerkin, Hayden Smith, Robert Isaak
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Class solution IMRT planning: blinded comparison to RTOG 0539
Anita Mahajan*, Denise Manfredi, C. Leland Rogers, Matthew Palmer, Evangeline Hillebrandt, Stephen Bilton, Greg Robinson, Kyle Velasco, Minesh Mehta
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Clinical and therapeutic implications of solitary versus single brain metastasis
Jared Robbins*, Raphael Yechieli, Samuel Ryu
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Cranio-spinal irradiation for medulloblastoma: dosimetric comparison of proton and photon modalities to reduce the late development of diabetes mellitus
Jeffrey Brower*, Shae Gans, William Hartsell, Stewart Goldman, John Han-Chih Chang, Nasiruddin Mohammed, Moe Siddiqui, Vinai Gondi
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Deferred radiation is an appropriate option for patients presenting for treatment of non-functioning pituitary macroadenomas with residual post surgical tumor
Sarah Nicholas*, Roberto Salvatori, Michael Lim, Kristin Redmond, Alfredo Quinones, Gary Gallia, Daniele Rigamonti, Lawrence Kleinberg
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Diffusion tensor imaging confirms efficacy of re-irradiation in pediatric patients with  diffuse intrinsic pontine glioma
Soumen Khatua*, Ping Hou, Johannes Wolff, Jackson Hamilton, Wafik Zaky, Anita Mahajan, Leena Ketonen
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Fetal radiation monitoring and dose minimization during radiation therapy for glioblastoma in pregnancy
David Horowitz*, Cheng-Shie Wuu, Wenzheng Feng, Daphnie Drassinower, Anita Lasala, Andrew Lassman, Tony Wang
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Gamma Knife radiosurgery for cystic brain metastases
Se-Hyuk Kim*, Sang Ryul Lee, Ji Young Oh
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Hypofractionated re-irradiation of recurrent enhancing gliomas with 35 Gy: Can 20 Gy be delivered to surrounding T2 edema safely?
Beant Gill*, Dawn Peskorski, Ron Lalonde, M Saiful Huq, John Flickinger
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Hypopituitarism following stereotactic radiosurgery for pituitary adenomas
Zhiyuan Xu*, Mary Lee Vance, David Schlesinger, Jason Sheehan
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Intractable seizures secondary to meningioangiomatosis controlled with single fraction stereotactic radiosurgery
Jonathan Ashman*, Joseph Drazkowski, Richard Zimmerman, Thomas Lidner, Caterina Giannini, Alyx Porter, Naresh Patel
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Intracranial calcifications in pediatric brain tumor patients after receiving proton beam therapy
April Morrison*, Branko Cuglievan, Ziad Khatib
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Judicious use of radiosurgery (SRS) may change the ultimate patterns of failure in patients with brain metastasis from melanoma
Uzma Rezvi*, Edward Melian, Murat Surucu, Ibrahim Mescioglu, Vikram Prabhu, Joseph Clark, Douglas Anderson
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Long term follow-up after stereotactic radiosurgery for the treatment of meningiomas
John McGregor*, John Grecula, Mario Ammirati, Christopher Pelloski, Lanchun Lu, Nilendu Gupta, Susan Bell
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Molecular profiling of GBM patients developed pseudoprogression after chemoradiation treatment
Wenyin Shi*, Joshua Palmer, Jianliang Li, Lawrence Kenyon, Jon Glass, Lyndon Kim, Maria Werner-wasik, David Andrews
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Outcomes in patients with papillary tumors of the pineal region: single institutional experience
Mark Edson*, Gregory N Fuller, Pamela Allen, Jing Li
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Outcomes in stereotactic body radiotherapy for spinal tumors: an updated MD Anderson experience with patterns of failure analysis
Eva Christensen*, Slade Klawikowski, Amit Garg, Mary McAleer, Laurence Rhines, James Yang, Paul Brown, Eric Chang, Stephen Settle, Amol Ghia
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Patterns of tumor response after stereotactic radiosurgery for vestibular schwannoma
Rafi Kabarriti*, Waleed F Mourad, Diana Molinares Mejía, Jonathan Glanzman, Shyamal Patel, Rebekah Young, Michael Bernstein, Linda Hong, Jana Fox, Patrick LaSala, Shalom Kalnicki, Madhur Garg
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Palliation of sacral spine metastases with Stereotactic Body Radiation Therapy: an evaluation of local control and toxicity
J Bowers*, N Bennion, H Lomas IV, K Spencer, M Richardson, W McAllister, J Sheehan, D Schlesinger, R Kersh
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Predicting the intellectual outcome in children and adolescent with brain tumors treated with modern radiation techniques: a population-based study
I Atean*, N Shin, A Toltz, C Laude, C Freeman, J Seuntjens, D Roberge
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Predicting voxel outcomes in patients with GBM treated with anti-angiogenic agents using integrated dosimetry, metabolic and physiologic imaging
Mekhail Anwar*, Janine Lupo, Annette Molinaro, Jennifer Clarke, Nicholas Butowski, Michael Prados, Susan Chang, Daphne HaasKogan, Sarah Nelson
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Prognostic value of FET-PET imaging in reirradiation of high-grade glioma: results of a prospective trial
Soren Moller*, Ian Law, Per Munck af Rosenschold, Junia Costa, Hans Skovgaard Poulsen, Svend Aage Engelholm
Sunday, November 24, Scientific Meeting:  Concurrent Session 8B - Imaging and RANO Update  -  8:15am - 10:05am
Proton MR spectroscopy (MRS) and neuro-psychological dysfunction following cranial irradiation for pediatric malignancies: a prospective study
Kristin Redmond*, Omar Mian, Mahaveer Degaonkar, Haris Sair, Stephanie Terezakis, Lawrence Kleinberg, Todd McNutt, Moody Wharam, Mark Mahone, Alena Horska
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Prospective long-term neuroendocrine assessment in children and young adults with progressive benign/low-grade brain tumors treated with conventional or stereotactic conformal radiotherapy (SCRT) - results of a randomised controlled trial
Uday Krishna*, Nalini Shah, Rima Pathak, Tejpal Gupta, Anurag Lila, Padma Menon, Atul Goel, Rakesh Jalali
Friday, November 22, Scientific Meeting:  Concurrent Session 3B - Pediatric Clinical  -  3:15pm - 5:00pm
Prospective longitudinal assessment of sensori-neural hearing loss with hyperfractionated radiation therapy alone in patients with average-risk medulloblastoma
Tejpal Gupta*, Sarthak Mohanty, Sadhana Kannan, Rakesh Jalali
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Radiation-induced brain necrosis following primary stereotactic radiosurgery:  prognostic factors and clinical sequelae
Rebekah Young*, Dukagjin Blakaj, Merritt Drew Kinon, WF Mourad, Patrick A. LaSala, Linda Hong, Shalom Kalnicki, Madhur Garg
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Recurrence patterns in anaplastic astrocytoma: a retrospective study of patients treated at the Mayo Clinic
John Hardie*, Nadia Laack, Sani Kizilbash, Jan Buckner, Caterina Giannini, Joon Uhm, Ian Parney, Robert Jenkins, Paul Decker, Jesse Voss
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Reirradiation of primary CNS gliomas: a single institution experience
Corey Hobbs*, Laura Vallow, Jennifer Peterson, Kurt Jaeckle, Michael Heckman, Rawal Bhupendra
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Re-irradiation plus bevacizumab treatment in patients with recurrent high-grade gliomas
Jeffrey Dinh, David Grosshans*, Pamela Allen, John de Groot, Susan McGovern, Mary McAleer, Mark Gilbert, Paul Brown, Anita Mahajan
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Re-irradiation with hypo-fractionated stereotactic robotic radiosurgery for salvage in adult patients with brainstem glioma
Sridhar Susheela*, Swaroop Revannasiddaiah, Sandeep Muzumder, Govindarajan Mallarajapatna, Ajaikumar Basavalingaiah, Monica Gupta, Kumar Kallur, Madhusudhan Hassan, Ramesh Bilimagga
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Retreatment radiation as salvage therapy for progressive glioblastoma after bevacizumab failure
William Magnuson*, H. Ian Robins, Pranshu Mohindra, Steven Howard
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Salvage and primary stereotactic radiosurgery for breast cancer brain metastases: the impact of receptor status and time to treatment on clinical outcomes
Rebekah Young*, WF Mourad, Shyamal Patel, Jana Fox, Patrick A. LaSala, Linda Hong, Jerome J. Graber, Tamara Santiago, Shalom Kalnicki, Madhur Garg
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Stereotactic brachytherapy using iodine-125 as a treatment option for primary and recurrent anaplastic gliomas WHO°III
Maximilian I. Ruge*, Bogdana Suchorska, Christina Hamisch, Kerstin Mahnkopf, Ralf Lehrke, Harald Treuer, Volker Sturm, Juergen Voges
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Stereotactic proton therapy for pediatric supratentorial ependymoma: Early clinical outcomes
Daniel Indelicato*, Ronny Rotondo, Julie Bradley, Eric Sandler, Philipp Aldana, Nancy Mendenhall, Robert Marcus
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Stereotactic radiosurgery for brain metastases from lung cancer: the impact of post-SRS systemic therapy
Shyamal Patel*, Waleed Mourad, Rebekah Young, Rafi Kabarriti, Tamara Santiago, Jonathan Glanzman, Michael Bernstein, Asif Patel, Ravi Yaparpalvi, Linda Hong, Jana Fox, Patrick LaSala, Shalom Kalnicki, Madhur Garg
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Surgical resection of epidural disease improves local control following post-operative spine stereotactic body radiotherapy (SBRT)
Arjun Sahgal*, Ameen Al-Omair, Laura Masucci, Laurence Masson-Cote, Eshetu Atenafu, Daniel Letourneau, Eugene Yu, Raja Rampersaud, Stephen Lewis, Albert Yee, Isabelle Thibault, Michael Fehlings
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
TEMOFRAC, an innovative and novel irradiation schedule, concurrent 3-times daily ultrafractionated radiation therapy and temozolomide for newly inoperable glioblastoma
Patrick Beauchesne*, Guillaume Faure, Georges Noel, Thierry Schmitt, Laurent Martin, Eric Jadaud, Charlotte Carnin
Friday, November 22, Scientific Meeting:  Concurrent Session 2B - Adult Clinical Studies  -  1:00pm - 3:00pm
The utility of boron neutron capture therapy using reactor neutron for irradiated patients with recurrent malignant glioma
Ryo Hiramatsu*, Shinji Kawabata, Motomasa Furuse, Shin-Ichi Niyatake, Toshihiko Kuroiwa, Minoru Suzuki, Koji Ono
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
The incidence of brain metastases in correlation to dominant hemisphere and different brain lobes
Waleed F. Mourad*, Rafi Kabarriti, Rebekah Young, Tamara Santiago, Dukagjin M. Blakaj, Mary Welch, Jerome Graber, Shyamal Patel, Linda X. Hong, Asif Patel, Adesh Tandon, Michael B. Bernstein, Rania A. Shourbaji, Jonathan Glanzman, Merritt D. Kinon, Jana L. Fox, Patrick Lasala, Shalom Kalnicki, Madhur K. Garg
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Tumor location predicts for local control of brain metastases from non-small cell lung cancer treated with stereotactic radiosurgery
Adam Garsa*, Shahed Badiyan, Joseph Simpson, Joshua Dowling, Keith Rich, Michael Chicoine, Eric Leuthardt, Albert Kim, Clifford Robinson
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Tumor vascular damage and glioma stem-like cell expansion after radiotherapy in malignant gliomas
Kaoru Tamura*, Masaru Aoyagi, Noboru Ando, Takahiro Ogishima, Massaki Yamamoto, Kikuo Ohno, Taketoshi Maehara
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Treatment of large brain metastases with stereotactic radiosurgery (SRS)
Amy L. Zimmerman*, Michael A. Vogelbaum, Gene H. Barnett, Erin S. Murphy, John H. Suh, Lilyana Angelov, Chandana A. Reddy, Samuel T. Chao
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Very low dose stereotactic radiosurgery for vestibular schwannoma
Rohan Lall*, Rishi Lall, Timothy Smith, Andrew Schumacher, Addason McCaslin, John Kalapurakal, James Chandler
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Wide-field re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high grade glioma
Michael Back*, Marina Kastelan, Linxin Guo, Helen Wheeler
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
^Top
 
 
CLIN-Symptom Management/Quality of Life
Association of health-related quality of life and neurocognitive function with progression-free survival and progressive disease in patients with glioblastoma: A review of the literature
Alan Shilds, Somali Burgess, Arliene Ravelo*, Fiona Taylor, Iyar Mazar, Lauren Abrey
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Capitalizing on a unique opportunity: establishing a sustainable brain tumour support service in Melbourne, Australia
Dianne Legge*, Lawrence Cher
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Caregivers of long-term survivors of malignant brain tumors: a descriptive analysis
Christina Amidei*, Mary Lovely, Jean Arzbaecher, Margaretta Page, Kathy Mogensen, Kathy Lupica, Mary Ellen Maher
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Comparative impact of tumor and treatment on patient reported outcomes (PROs) in patients with glioblastoma (GBM) enrolled in RTOG 0825
Terri S. Armstrong*, Minhee Won, Jeffrey S. Wefel, Mark R. Gilbert, Stephanie Pugh, Meredith M. Wendland, David G. Brachman, Paul D. Brown, Ian R. Crocker, H. Ian Robins, R. Jeffrey Lee, Minesh Mehta
Saturday, November 23, Scientific Meeting:  Concurrent Session 7B - Neurocognitive Outcomes and Quality of Life  -  3:15pm - 5:00pm
Detection of nonconvulsive seizures in primary and secondary brain tumors
Jeffrey Kennedy, Wendy Sherman*, Indranil Sen-Gupta, Irena Garic, Michael Macken, Elizabeth Gerard, Jeffrey Raizer, Stephan Schuele
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Depression and survival in glioma: three-year follow-up data from a twin-centre prospective cohort study
Alasdair Rooney*, Cat Graham, Helen McKenzie, Mary Fraser, Mairi MacKinnon, Shanne McNamara, Roy Rampling, Alan Carson, Robin Grant
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Dermatologic event characteristics and management with the NovoTTF-100A System, a novel anti-mitotic device for the treatment of recurrent glioblastoma (rGBM)
Mario Lacouture*, Mary Elizabeth Davis, Grace Elzinga, Nicholas Butowski, David Tran, John Villano, Eric Wong
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Desires regarding childbearing in women with gliomas
Jessica Chan*, Jennifer Clarke, Kristen Lawton, Jane Rabbitt, Ashley DeSilva, Michael Prados, Mitchell Rosen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Distress and quality of life in patients with primary brain tumors  
Emily Porensky*, Robert Cavaliere, Herbert Newton
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Greater levels of depression and anxiety symptoms are associated with poor health related quality of life in adult brain tumor patients
Adomas Bunevicius*, Sarunas Tamasauskas, Arimantas Tamasauskas, Vytenis Deltuva, Robertas Bunevicius
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Health-related quality of life (HRQoL) analyses in the AVAglio study, a randomized, placebo-controlled phase III trial of bevacizumab, temozolomide and radiotherapy in newly diagnosed glioblastoma
Martin JB Taphoorn*, Roger Henriksson, Andrew Bottomley, Timothy Cloughesy, Wolfgang Wick, Warren Mason, Frank Saran, Ryo Nishikawa, Arliene Ravelo, Magalie Hilton, Olivier L Chinot
Saturday, November 23, Scientific Meeting:  Concurrent Session 7B - Neurocognitive Outcomes and Quality of Life  -  3:15pm - 5:00pm
Hopefulness in glioma patients
Alvina A. Acquaye*, Elizabeth Vera-Bolanos, Mark R. Gilbert, Terri S. Armstrong, Lin Lin
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Hospitalization burden and survival among elderly patients with glioblastoma
Nils Arvold*, Yun Wang, Cory Zigler, Deborah Schrag, Francesca Dominici
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Impacts of treatments on symptom burden in pituitary tumor patients
Mollie Oudenhoven, Casey Farin, Riane Hoffman, Terri Armstrong, Matthew Ewend, Jing Wu*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Long term quality of life after meningioma surgery of patients of different age groups
Matthias Seibl-Leven*, Klaus Wittenstein, Gabriele Röhn, Roland Goldbrunner, Marco Timmer
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Neuro oncology treatment and symptom management learning preferences for healthcare professionals.
Mary Lovely*, Diana Sullivan
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Neurocognitive assessment following whole brain radiation therapy and radiosurgery for patients with cerebral metastases
Susan McDuff, Zack Taich, Joshua Lawson, Parag Sanghvi, Eric Wong, Fred Hochberg, Jay Loeffler, Peter Warnke, Kevin Murphy, Arno Mundt, Bob Carter, Carrie McDonald, Clark Chen*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Nitrosourea based chemotherapy and radiotherapy for grade 2 and 3 gliomas do not affect fertility.
Soko Ikuta*, Yoshihiro Muragaki, Takashi Maruyama, Masayuki Nitta, Manabu Tamura, Saori Okamoto, Hiroshi Iseki, Yoshikazu Okada
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Normal tissue complication probability (NTCP) model of radiation-induced mood disruption
Ann M. Peiffer*, Aidan Burke, C. Marc Leyer, Elaine Shing, William T Kearns, William H Hinson, Doug Case, Steven R Rapp, Edward G Shaw, Michael D Chan
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Personal health records, symptoms, uncertainty and mood in brain tumor patients
Jennifer Cahill*, Lin Lin, Terri Armstrong, Alvina Acquaye, Elizabeth Vera-Bolanos, Mark Gilbert, Nikhil Padhye
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Prognostic awareness (PA) and communication of prognostic information in malignant glioma (MG): A systematic review
Eli Diamond*, Allison Applebaum, Geoffrey Corner, Antonio DeRosa, William Breitbart, Lisa DeAngelis
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Psychosocial support by medical social worker is beneficial for patients with malign brain tumors
Marianne Gröntoft, Giuseppe Stragliotto*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Recurrent stroke risk in childhood cancer survivors
Sabine Mueller*, Heather Fullerton, Kayla Stratton, Wendy Leisenring, Gregory Armstrong, Rita Weathers, Marilyn Stovall, Robert Goldsby, Charles Sklar, Leslie Robison, Kevin Krull
Friday, November 22, Scientific Meeting:  Plenary Session - Award Winning Abstracts  -  8:15am - 10:15am
Regional professional support network for primary malignant brain tumours
Dianne Legge*, Lawrence Cher, Kelly Mills
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Secondary primary headache syndromes in patients with glioma
Lawrence Cher*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Structure and reliability of the Dexamethasone Symptom Questionnaire-Chronic in primary or metastatic brain tumor patients
Elizabeth Vera-Bolanos*, Alvina A. Acquaye, Paul D. Brown, Caroline Chung, Mark R. Gilbert, Janette Vardy, Terri S. Armstrong
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Telemedicine and palliative care in neuro-oncology: web assistance for symptoms management and end of life support
Andrea Pace*, Veronica Villani, Silvia Focarelli, Dario Benincasa, Antonella Benincasa, Carmine Maria Carapella, Alfredo Pompili
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The change of uncertainty over time in patients with primary brain tumors (PBTs)
Lin Lin*, Alvina Acquaye, Elizabeth Vera-Bolanos, Mark Gilbert, Terri Armstrong
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The development of a patient and family quality of life monitor
Petra Hoogendoorn*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The effect of modafinil on fatigue, cognitive functioning and mood in primary brain tumor patients: a multi-center RCT
Florien Boele*, Linda Douw, Marjolein de Groot, Hinke van Thuijl, Wilmy Cleijne, Jan Heimans, Martin Taphoorn, Jaap Reijneveld, Martin Klein
Saturday, November 23, Scientific Meeting:  Concurrent Session 7B - Neurocognitive Outcomes and Quality of Life  -  3:15pm - 5:00pm
The Ependymoma Outcomes (EO) Project II: symptoms and socio-economic impact
Tobias Walbert*, Tito Mendoza, Elizabeth Vera-Bolaños, Mark Gilbert, Alvina Acquaye, Terri Armstrong
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The extent, associations, and longitudinal course of distress and fatigue in glioma outpatients
Alasdair Rooney*, Lotte Heimans, Sarah Woltz, Simon Kerrigan, Shanne McNamara, Robin Grant, The University of Edinburgh SSC4 Medical Student Group
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The Neuro-oncology care coordinator: a key role in facilitating complex care
Wafa Trad*, Teresa Simpson, Kylie Wright, Thanh Tran, Callie Choong, Michael Barton, Elizabeth Hovey, Karen Robinson, Eng-Siew Koh
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Utilization patterns of palliative care in neuro-oncology - results of an international provider survey
Tobias Walbert*, Michael Glantz, Lonni Schultz, Vinay K. Puduvalli
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
^Top
 
 
CLIN-Medical + Radiation Therapies
A model for survival from glioblastoma multiforme in a cohort of consecutive non-selected patients from a single institution
Signe Regner Michaelsen, Ib Jarle Christensen*, Kirsten Grunnet, Marie-Thérése Stockhausen, Helle Broholm, Michael Kosteljanetz, Hans Skovgaard Poulsen
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A phase 1 study of Repeat rAdiation, Minocycline, and Bevacizumab in patients with recurrent gliOma (RAMBO)
Adam L. Cohen*, Christopher Anker, Dennis Shrieve, Britney Hall, Karen Salzman, Randy Jensen, Howard Colman
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A phase II randomized study of TTFields therapy versus supportive care in non-small cell lung cancer (NSCLC) patients with 1-3 brain metastases (BM) following stereotactic radio-surgery (SRS)
Uri Weinberg*, Ori Farber, Yoram Palti
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A pilot phase II trial of hypofractionated intensity-modulated radiation therapy (hypo-IMRT) combined with temozolomide (TMZ) and bevacizumab (BEV) for patients with newly diagnosed glioblastoma multiforme (GBM)
Douglas Ney*, Julie Carlson, Denise Damek, Patrick Blatchford, Laurie Gaspar, Brian Kavanagh, Allen Waziri, Kevin Lillehei, Krishna Reddy, Changhu Chen
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A randomized phase II study on bevacizumab versus bevacizumab plus lomustine versus lomustine single agent in recurrent glioblastoma: the Dutch BELOB study
Walter Taal, H Oosterkamp, Annemieke Walenkamp, Lucas Beerenpoot, Monique Hanse, Jan Buter, Aafke Honkoop, Dolf Boerman, Filip de Vos, R Jansen, Franchette van der Berkmortel, Dieta Brandsma, Roelien Enting, Johan Kros, Jacoline Bromberg, Irene van Heuvel, Marion Smits, Ronnie van der Holt, Rene Vernhout, Martin van den Bent*
Friday, November 22, Scientific Meeting:  Concurrent Session 2B - Adult Clinical Studies  -  1:00pm - 3:00pm
Adult medulloblastoma: survival, recurrence, and prognostic factors
Andrew J. Song*, Aryavarta M.S. Kumar, Erin S. Murphy, Tanya Tekautz, John H. Suh, Violette Recinos, Samuel T. Chao
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Aflibercept induced thrombotic microangiopathy in a patient with malignant glioma
Navya Nambudiri*, Lakshmi Nayak, Debra LaFrankie, Patrick Wen
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Bevacizumab for progressive radiation necrosis with the nuclear medicine diagnosis: institutional results and ongoing nation-wide clinical trial
Shin-Ichi Miyatake*, Motomasa Furuse, Tomo Miyata, Erina Yoritsune, Shinji Kawabata, Toshihko Kuroiwa
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Bevacizumab, irinotecan and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: updated results from the randomized multicenter GLARIUS trial
Ulrich Herrlinger*, Niklas Schäfer, Joachim Steinbach, Anja Weyerbrock, Peter Hau, Roland Goldbrunner, Ralf Kohnen, Horst Urbach, Walter Stummer, Martin Glas
Friday, November 22, Scientific Meeting:  Concurrent Session 2B - Adult Clinical Studies  -  1:00pm - 3:00pm
Biomarkers for the prediction of venous thromboembolism in patients with malignant gliomas
Christine Marosi*, Johannes Thaler, Cihan Ay, Alexandra Kaider, Eva-Maria Reitter, Johanna Haselböck, Matthias Preusser, Birgit Flechl, Christoph Zielinski, Ingrid Pabinger
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Cilengitide in combination with standard treatment for patients with newly diagnosed glioblastoma with unmethylated O6-methylguanine-DNA methyltransferase (MGMT) gene promoter: key results of the open-label, controlled, randomized phase II CORE study
Louis Burt Nabors*, Karen L Fink, Tom Mikkelsen, Dana Grujicic, Rafal Tarnawski, Do-Hyun Nam, Maria Mazurkiewicz, Michael Salacz, Lynn Ashby, Laszlo Thurzo, Vittorina Zagonel, Roberta Depenni, James R Perry, Jean Henslee-Downey, Martin Picard, David A Reardon
Friday, November 22, Scientific Meeting:  Concurrent Session 2B - Adult Clinical Studies  -  1:00pm - 3:00pm
Favorable responses with biweekly Bevacizumab and Irinotecan in children with recurrent high and low-grade gliomas
Gauri Sunkersett*, Ziad Khatib
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Final results of a single-institution phase II trial of radiation (RT), temozolomide (TMZ), erlotinib and bevacizumab for initial treatment of glioblastoma (GBM)
Jennifer Clarke*, Annette Molinaro, Joanna Phillips, Nicholas Butowski, Susan Chang, Arie Perry, Joseph Costello, Ashley DeSilva, Jane Rabbitt, Michael Prados
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Final results of open-label, dose confirmation study of interstitial Cotara (131I-chTNT-1/b MAb) for the treatment of glioblastoma multiforme (GBM) at first relapse
William Shapiro*, Swaroop Gopal, Kevin Judy, Sunil Patel, Ashok Mahapatra, Joseph Shan, Deepak Gupta
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Glycemia impacts survival of glioblastoma patients treated with radiation and temozolomide
Mimi Tieu, Erik Lovblom, Mairead Macnamara, Warren Mason, Danielle Rodin, Elizabeth Tai, Kuldesh Ubhi, Normand Laperriere, Barbara-Ann Millar, Cynthia Menard, Bruce Perkins, Caroline Chung*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
HDAC inhibitor Scriptaid and proteasome inhibitor G5 synergistically enhance cell death in malignant glioma cell cultures
Jochem Spoor*, Khoshal Korami, Jenneke Kloezeman, Rutger Balvers, Clemens Dirven, Martine Lamfers, Sieger Leenstra
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
High survival in glioblastoma patients receiving oral antiviral therapy against cytomegalovirus
Cecilia Söderberg-Naucler*, Afsar Rahbar, Giuseppe Stragliotto
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Induction chemotherapy prior to whole brain radiotherapy in lung cancer with synchronous brain metastases reduces intracranial progression of disease without negatively impacting survival outcomes
Supriya Jain*, Edward Melian, Anil Sethi, Kathy Albain, Danielle Shafer, Bahman Emami
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
MRI-based maps differentiating tumor from non tumoral tissues: potential for improved management of patients with high grade gliomas
Leor Zach*, David Guez, David Last, Dianne Daniels, Ouzi Nissim, Yuval Grober, Chen Hoffmann, Dvora Nass, Alisa Talianski, Roberto Spiegelmann, Zvi Cohen, Yael Mardor
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Outcomes of screen-failures from a single institution in an international co-operative group trial in patients with newly diagnosed glioblastoma
Tejpal Gupta*, Vimoj Nair, Sridhar Epari, Jayant Godasastri, Aliasgar Moiyadi, Prakash Shetty, Shashikant Juvekar, Rakesh Jalali
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase 1 dose escalation trial of the safety and pharmacokinetics (PK) of cabozantinib (XL184) concurrent with temozolomide (TMZ) & radiation (RT) or TMZ Post-RT in newly diagnosed high-grade gliomas (HGG)
David Schiff*, Annick Desjardins, Timothy Cloughesy, Tom Mikkelsen, Michael Glantz, Marc Chamberlain, David A Reardon, Patrick Wen
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase 1b/2a study evaluating safety, pharmacokinetics and pharmacodynamics responses of the oral transforming growth factor-beta (TGF-β) receptor I kinase inhibitor LY2157299 monohydrate combined with chemoradiotherapy in newly diagnosed malignant gliomas
Wolfgang Wick*, Cristina Suarez, Jordi Rodon, Annick Desjardins, Peter Forsyth, Ivelina Gueorguieva, Ann Cleverly, Tiana Burkholder, Durisala Desaiah, Michael Lahn
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase I/II study of VAL-083 in patients with recurrent malignant glioma or progressive-secondary brain tumor
Kent Shih*, Jeffrey A. Bacha, Dennis Brown, William J. Garner, Anne Steino, Richard Schwart, Sarath Kanekal, Mike Li, Lorena Lopez, Howard A. Burris, III
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors
Yoshihiro Muragaki*, Takashi Maruyama, Hiroshi Iseki, Jiro Akimoto, Soko Ikuta, Masayuki Nitta, Katsuya Maebayashi, Taiichi Saito, Yoshikazu Okada, Sadao Kaneko, Akira Matsumura, Toshihiko Kuroiwa, Katsuyuki Karasawa, Yoichi Nakazato, Takamasa Kayama
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase II pilot study of VELCADE® (Bortezomib) in combination with Temozolomide and regional radiation therapy for upfront treatment of patients with newly-diagnosed glioblastoma multiforme
Xiao-Tang Kong*, Stacey Green, Emese Filka, Richard Green, William Yong, Phioanh Nghiemphu, Timothy Cloughesy, Albert Lai
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase III trial of Tumor Treating Fields (TTFields) together with temozolomide(TMZ) compared to temozolomide alone in patients with newly diagnosed glioblastoma (GBM)
Ori Farber*, Uri Weinberg, Yoram Palti
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Primary central nervous system lymphoma- clinical experience from a regional cancer centre in north India
Imtiaz Ahmed*, Ahitagni Biswas, Sapna Krishnamurthy, PK Julka, GK Rath
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Proliferation index rather than presence of residual tumour predicts for median survival following second craniotomy within six months of adjuvant radiation therapy for high-grade glioma
Michael Back*, Denise Huang, Cecilia Gzell, Jason Chen, Marina Kastelan, Pankaj Gaur, Helen Wheeler
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Radiation recall of the central nervous system in two pediatric patients with aytpical teratoid/rhabdoid tumor
Rebecca Rusch*, Meghan Belongia, Mohit Maheshwari, Selim Firat
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Radiotherapy dose-escalation for glioblastoma multiforme in the era of temozolomide
Shahed N Badiyan*, Clifford G Robinson, Joseph R Simpson, David D Tran, Keith M Rich, Joshua L Dowling, Michael R Chicoine, Eric C Leuthardt, Albert H Kim, Jiayi Huang
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Recurrence of Cushing's disease following pituitary irradiation: A literature survey
Chioma Iweha*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Retrospective study in primary central nervous system lymphoma (PCNSL): impact of treatment strategies of the last 20 years
Omar Iskanderani*, Françoise Izar, Alexandra Benouaich-Amiel, Thomas Filleron, Elisabeth Moyal
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Rituximab, methotrexate, procarbazine, vincristine and intensified cytarabine consolidation for primary CNS lymphoma (PCNSL) in the elderly: a LOC national network study (INCa)
Caroline Houillier*, Herve Ghesquieres, Cecile Chabrot, Carole Soussain, Guido Ahle, Sylvain Choquet, Pierre Faurie, Jacques-Olivier Bay, Jacques Vargaftig, Claude Gaultier, Emmanuelle Nicolas-Virelizier, Khe Hoang-Xuan
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
RTOG 0424: Phase II study of a temozolomide (TMZ)-based chemo-radiotherapy (RT) regimen for high risk low-grade gliomas (LGGs) preliminary results including quality of life (QOL) and neurological function (NCF)
Barbara Fisher*, Hu Chen, David Macdonald, Glenn Lesser, Stephen Coons, Daniel Brachman, Samuel Ryu, Maria Werner-Wasik, Jean-Paul Bahary, Arnab Chakravarti, Minesh Mehta
Saturday, November 23, Scientific Meeting:  Concurrent Session 7B - Neurocognitive Outcomes and Quality of Life  -  3:15pm - 5:00pm
Spine radiosurgery for metastatic tumors: initial experience at St. Luke's Medical Center-Philippines
Chandra Man Prajapati, Emmanuel Enrique Magalona, Manuel Mariano, Ibet Marie Sih, Roy Torcuator*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Supratentorial primitive neuroectodermal tumor- clinical experience from a regional cancer centre in north India
Supriya Mallick*, Ahitagni Biswas, Soumyajeet Roy, Suvendu Purkait, Subhash Gupta, P K Julka, G K Rath
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Survival outcomes and prognostic considerations of stereotactic radiosurgery in the treatment of recurrent malignant gliomas with and without bevacizumab
Issra Rashed*, Edward Melian, Anil Sethi, Kevin Barton, Doug Anderson, Vikram Prabhu
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Use of NovoTTF-100ATM  in heavily pre-treated patients with relapsed high grade glioma: a retrospective chart review 
Ashley Sumrall*, Daniel Haggstrom, Anthony Crimaldi, James Symanowski, Pierre Giglio, Anthony Asher, Stuart Burri
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
^Top
 
 
CLIN-Epidemiology
Predictive Factors for Brain Metastases and Relapse and Prognostic Factors for Survival in Stage III-IV Non-Small Cell Lung Cancer (NSCLC)
H. Yoon*, O. Offor, I. Helenowski, R. Bhandari, K. Raparia, M. Marymont, M. DeCamp, A. de Hoyos, J. Chandler, B. Bendok, S. Chmura, M. Mehta
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
A retrospective study: the incidence of glioblastoma within the Scott & White Healthcare integrated system from 1976-2011
Jennifer Griffin*, Richard Tobin, M.Karen Newell-Rogers, Eromata Ebwe, Ekokobe Fonkem
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Adolescent primary CNS tumors – different from tumors in younger patients?  One institution experience
Bozenna Dembowska-Baginska*, Ewa Swieszkowska, Monika Drogosiewicz, Marta Perek- Polnik, Iwona Filipek, Marta Grudzińska, Wieslawa Grajkowska, Danuta Perek
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Atopic conditions, antihistamine use, and glioma risk: Preliminary results from the Glioma International Case-Control Study
E. Susan Amirian*, Michael E. Scheurer, Margaret Wrensch, Sara H. Olson, Rose Lai, Daniel Lachance, Georgina Armstrong, Renke Zhou, Joseph Wiemels, Ching Lau, Elizabeth Claus, Jill Barnholtz-Sloan, Dora Il'yasova, Joellen Schildkraut, Richard Houlston, Sanjay Shete, Jonine Bernstein, Robert Jenkins, Faith Davis, Ryan Merrell, Christoffer Johansen, Siegal Sadetzki, The Gliogene Corsortium, Beatrice Melin, Melissa Bondy
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Disseminated glioblastoma multiforme in a child with thoracolumbar spinal cord pilocytic astrocitoma
Andreza Senerchia*, Sabrina Eleuterio, Emanuella Souza, Andrea Cappellano, Teresa Seixas, Sergio Cavalheiro, Nasjla Saba
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Glioblastoma survival in the Unites States improved following FDA approval of bevacizumab
Derek Johnson*, Heather Leeper, Joon Uhm
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Incidence of glioblastoma multiforme (GBM) is higher in white collar workers compared to lower grade gliomas
Adrian Lee*, Michael Back, Cecilia Gzell, Marina Kastelan, Helen Wheeler
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Incidence of neoplastic lesions treated surgically in the last two years in the Department of Neurosurgery and Neurological Endovascular Therapy, University Hospital Dr. José Eleuterio González, México
Armando Torres-Carranza*, Luis Carlos Canales-Martínez, Samuel Pérez-Cárdenas, Ivette Miranda-Maldonado, Oralia Barbosa-Quintana, Angel Martínez-Ponce de León
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Intracranial germ cell tumors in children: Experience at Taipei VGH 1971-2010
Tai-Tong Wong*, Donald M. Ho, Kai-Ping Chang, Sang-Hue Yen, Wan-You Guo, Feng-Chi Chang, Muh-Lii Liang, H-Hung sin Chen, Yi-Wei Chen, David Hung-Chi Pan, Wen-Yuh Chung
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Intracranial meningiomas in individuals under 30 years of age
Vikram Prabhu*, Edward Perry, Edward Melian, Kevin Barton, John Lee, Douglas Anderson
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Pineal region tumor in children. Is the gross resection necessary? A single centre experience
Enrique López, Carolina Sepulveda, Jaime Diego-Perez, Yadira Betanzos, Andrea Ponce de Leon*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Population based analysis of patients with ependymoma diagnosed in Alberta from 1975  to 2007
Gloria Roldán Urgoiti*, Amitabh Singh, Roger Y Tsang, Robert Nordal, Gerald Lim, Jennifer Chan, Yves Starreveld, Paula de Robles, Bradley Biagioni, Mark Hamilton, Jacob Easaw
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Population-based incidence and survival for primary central nervous system lymphoma in Korea, 1999-2009
Heon Yoo*, Kyu-Won Jung, Seung Hoon Lee, Sang-Hoon Shin, Johyun Ha, Young-Joo Won
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Rapid multi-focal development of aggressive meningiomas in an elderly male following androgen deprivation therapy for high-risk prostate cancer
Jonathan Wallach*, Patrick LaSala, Shalom Kalnicki, Madhur Garg
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Spectrum of neurologic presentations of intravascular lymphoma: a 643 patient study
Paul Bricker, Ekokobe Fonkem*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Survival factors in children with central nervous system brain tumors in California between 1988 and 2009
Katrina Flores*, John Crawford, David Piccioni, Hector Lemus, Suzanne Lindsay, Santosh Kesari
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
survMisc: An R package to facilitate survival analysis
Christopher Dardis*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The incidence of astrocytoma at an integrated health care system: the experience of Scott & White Health Care System.
Eromata Ebue, Juhee Song, Frank Harris, Nitika Thawani, Pier Luigi DiPatre, M. Karen Newell-Rogers, Ekokobe Fonkem*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Tumors of the pituitary: is incidence rising?
Haley Gittleman*, Carol Kruchko, Quinn Ostrom, Yanwen Chen, Paul Farah, Annie Ondracek, Yingli Wolinsky, Jill Barnholtz-Sloan
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Twenty years of treating children with malignant pontine glioma: What have we done?
Sophie Veldhuijzen van Zanten*, Marc Jansen, Dannis van Vuurden, Peter Vandertop, Gert Jan Kaspers
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
VGKC autoimmunity: Are we missing patients who can benefit from immunotherapy?
Yoshie Umemura*, Lara Ronan
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
What can radiographic diagnosis tell us about meningioma?
Quinn Ostrom*, Carol Kruchko, Haley Gittleman, Yanwen Chen, Annie Ondracek, Paul Farah, Yingli Wolinsky, Jill Barnholtz-Sloan
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
^Top
 
 
CLIN-Pediatrics Clinical Research
2 cases of ependymoma with extracranial extension
Mario Suzuki*, Akihide Kondo, Masakazu Miyajima, Hajime Arai
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A multi-institutional experience in pediatric high grade glioma
Steve Walston*, Terence Williams, Daniel Hamstra, Kevin Oh, Christopher Pelloski
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Analysis of the Wnt5b signaling pathway to identify novel therapeutics for atypical teratoid rhabdoid tumors
Ratan Bhardwaj*, Chris Hampton, Victor Ozols, Madhavi Chakravadhanula
Saturday, November 23, Scientific Meeting:  Concurrent Session 7A - Pediatric Basic and Translational Research  -  3:15pm - 5:00pm
Atypical Teratoid Rhabdoid Tumor (ATRT): Improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna experience 1992-2012
Irene Slavc*, Monika Chocholous, Ulrike Leiss, Christine Haberler, Andreas Peyrl, Amedeo A. Azizi, Karin Dieckmann, Adelheid Woehrer, Christian Dorfer, Thomas Czech
Friday, November 22, Scientific Meeting:  Concurrent Session 3B - Pediatric Clinical  -  3:15pm - 5:00pm
C19MC amplified tumours: a new histo-genetic and diagnostic entity
Tara Spence*, Daniel Picard, Mark Barszczyk, Seung-Ki Kim, Young-Shin Ra, Jason Fangusaro, Helen Toledano, Hideo Nakamura, Lucy Lafay-Cousin, Xing Fan, Karin M. Muraszko, Ho-Keung Ng, Eric Bouffet, William Halliday, Mary Shago, Cynthia E. Hawkins, Annie Huang
Friday, November 22, Scientific Meeting:  Concurrent Session 2A - Pathology/Genomics  -  1:00pm - 3:00pm
Cenvection Enhanced Delivery (CED) of carmustin in children with diffuse intrinsic pontine glioma (DIPG)
Sophie Veldhuijzen van Zanten*, Marc Jansen, Dannis van Vuurden, Esther Hulleman, Sander Idema, David Noske, Nicole Wolf, Harry Hendrikse, Peter Vandertop, Gert Jan Kaspers
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Clinical significance and limitations of repeat resection for pediatric malignant neuroepithelial tumors
Toshihiro Kumabe*, Tomohiro Kawaguchi, Ryuta Saito, Masayuki Kanamori, Yoji Yamashita, Yukihiko Sonoda, Teiji Tominaga
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Craniospinal irradiation with concurrent metronomic temozolomide for the treatment of primary metastatic high-grade or diffuse intrinsic pontine gliomas in children: experiences from the German multicenter HIT-HGG 2007 trial
Klaus Müller, Annika Schlamann, Monika Warmuth-Metz, Torsten Pietsch, Sophie Pietschmann, Rolf-Dieter Kortmann, Christof M. Kramm, André O. von Bueren*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Disseminated PNET with an unusual presentation and course
Reuben Antony*, Michael Zagardo, Meena Gujrati, Julian Lin
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Effects of treatment modality on health related quality of life (HRQOL) in long-term survivors of pediatric low grade glioma (LGG)
Chika Nwachukwu*, Ryan Youland, Nadia Laack
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Feasibility, risk profile and diagnostic yield of stereotactic biopsy in the pediatric population
Maximilian I. Ruge*, Tobias Blau, Vanessa Hafkemeyer, Christina Hamisch, Katharina Klinger, Thorsten Simon
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Glioblastoma multiforme with primitive neuro-ectodermal-like components (GBM-PNET): clinical course and management of three pediatric cases
Nathan Robison*, Girish Dhall, Robert Brown, Timothy Cloughesy, Tom Belle Davidson, Mark Krieger, Mitchel Berger, Kenneth Wong, Arie Perry, Floyd Gilles, Jonathan Lester Finlay
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
HERBY: a phase II comparative study of bevacizumab-based therapy in children with high-grade glioma
Jacques Grill*, Darren Hargrave, Maura Massimino, Tim Jaspan, Pascale Varlet, Chris Jones, Paul Morgan, Marie Cecile Le Deley, Amedeo Azizi, Adela Cañete, Eric Bouffet, Frank Saran, Jeanette Bachir, Lida Bubuteishvili-Pacaud, Raphael Rousseau, Gilles Vassal
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Immunohistochemical evaluation for the pathogenesis of intracranial germ cell tumors: expression of pluripotency and cell differentiation markers
Tadashi Miyagawa*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Irinotecan with carboplatin- an alternative therapeutic option for children with high grade gliomas (HGG). One institution experience
Iwona Filipek, Monika Drogosiewicz, Marta Perek- Polnik, Ewa Swieszkowska, Bozenna Dembowska-Baginska, Elzbieta Jurkiewicz, Danuta Perek*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Late causes of death in survivors of childhood medulloblastoma
Eric Shinohara*, Stephanie Perkins, Todd DeWees
Friday, November 22, Scientific Meeting:  Concurrent Session 3B - Pediatric Clinical  -  3:15pm - 5:00pm
MDACC experience with clinical and molecular heterogeneity in pediatric pilocytic astrocytoma
Zsila Sadighi*, Benjamin Ellezam, Michele Guindani, Joann Ater
Friday, November 22, Scientific Meeting:  Concurrent Session 3B - Pediatric Clinical  -  3:15pm - 5:00pm
Medulloblastoma in the operative theater: are they playing according to their subtypes?
Sebastien Perreault*, Kevin Chao, Vijay Ramaswamy, David Shih, Marc Remke, Betty Luu, Simone Schubert, Paul Fisher, Sonia Partap, Hannes Vogel, Michael Taylor, Liliana Goumnerova, Yoon-Jae Cho
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Non-germinomatous germ cell tumors of the central nervous system in children: a single institution experience
Nathan Robison*, Nitika Dhir, Jyotsana Khemani, Kenneth Wong, Shveta Gupta, Barbara Britt, John Grimm, Jonathan Finlay, Girish Dhall
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Pediatric Multidisciplinary Neuro-Oncology Program translates into improvement of  survival rates of children with central nervous system (CNS) tumors. Polish experience
Danuta Perek*, Bozenna Dembowska-Baginska, Monika Drogosiewicz, Marta Perek- Polnik, Wieslawa Grajkowska, Marcin Roszkowski, Grazyna Sobol, Katarzyna Musiol, Jacek Wachowiak, Bogna Kazmierczak, Jaroslaw Peregud - Pogorzelski, Wojciech Młynarski, Beata Zalewska- Szewczyk, Mariusz Wysocki, Ewa Niedzielska, Jerzy Kowalczyk, Hanna Wiśniewska - Slusarz, Walentyna Balwierz, Ewa Zaleska - Czepko, Anna Szołkiewicz
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Pediatric spinal cord astrocytomas: a single institution experience
Shveta Gupta*, Nathan Robinson, Nitika Dhir, Kenneth Wong, Shengmei Zhou, Jonathan Finlay, Girish Dhall
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase I Trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system (CNS) tumors
Girish Dhall*, Kelley Haley, Jonathan Finlay, Teresa Rushing, Richard Sposto, Robert Seeger
Friday, November 22, Scientific Meeting:  Concurrent Session 3B - Pediatric Clinical  -  3:15pm - 5:00pm
Pilomyxoid astrocytoma: impact of pre-emptive chemotherapy
James Garvin*, Karishma Rupani, Eileen Stark, Richard Anderson, Neil Feldstein
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Rosette forming glioneuronal tumors (RGNT) - different outcomes in two patients with diffuse tumors
Reuben Antony*, Mohamad Al-Rahawan, Michael Zagardo, Meena Gujrati, Julian Lin, Alberto Broniscer
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
The metastasis theory of medulloblastoma
Yuzaburo Shimizu*, Hajime Arai, Masakazu Miyajima, Kazuaki Shimoji, Akihide Kondo
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Treatment results of metastatic medulloblastoma (M2 and M3 according to Chang classification)  in children over 3 years of age.   Experience from one  institution
Danuta Perek*, Marta Perek-Polnik, Bozenna Dembowska-Baginska, Monika Drogosiewicz, Wieslawa Grajkowska, Maria Lastowska, Marzanna Chojnacka, Iwona Filipek, Magdalena Tarasinska, Marcin Roszkowski
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Very long-term survival of paediatric low grade glioma patients; possible role of BRAF-KIAA1549 fusion
Nataliya Zhukova*, Jason Pole, Matthew Mistry, Iris Fried, Ute Bartels, Annie Huang, Normand Lapperiere, Peter Dirks, Katrin Scheinemann, Jason An, Noa Alon, Paul Nathan, Mark Greenberg, Eric Bouffet, David Malkin, Cynthia Hawkins, Uri Tabori
Saturday, November 23, Scientific Meeting:  Concurrent Session 7A - Pediatric Basic and Translational Research  -  3:15pm - 5:00pm
Weekly vinblastine in chemotherapy naive children and adolescent with unresectable or progressive low grade glioma: a Canadian cooperative study
Eric Bouffet*, Cynthia Hawkins, Katrin Scheinemann, Shayna Zelcer, Donna Johnston, Lucie Lafay-Cousin, Valerie Larouche, Nada Jabado, Anne Sophie Carret, Juliette Hukin, David Eisenstat, Gregory Pond, Ken Poskitt, Beverley Wilson, Ute Bartels, Uri Tabori
Saturday, November 23, Scientific Meeting:  Plenary Session 5 - Award Winning Abstracts  -  10:45am - 11:30am
^Top
 
 
CLIN-Pathology
A new IDH1/2 PCR assay for one-step detection of 12 IDH1 and IDH2 mutations in glioma
Hélène Girardi, Florence Monville, Sabrina Carpentier, Marine Giry, Jesse Voss, Robert Jenkins, Blandine Boisselier, Véronique Frayssinet, Cécile Poggionovo, Aurélie Catteau, Karima Mokhtari, Marc Sanson, Hélène Peyro-Saint-Paul, Caterina Giannini*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A novel paradigm for determining molecular correlates of tumor cell morphology in human glioma whole slide images
Jun Kong*, Lee Cooper, Fusheng Wang, Jingjing Gao, George Teodoro, Lisa Scarpace, Tom Mikkelsen, Matthew Schniederjan, Carlos Moreno, Joel Saltz, Daniel Brat
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A predictive model of IDH mutation probability in gliomas
Zoya Voronovich*, Li Chen, Kenneth Clark, Meggen Walsh, Jonathan Mannas, Craig Horbinski
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Application of rapid IDH1 gene mutation analysis for pathological diagnosis during glioma surgery
Jun-ichi Adachi*, Kyoko Totake, Mitsuaki Shirahata, Kazuhiko Mishima, Tomonari Suzuki, Takaaki Yanagisawa, Kohei Fukuoka, Ryo Nishikawa
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Astrocytoma biomarkers of diagnostic and prognostic significance - immunohistochemical validation study
Vani Santosh*, Balaram Thota, MR Srividya, K Sravani, SD Shwetha, A Arivazhagan, K Thennarasu, BA Chandramouli, AS Hegde, Paturu Kondaiah, Kumaravel Somasundaram, MRS Rao
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Association between symptom duration and survival in children with brain tumors
Robert Lober*, Louis Lu, Melanie Hayden Gephart, Paul Fisher
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
ATRX loss refines the classification of anaplastic gliomas and identifies a subgroup of IDH mutant astrocytic tumors with better prognosis
Benedikt Wiestler*, David Capper, Tim Holland-Letz, Andrey Korshunov, Andreas von Deimling, Stefan Michael Pfister, Michael Platten, Michael Weller, Wolfgang Wick
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
BRAF V600E mutation is associated with mTOR signalling activation in glioneuronal tumors
AS Prabowo*, AM Iyer, TJ Veersema, JJ Anink, AYN Schouten-van Meeteren, WGM Spliet, PC van Rijen, TJC Ferrier, D Capper, M Thom, E Aronica
Friday, November 22, Scientific Meeting:  Concurrent Session 2A - Pathology/Genomics  -  1:00pm - 3:00pm
BRAF-V600E mutation in pediatric and adult glioblastomas 
Sonika Dahiya*, Ryan Emnett, Joanna Phillips, Devon Haydon, Jeffrey Leonard, Arie Perry, David Gutmann
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Clinical characteristics of glioblastoma occuring in the thalamic area 
Takuichiro Hide*, Hideo Nakamura, Keishi Makino, Shigetoshi Yano, Shigeo Anai, Naoki Shinojima, Jun-ichiro Kuroda, Tatsuya Takezaki, Jun-ichi Kuratsu
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Clinical features and prognostic impact of immunohistochemical subtypes of primary CNS lymphoma
Takanori Ohnishi*, Hironobu Harada, Shiro Ohue, Shohei Kouno, Akihiro Inoue, Daisuke Yamashita
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
C-met is a new prognostic biomarker in glioblastoma patients
Stine Asferg Petterson*, Simon Kjær Hermansen, Rikke Hedegaard Dahlrot, Steinbjørn Hansen, Bjarne Winther Kristensen
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
CNS lymphomas: geographical variations and effect of steroids on histological diagnosis
Arivazhagan Arimappamagan*, N Manoj, Anita Mahadevan, DI Bhat, HR Arvinda, B Indiradevi, Sampath Somanna, BA Chandramouli
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Critical role of IGFBP isoforms  and their downstream signaling pathways in glioblastoma pathogenesis
Vani Santosh*, VR Praveen Kumar, Balaram Thota, Arun Shastry, A Arivazhagan, K Thennarasu, Paturu Kondaiah
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Correlation of genetic signatures and histological subtypes of meningiomas
Sacit Bülent Omay*, Jennifer Moliterno Günel, Victoria E. Clark, Jie Li, E. Zeynep Erson Omay, Akdes Serin, Luis E. Kolb, Ryan M. Hebert, Kaya Bilgüvar, Koray Özduman, M. Necmettin Pamir, Türker Kilic, Joachim Baehring, Joseph M. Piepmeier, Cameron W. Brennan, Jason Huse, Philip H. Gutin, Katsuhito Yasuno, Alexander Vortmeyer, Murat Günel
Friday, November 22, Scientific Meeting:  Concurrent Session 2A - Pathology/Genomics  -  1:00pm - 3:00pm
Evaluation of H3K27me3 and EZH2 in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant GBM
Sriram Venneti*, Mihir Garimella, Lisa Sullivan, Daniel Martinez, Jason Huse, Adriana Heguy, Mariarita Santi, Craig Thompson, Alexander Judkins
Saturday, November 23, Scientific Meeting:  Concurrent Session 7A - Pediatric Basic and Translational Research  -  3:15pm - 5:00pm
Expression patterns of Insulin-like growth factor binding protein (IGFBP) isoforms in medulloblastoma subtypes and clinical correlation.
Arun Shastry*, Reshma Narayan, Balaram Thota, Sampath Somanna, Kandavel Thennarasu, Arimappamagan Arivazhagan, Vani Santosh
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Hemangiopericytomas in central nervous system: a multicenter study of  Korean cases
Junjeong Choi*, Sung-Hye Park, Shin Kwang Khang, Yeon-Lim Suh, Sang Pyo Kim, Youn Soo Lee, Se Hoon Kim
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Histological and angiogenic changes after bevacizumab treatment in recurrent malignant gliomas
Saori Okamoto*, Masayuki Nitta, Yoshihiro Muragaki, Takashi Maruyama, Tatsuo Sawada, Takashi Komori, Taichi Saito, Yoshikazu Okada
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
IDH1 mutations, EGFR gene amplification and MGMT gene promoter methylation in gliosarcomas : series of 31 cases with clincopathological features
Sridhar Epari*, Sharique Ahmed, Mamta Gurav, Swati Raikar, Aliasgar Moiyadi, Prakash Shetty, Tejpal Gupta, Rakesh Jalali
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Immediate screening of glioblastoma biospecimens with confocal reflectance microscopy to improve the quality of biobanked specimens
Joseph Georges*, Aqib Zehri, Elizabeth Carlson, Nikolay Martirosyan, Ali Elhadi, Joshua Nichols, Layla Ighaffari, Jennifer Eschbacher, Burt Feuerstein, Trent Anderson, Mark Preul, Kendall Jensen, Peter Nakaji
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Intertumoral heterogeneity of EGFRvIII expression in glioblastoma multiforme and potential implications for the AMG 595 Phase 1 clinical trial
Suzanne Coberly*, Kimberly Samayoa, Yi Liu, Panteha Kiaei, John Hill, Scott Patterson, Michael Damore
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Oligoastrocytoma can be devided to three subgroups by molecular markers and histological features.
Fumi Higuchi*, Hadzuki Matsuda, Kayoko Iwata, Keisuke Ueki, Phyo Kim
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Pathology concordance levels for meningioma classification and grading in RTOG Trial 0539
Arie Perry*, Stephanie Pugh, C. Leland Rogers, David Brachman, William McMillan, Joseph Jenrette, Igor Barani, Dennis Shrieve, Andrew Sloan, Minesh Mehta
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Predicting progressive gangliogliomas: early identification of those at risk in a sample of 156 consecutive patients treated at the Barrow Neurological Institute
Glynnis Zieman*, Christopher Dardis, Lynn Ashby, Jennifer Eschbacher
Saturday, November 23, Scientific Meeting:  Concurrent Session 6B - Molecular Epidemiology/Biomarkers  -  1:00pm - 3:00pm
Prognostic value of immunophenotypical subclassification in primary CNS lymphoma
Uiju Cho, Yong-Kil Hong, Youn Soo Lee*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Status of microRNA biogenesis machinery has prognostic significance in meningiomas
Felipe Carvalho*, Shahrzad Jalali, Sanjay Singh, Sidney Croul, Kenneth Aldape, Gelareh Zadeh
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Significance of immunohistochemical expression of Ki-67, p53 and p16 in clinical outcome of meningioma
Nathalie Nguyen*, Gregory Moes, John Lee Villano
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
SNP-CN array and Hot-Spot Mutation sequencing provide a genomic description for diffuse astrocytoma diagnosis
Michael Rossi, Christina Appin, Anita Bellail, Karen Mann, Debra Saxe, Charles Hill, Constantinos Hadjipanayis, Stephen Hunter, Daniel Brat, Chunhai Hao, Jeffrey Olson*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
To analyze frequency of CDKN2A deletion in ependymomas and coorelation with p16 protein expression, clinical and histopathological parameters
Taher Chharchhodawala, Mukund Sable*, Mehar C Sharma, Chitra Sarkar, Vaishali Suri, Manmohan Singh
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
The clinicopathological evaluation of CD163 and COX-2 in meningioma; immunohistochemical analysis of 76 cases of low- and high-grade meningioma
Hiroshi Nishihara*, Hiromi Kanno, Yasutaka Kato, Shinya Tanaka
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
The clinicopathological evaluation of O6-mehylguanine-DNA methyltransferase in glioblastoma multiformes
Masaya Miyazaki*, Hiroshi Nishihara, Tamio Itoh, Masahito Kato, Shin Fujimoto, Taichi Kimura, Mishie Tanino, Shinya Tanaka
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Therapy resistance and survival in glioblastoma – the role of STAT-1.
Arun Shastry*, Sarwat Naz, Balaram Thota, Kandavel Thennarasu, Arimappamagan Arivazhagan, Sampath Somanna, Vani Santosh, Paturu Kondaiah
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
^Top
 
 
CLIN-Neuro/Medical Oncology
11C Methionine-PET for detection and early re-intervention of low grade glioma recurrence
Keisuke Ueki*, Fumi Higuchi, Setsu Sakamoto, Phyo Kim
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A case of malignant gemistocytic astrocytoma with synchronous glioblastoma
Mimi Lee, Augustus Perez*, John Norton, Hartmut Uschmann, Andrea Chamczuck, Majid Khan, Jonathan Fratkin
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A case report: primary glioblastoma of the pineal
Regina Krel*, Yana Krutoshinskaya, Arthur Rosiello, Roberta Seidman, Agnieszka Kowalska
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A direct comparison of response assessments in a phase II clinical trial of WT1 peptide vaccination; Macdonald, RECIST and RANO criteria
Naoya Hashimoto*, Yasuyoshi Chiba, Akihiro Tsuboi, Manabu Kinoshita, Ryuichi Hirayama, Naoki Kagawa, Yoshihiro Oka, Yusuke Oji, Haruo Sugiyama, Toshiki Yoshimine
Sunday, November 24, Scientific Meeting:  Concurrent Session 8B - Imaging and RANO Update  -  8:15am - 10:05am
A meta-analysis of survival in leptomeningeal metastasis in melanoma, lung, and gastrointestinal carcinoma
Nancy Ann Oberheim Bush*, Santosh Kesari, Brian Scott
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A multicenter phase I/II study of the BCNU implant (Gliadel® wafer) for Japanese patients with malignant gliomas(long-term follow up (NPC-08 Study Group)
Tomokazu Aoki*, Ryo Nishikawa, Kazuhiko Sugiyama, Naosuke Nonoguchi, Noriyuki Kawabata, Kazuhiko Mishima, Jun-ichi Adachi, Kaoru Kurisu, Fumiyuki Yamasaki, Teiji Tominaga, Toshihiro Kumabe, Keisuke Ueki, Fumi Higuchi, Tetsuya Yamamoto, Eiichi Ishikawa, Hideo Takeshima, Shinji Yamashita, Kazunori Arita, Hirofumi Hirano, Shinobu Yamada, Masao Matsutani
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A phase 3, multicenter, open-label, randomized, controlled study of the efficacy and safety of oral sonidegib (LDE225) versus temozolomide in patients with Hedgehog pathway-activated relapsed medulloblastoma
Mark Kieran*, Darren Hargrave, Patrick Y. Wen, Stewart Goldman, Dereck Amakye, Margaret Patton, Feng Tai, Lucas Moreno
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A phase 1/2 safety and preliminary efficacy study of sonidegib (LDE225), a Hedgehog pathway inhibitor, in pediatric and adult patients with relapsed or refractory medulloblastoma and other solid tumors
Mark Kieran*, Birgit Geoerger, Michela Casanova, Julia Chisholm, Isabelle Aerts, Eric Bouffet, Alba A. Brandes, Sarah E. S. Leary, Michael Sullivan, Simon Bailey, Kenneth Cohen, Warren Mason, Stacey Kalambakas, Priya Deshpande, Feng Tai, Eunju Hurh, Tobey J. McDonald
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A Phase II study of antineoplastons A10 and AS2-1 (ANP) in children with high-grade glioma(Protocol BT-06)
Tomasz Janicki*, Stanislaw Burzynski, Gregory Burzynski, Ania Marszalek
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A Phase II study of antineoplastons A10 and AS2-1 in adult patients with recurrent glioblastoma multiforme based on Protocol BT-21
Gregory Burzynski*, Stanislaw Burzynski, Tomek Janicki, Ania Marszalek
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A Phase II study of antineoplastons A10 and AS2-1 in pediatric recurrent diffuse intrinsic pontine glioma
Stanislaw Burzynski*, Tomasz Janicki, Gregory Burzynski, Ania Marszalek
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A pilot trial exploring the predictive value of excision repair cross complementing 1 (ERCC1) testing in high grade glioma (HGG) patients treated with carboplatin and bevacizumab
Silviya Meletath, Monica Bennett, Vanessa A. Nestor, Karen L. Fink*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A regional multi-center retrospective study of treatment patterns and clinical outcomes from 2000-2012 of patients with primary CNS Lymphoma (PCNSL)
Aaron Spalding, Renato LaRocca, Diana Haninger, Tanuj Saaraswat, Lennea Coombs, Shesh Rai, Eric Burton*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A retrospective review of patients with recurrent glioblastoma (GBM) treated with bevacizumab (Avastin), lomustine (CCNU) and sirolimus (Rapamune)
Tulika Ranjan*, Katherine Peters, Gordana Vlahovic, Henry Friedman, Annick Desjardins
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A retrospective study of outcomes in older patients with low-grade gliomas
Priya Kumthekar*, Carly Bridge, Vaibhav Patel, Alfred Rademaker, Irene Helenowski, Maciej Mrugala, Jason Rockhill, Kristin Swanson, Sean Grimm, Jeffrey Raizer
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Activity and safety of the combination Bevacizumab and Fotemustine in recurrent malignant gliomas
Alessandra Fabi*, Veronica Villani, Vanja Vaccaro, Antonello Vidiri, Diana Giannarelli, Francesca Piludu, Vincenzo Anelli, Carmine Carapella, Francesco Cognetti, Andrea Pace
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
An open-label, multi-center, phase II study of patupilone (EPO906), in the treatment of recurrent or progressive brain metastases in patients with non-small cell lung cancer (NSCLC)
Lakshmi Nayak*, Antonio Omuro, Lisa DeAngelis, H. Ian Robins, Ramaswamy Govindan, Shirish Gadgeel, Karen Kelly, James Rigas, Hans-Joachim Reimers, David Peereboom, Steven Rosenfeld, Jennifer Garst, Nithya Ramnath, Patricia Wing, Ming Zheng, Patrick Urban, Lauren Abrey, Patrick Wen
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Anaplastic lymphoma kinase (ALK) positive central nervous system (CNS) metastases from non small cell lung cancer (NSCLC)
Samuel Singer*, Gregory J. Riely, Mark G. Kris, Christian Grommes
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Antiepileptic drug efficacy in gliobastoma patients (RedLANO 2013)
Andrés F. Cardona*, Luis C. Mayor, Enrique Jiménez, Fernando Hakim, Carlos Yepes, Sonia Bermúdez, Nícolas Useche, José L. Asencio, Juan A. Mejía, Carlos Vargas, Jorge M. Otero, Hernán Carranza, León D. Ortíz
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Are meningiomas at higher risk of thromboembolism than gliomas? Early result of a prospective study
Giorgio Carrabba*, Lorenzo Giammattei, Riccardo Draghi, Valeria Conte, Ida Martinelli, Manuela Caroli, Giulio Bertani, Marco Locatelli, Paolo Rampini, Andrea Artoni
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Bevacizumab for radiation injury in metastatic brain tumors and meningiomas
Motomasa Furuse*, Shin-Ichi Miyatake, Shinji Kawabata, Toshihiko Kuroiwa
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Bevacizumab in children and adults with neurofibromatosis type 2 and symptomatic vestibular schwannomas
Jaishri Blakeley*, Xiaobu Ye, Amanda Bergner, Eva Dombi, Christopher Zalewski, Krista Follmer, Chris Halpin, Laura Fayad, Michael Jacobs, Andrea Baldwin, Shannon Langmead, Trish Whitcomb, Dominique Jennings, Brigitte Widemann, Scott Plotkin
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Bevacizumab salvage therapy for glioblastoma refractory to monoclonal antibodies targeting VEGF and PDGF pathway
Saurabh Dahiya*, Glen Stevens, David Peereboom, Manmeet Ahluwalia
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Brainstem venous congestion due to dural arterio-venous fistula mimicking brainstem tumors
Michelle Bell*, Cynthia Harrison, Francine Armentano, Andrew Lassman, E. Sander Connolly, Alexander Khandji, Fabio Iwamoto
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Changes in the progesterone-, estrogen-, HER2/neu-receptor status and the proliferation marker Ki-67 in metastasized breast cancer: discordance rates and time to progression in brain metastasis
Marco Timmer*, Christina Cramer, Gabriele Röhn, Roland Goldbrunner
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Characteristics of long-term survivors in glioblastoma
Carly A Bridge*, Anne Baldock, Priya Kumthekar, Paul Dilfer, Sandra K Johnston, Joshua Jacobs, David Corwin, Laura Guyman, Russell Rockne, Adam Sonabend, Michael Cloney, Peter Canoll, Kristin R Swanson
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Chloroquine response in glioblastoma patients
León D. Ortíz*, Andrés F. Cardona, Fernando Hakim, Enrique Jiménez, Carlos Yepes, Nícolas Useche, Sonia Bermúdez, Juan Armando Mejía, José Luis Asencio, Hernán Carranza, Carlos Vargas, Jorge M. Otero, Mauricio Lema
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Clinical and demographic features of adult patients with glioblastoma (GB) participating on clinical trial protocols at the University of Texas MD Anderson Cancer Center (MDACC)
Mark D. Anderson*, Diane Liu, Charles Conrad, Marta Penas-Prado, Mark R. Gilbert, Alfred W.K. Yung, John de Groot
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Clinical and molecular characteristics of newly diagnosed glioblastomas with IDH1 mutation and correlation of IDH1 mutations with prognosis 
Makoto Ohno*, Yoshitaka Narita, Yasuji Miyakita, Hideyuki Arita, Yuko Matsushita, Akihiko Yoshida, Shintaro Fukushima, Koichi Ichimura, Soichiro Shibui
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Clinical and  radiographic response in a patient with brain metastasis from ovarian cancer treated with bevacizumab
Paul Opinaldo*, Roy Torcuator
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Clinical aspects of tumor- versus non-tumor-related status epilepticus: a retrospective cohort study
Maurits W.C.B. Sanders, Yunus Arik, Tatjana Seute, Pierre A.J.T. Robe, Frans S.S. Leijten, Tom J. Snijders*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Clinical characteristics and outcome of papillary glioneuronal tumor, rosette-forming glioneuronal tumor of the fourth ventricle and glioneuronal tumor with neuropil-like islands- update of an ongoing international individual patient data meta-analysis
Annika Schlamann, André O. von Bueren*, Christian Hagel, Christof Kramm, Rolf-Dieter Kortmann, Klaus Müller
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Combination of bevacizumab and everolimus in patients with refractory, progressive intracranial meningioma:  Updated results from a phase II trial of the Sarah Cannon Research Institute
Kent Shih*, Sajeel Chowdhary, Paul Rosenblatt, Alva B. Weir III, Gregg Shepard, Jeffery T. Williams, Mythili Shastry, John D. Hainsworth
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Combined immuno-chemotherapy for primary CNS lymphoma: a single institution experience
Ivan Reveles*, Andrew Brenner
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Continuous low-dose temozolomide (50 mg/mq 1 week on/ 1 week off) in the treatment of newly diagnosed low grade gliomas
Andrea Pace*, Veronica Villani, Alessandra Fabi, Carmine Maria Carapella
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Correlation between genetic alterations and clinical prognosis in grade III glioma
Hideo Nakamura*, Keishi Makino, Takuichiro Hideo, Jun-ichiro Kuroda, Naoki Shinojima, Shigetoshi Yano, Jun-ichi Kuratsu
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
CSF rituximab concentration and effect after intrathecal administration of Rituximab in CNS relapse of systemic lymphoma - results from the prospective phase II HOVON 80 study
Jacoline Bromberg*, Harry Schouten, Ron Schaafsma, Joke Baars, Dieta Brandsma, Petronella Lugtenburg, Cees van Montfort, Martin van den Bent, Jeanette Doorduijn
Sunday, November 24, Scientific Meeting:  Concurrent Session 9B - Biologic/Immunologic Therapies  -  10:20am - 12:00pm
Dual phase I/II study of TH-302 and bevacizumab in recurrent glioblastoma following bevacizumab failure
Andrew Brenner*, Jessica Sun, John Floyd, Charles Hart, Clarence Eng, Lisa Fichtel, Aleksandra Gruslova, Alessia Lodi, Stefano Tiziani
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Does time to first progression (TTP) impact post-progression survival in glioblastoma (GBM) in the temozolomide (TMZ) treatment era? 
Mairead G McNamara*, Zarnie Lwin, Haiyan Jiang, Caroline Chung, Barbara-Ann Millar, Arjun Sahgal, Normand Laperriere, Warren P Mason
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Dynamic 18FET-PET identifies patients at risk for malignant transformation in newly diagnosed low grade astrocytomas
Bogdana Suchorska*, Nathalie Jansen, Vera Wenter, Sabina Eigenbrod, Christine Schmid-Tannwald, Andreas Zwergal, Maximilian Niyazi, Peter Bartenstein, Oliver Schnell, Friedrich-Wilhelm Kreth, Christian LaFougere, Jörg-Christian Tonn
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Effect of neoadjuvant temozolomide upon volume reduction and resectability of diffuse low-grade glioma
Jasmin Jo*, Brian Williams, Mark Smolkin, Max Wintermark, Mark Shaffrey, David Schiff
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Efficacy of bevacizumab for glioblastoma at first versus subsequent recurrence - a single-institution retrospective analysis
J. Manuel Sarmiento, Diana Ly, Jaswinder Jutla, Alicia Ortega, Christine Carico, Holly Dickinson, Surasak Phuphanich, Jeremy Rudnick, Chirag Patil, Jethro Hu*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Elucidating glioblastoma regional edema and hypoxia changes induced by anti-angiogenic treatment through mathematical modeling combined with clinical imaging
Andrea Hawkins-Daarud*, Pamela R. Jackson, Kristin R. Swanson
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Epigenetic silencing of KAZALD1 confer a better prognosis and associate with malignant transformation/progression in glioma
Hongjun Wang*, Chuanlu Jiang
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Eribulin induced neuropathy in a patient with previously undiagnosed Charcot-Marie-Tooth (CMT) disease
Isabel Arrillaga-Romany*, Kathryn Ruddy, Steven Greenberg, Lakshmi Nayak
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
ETANTR a biologically elusive tumor with clinical and radiographical heterogenity- MD Anderson Cancer Center experience
Soumen Khatua*, Gregory Fuller, Soham Dasgupta, Michael Rytting, Tribhwan Vats, Wafik Zaky
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Extended treatment with Temozolomide prolongs progression free survival in a patient with astrocytic gliomatosis cerebri
Alexandra Flowers*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Final efficacy and safety results from AVAglio, a phase III trial of bevacizumab (BEV) plus temozolomide (TMZ) and radiotherapy (RT) in newly diagnosed glioblastoma
Olivier L Chinot*, Wolfgang Wick, Warren Mason, Roger Henriksson, Frank Saran, Ryo Nishikawa, Antoine F Carpentier, Khe Hoang-Xuan, Petr Kavan, Dana Cernea, Alba A Brandes, Magalie Hilton, Yannick Kerloeguen, Abajo Guijarro, Timothy Cloughsey
Friday, November 22, Scientific Meeting:  Plenary Session - Award Winning Abstracts  -  8:15am - 10:15am
GB-RedLANO registry 2013
Andrés F. Cardona*, León D. Ortiz, Enrique Jiménez, Fernando Hakim, Carlos Yepes, Nicolás Useche, Sonia Bermúdez, José L. Asencio, Hernán Carranza, Carlos Vargas, Jorge M. Otero, Carlos Bartels, Andrés Quintero, Carlos E. Restrepo, Sonia Gómez, Laura Bernal-Vaca, Mauricio Lema
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Genome sequencing of SHH medulloblastoma predicts age-dependent response to smoothened-inhibition and rational therapeutic combinations
Marcel Kool*, David T.W. Jones, Natalie Jäger, Paul A. Northcott, Trevor Pugh, Volker Hovestadt, Shirley Markant, L. Adriana Esparza, Franck Bourdeaut, Marc Remke, Michael D. Taylor, Yoon-Jae Cho, Scott L. Pomeroy, Ulrich Schüller, Andrey Korshunov, Roland Eils, Robert J. Wechsler-Reya, Peter Lichter, Stefan M. Pfister
Friday, November 22, Scientific Meeting:  Plenary Session - Award Winning Abstracts  -  8:15am - 10:15am
Glioblastoma and leptomeningeal dissemination
Jacob Mandel*, Shlomit Yust-Katz, John de Groot, Alfred Yung, Mark Gilbert
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Glioblastoma multiforme in siblings with biallelic MSH6 mutations: a case report and review of the literature
Wafik Zaky*, Jeffrey Weinberg, Gregory Fuller, Leena Ketonen, Mary Frances McAleer, Nabil Ahmed, Soumen Khatua
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Glioblastoma treatment patterns and outcomes and resource use in the United States
Allicia Girvan*, Gebra Carter, Li Li, Anna Kaltenboeck, Anita Chawla, Jasmina Ivanova, Maria Koh, Jessi Stevens, Michael Lahn
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Glioblastoma recurrence: impact of the molecular profile 
Jad Alshami, Magali Lecavalier-Barsoum, Marie-Christine Guiot, Donatella Tampieri, Petr Kavan, Thierry Muanza*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
GNAQ gene mutation in an intermediate-grade melanocytic tumor of the thoracic spinal cord
David Cachia*, Thomas Smith
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
HD-Methotrexate/liposomal cytarabine/rituximab for the treatment of a patient with secondary CNS lymphoma, lymphomatous meningitis and neurolymphomatosis
John Cullen*, Eric Winer, Fred Hochberg, George Sachs, Suriya Jeyapalan
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Her2 targeted therapies and leptomeningeal disease 
Monica Loghin*, Amal Melhem-Bertrandt, Marta Penas-Prado, Tanweer Zaidi, Ruth Katz
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
High-dose methotrexate for metastatic breast cancer to the central nervous system
Margaret Schwartz*, Sean Grimm, Priya Kumthekar, Sherese Fralin, Laurie Rice, Ashlee Drawz, Irene Helenowski, Alfred Rademaker, Jeffrey Raizer
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Histopathological and molecular genetic study of meningiomas - experience from a tertiary care centre in India
Aanchal Kakkar*, Sawan Kumar, Utkarsh Bhagat, Anupam Kumar, Ashish Suri, Manmohan Singh, Mehar Sharma, Chitra Sarkar, Vaishali Suri
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Historical benchmarks for medical therapy trials in surgery and radiation refractory meningioma: a RANO review
Thomas Kaley*, Igor Barani, Marc Chamberlain, Michael McDermott, Jeffrey Raizer, Leland Rogers, David Schiff, Michael Vogelbaum, Damien Weber, Patrick Wen
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
ICE as a salvage therapy in multiply recurrent intracranial malignant germ cell tumor
Soumen Khatua*, David Sandberg, Lauren Foresman, Wafik Zaky
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Identification and quantification of CSF malignant cells by the Cellsearch technology in patients with lung cancer leptomeningeal metastasis
Luc Taillandier*, Basile Wittwer, Marie Blonski, Gilbert Faure, Marcelo De Carvalho, Emilie Le Rhun
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
IDH1 expression correlates with incidence of preoperative seizures in patients with low-grade gliomas
Simon V Liubinas*, Giovanna M D'Abaco, Bradford Moffat, Michael Gonzales, Frank Feleppa, Cameron J Nowell, Alexandra Gorelick, Katharine J Drummond, Andrew P Morokoff, Terence J O'Brien, Andrew H Kaye
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Immunochemotherapy with rituximab and methotorexate with deferred radiotherapy for newly diagnosed primary CNS lymphoma (PCNSL) in the elderly
Kazuhiko Mishima*, Jun-ich Adachi, Tomonari Suzuki, Eita Uchida, Taro Yanagawa, Yuko Watanabe, Kohei Fukuoka, Takaaki Yanagisawa, Kenji Wakiya, Takamitsu Fujimaki, Ryo Nishikawa
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Impact of treatment on outcome in patients with grade II and III gliomas
Terri Armstrong*, Ying Yuan, Diane Liu, Alvina Acquaye, Elizabeth Vera-Bolanos, Kristin Diefes, Lindsey Heathcock, Daniel Cahill, Mark Gilbert, Kenneth Aldape
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Implications of  MGMT methylation status in pituitary adenoma and correlation with MGMT protein expression
Arivazhagan Arimappamagan*, Sneha Arya, Majaid MA, Sampath Somanna, Vani Santosh
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Improvement in visual fields after treatment of intracranial meningioma with bevacizumab
Ina Ly*, Steven Hamilton, Robert Rostomily, Jason Rockhill, Maciej Mrugala
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Innovative molecular imaging in children with diffuse intrinsic pontine glioma (DIPG): the role of 89-zirconium labeled bevacizumab.
Sophie Veldhuijzen van Zanten*, Marc Jansen, Dannis van Vuurden, Marc Huisman, Otto Hoekstra, Guus van Dongen, Gert Jan Kaspers
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Intracranial germ cell tumor in association with Marfan's syndrome
Navya Nambudiri*, Isabel Arrilaga, Ian Dunn, Rebecca Folkerth, Susan Chi, David Reardon
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Ischemic stroke as a potential late toxicity of Carmustine wafers (Gliadel®) combined with radio-chemotherapy: report of two cases
Lien Bekaert*, Alin Borha, Evelyne Emery, André Busson, Jean-Sébastien Guillamo
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Late relapses in primary central nervous system lymphoma treated with Hhgh dose methotrexate
Prakash Ambady*, Matthias Holdhoff, Clare Ferrigno, Stuart Grossman
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Leptomeningeal Assessment in Neuro-Oncology (LANO): A RANO proposed model of evaluation in leptomeningeal metastasis
Marc` Chamberlain*, Jeffrey Raizer, Riccardo Soffetti, Roberta Ruda, Dieta Brandsma, Wilhelm Boogerd, Sophie Taillibert, Emilie Le Rhun, Kurt Jaeckle, Martin van den Bent, Patrick Wen`
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Lung adenocarcinoma metastasis to scalp and skull: case report and literature review
Joseph Megyesi*, Fateme Salehi
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Long term follow up after the treatment of adult intracranial or intraspinal primary pure germinoma
Xiao-Tang Kong*, Tom Davidson, Albert Lai, Timothy Cloughesy, Phioanh (Leia) Nghiemphu
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Long-term survival (over 13 years) in a child with recurrent diffuse pontine gliosarcoma: a case report
Stanislaw Burzynski, Tomasz Janicki, Gregory Burzynski, Ania Marszalek*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Long-term survival in patients with brain metastases: a retrospective analysis
Tareq Juratli*, Silke Soucek, Matthias Kirsch, Gabriele Schackert
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Long-term toxicity of bevacizumab in patients with neurofibromatosis 2
Vanessa Merker*, Katie Slusarz, Alona Muzikansky, Sanjeev Francis, Scott Plotkin
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Making neoplastic meningitis diagnosable – a simple, versatile, powerful alternative to conventional techniques
Akshal Patel*, Joshua Allen, David Dicker, Jonas Sheehan, Wafik El-Deiry, Michael Glantz
Saturday, November 23, Scientific Meeting:  Concurrent Session 6B - Molecular Epidemiology/Biomarkers  -  1:00pm - 3:00pm
Malignant humoral hypercalcemia(MHH) associated with a WHO grade II meningioma in brain and lung: a case report and review of the literature.
Sarah Taylor*, Kathy Newell, Leland Graves
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Multicenter randomized phase II trial of methotrexate and temozolomide versus methotrexate, procarbazine, vincristine and cytarabine for newly-diagnosed primary CNS lymphoma (PCNSL) in the elderly: an ANOCEF / GOELAMS Intergroup study
Antonio Omuro*, Olivier Chinot, Luc Taillandier, Herve Ghesquieres, Carole Soussain, Vincent Delwail, Thierry Lamy, Remy Gressin, Sylvain Choquet, Pierre Soubeyran, Jean Philippe Maire, Alexandra Benouaich-Amiel, Sophie Lebouvier-Sadot, Emmanuel Gyan, Maryline Barrié, Monica Sierra del Rio, Alberto Gonzalez-Aguilar, Caroline Houllier, Marie-Laure Tanguy, Khe Hoang-Xuan
Friday, November 22, Scientific Meeting:  Concurrent Session 2B - Adult Clinical Studies  -  1:00pm - 3:00pm
Multidrug immunochemotherapy (R-MPV-A) for newly diagnosed and recurrent primary central nervous system lymphomas
Motoo Nagane*, Keiichi Kobayashi, Nobuyuki Takayama, Yoshiaki Shiokawa
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Multimodal treatment of adults with CNS primitive neuroectodermal tumors/pineoblastomas according to the pediatric HIT 2000 protocol
Carsten Friedrich, Klaus Müller, Katja von Hoff, Robert Kwiecien, Torsten Pietsch, Monika Warmuth-Metz, Nicolas U. Gerber, Peter Hau, Joachim Kuehl, Rolf D. Kortmann, André O. von Bueren*, Stefan Rutkowski
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Neoadjuvant chemotherapy and staged removal of chemosensitive glioma based on preoperative molecular diagnosis by imaging characteristics
Hikaru Sasaki*, Yuya Nishiyama, Kazunari Yoshida, Yuichi Hirose
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Neuroimaging of treatment associated neurotoxicity in glioblastoma patients
Morgan Prust, Jayashree Kalpathy-Cramer, Pavlina Poloskova, Kourosh Jafari-Khouzani, Elizabeth Gerstner, Jorg Dietrich*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Objective response in recurrent glioblastoma from adjuvant NovoTTF-100A and TCCC after temozolomide and bevacizumab failure
Eric T Wong*, Grace Elzinga, Amy Chung, Loretta Barron, Julianne Bloom, Kenneth D Swanson
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Outcome prediction in patients with glioblastoma using imaging, clinical and genomic biomarkers: focus on the non-enhancing component of the tumor
Rajan Jain*, Laila Poisson, Lisa Scarpace, Tom Mikkelsen, Justin Kirby, John Freymann, Scott Hwang, David Gutman, Carl Jaffe, Daniel Brat, Adam Flanders
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Oligodendroglial tumors: a single institution experience
Maria Angeles Vaz Salgado*, Ana Gomez Rueda, Luis Ley Urzaiz, Mercedes Garcia Villanueva, Juan Martinez San Millan, Eduardo Roberts Cervantes, Rebeca Alcalce Pampliega, Marta Del Alamo de Pedro, Victor Rodriguez Berrocal, Alfredo Carrato Mena
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Oligodendrogliomas and mixed oligoastrocytomas have a high incidence of pseudoprogression following chemoradiotherapy
Andrew Lin*, Jingxia Liu, John Evans, Eric Leuthardt, Ralph Dacey, Joshua Dowling, Albert Kim, Gregory Zipfel, Robert Grubb, Jiayi Huang, Clifford Robinson, Joseph Simpson, Gerald Linette, Michael Chicoine, David Tran
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Orofacial dyskinesia: a possible paraneoplastic disorder?
Ruxandra Costa*, Jennifer Lycette, Stephen Gancher
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase 1 trial of bevacizumab plus TPI 287 in adults with recurrent glioblastoma (GBM)
Charles Conrad*, W.K. Alfred Yung, John deGroot, Mark Gilbert, Monica Loghin, Marta Penas-Prado, Ivo Tremont, Sandra Silberman, Donald Picker
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase 1 study of an oncolytic polio/rhinovirus recombinant (PVSRIPO) against recurrent glioblastoma
Annick Desjardins*, John Sampson, Katherine Peters, Tulika Ranjan, Gordana Vlahovic, Stevie Threatt, James Herndon, II, Susan Boulton, Denise Lally-Goss, Frances McSherry, Allan Friedman, Henry Friedman, Darell Bigner, Matthias Gromeier
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase I dose escalating study of 2B3-101, glutathione PEGylated liposomal doxorubicin, in patients with solid tumors and brain metastases or recurrent malignant glioma
B. Milojkovic-Kerklaan, P. Aftimos, S. Altintas, A. Jager, W. Gladdines, F. Lonnqvist, P. Soetekouw, M. van Linde, A. Awada, J. Schellens, D. Brandsma*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase II trial of dose-dense 1 week on/1 week off temozolomide for patients with recurrent high grade glioma
Seunggu Han*, Annette Molinaro, Mitchel Berger, Michael Prados, Susan Chang, Jennifer Clarke, Nicholas Butowski
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase II trial of the phosphatidyinositol-3 kinase (PI3K) inhibitor buparlisib (BKM120) in recurrent glioblastoma: an Ivy Foundation early phase clinical trials consortium study
Patrick Wen*, Alfred Yung, Ingo Mellinghoff, Kathleen Lamborn, Shakti Ramkissoon, Timothy Cloughesy, Mikael Rinne, Antonio Omuro, Lisa DeAngelis, Mark Gilbert, Andrew Chi, Tracy Batchelor, Howard Colman, Susan Chang, Lakshmi Nayak, Cristian Massacesi, Emmanuelle DiTomaso, Michael Prados, David Reardon, Keith Ligon
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase II trial of triple receptor tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas
Andrew Norden*, David Schiff, Manmeet Ahluwalia, Glenn Lesser, Lakshmi Nayak, Eudocia Lee, Alona Muzikansky, Jorg Dietrich, Katrina Smith, Sarah Gaffey, Christine McCluskey, Keith Ligon, David Reardon, Patrick Wen
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma: final results
Andrew Norden*, Samantha Hammond, Jan Drappatz, Surasak Phuphanich, David Reardon, Eric Wong, Scott Plotkin, Glenn Lesser, Jeffrey Raizer, Tracy Batchelor, Eudocia Lee, Thomas Kaley, Alona Muzikansky, Lisa Doherty, Debra LaFrankie, Sandra Ruland, Katrina Smith, Mary Gerard, Christine McCluskey, Patrick Wen
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase II study of panobinostat in combination with bevacizumab for recurrent glioblastoma
Eudocia Lee*, David Reardon, David Schiff, Jan Drappatz, Alona Muzikansky, Samantha Hammond, Sean Grimm, Andrew Norden, Rameen Beroukhim, Christine McCluskey, Andrew Chi, Tracy Batchelor, Katrina Smith, Sarah Gaffey, Mary Gerard, Susan Snodgras, Jeffrey Raizer, Patrick Wen
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Pilot study to determine the effect of Sulfasalazine on glioma glutamate levels measured by MRS
Paula Warren*, SM Robert, A Lahti, David White, MA Reid, LB Nabors, H Sontheimer
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Prediction of primary glioblastoma recurrence by clinical and molecular factors
Ichiyo Shibahara*, Yukihiko Sonoda, Ryuta Saito, Masayuki Kanamori, Yoji Yamashita, Toshihiro Kumabe, Mika Watanabe, Hiroyoshi Suzuki, Takashi Watanabe, Chikashi Ishioka, Teiji Tominaga
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Pregnancy and brain tumors
Shlomit Yust-Katz*, Andrea Milbourne, Liu Diane, Mark Gilbert, Terri Armstrong
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Preliminary trial of mebendazole in patients with recurrent high-grade gliomas
Tatsunori Okamura*, Sadao Kaneko
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Pre-operative chemotherapy: a new option for low grade gliomas in eloquent areas?
Roberta Rudà*, Lorenzo Bello, Antonella Castellano, Luca Bertero, Chiara Bosa, Elisa Trevisan, Marco Riva, Marina Donativi, Andrea Falini, Riccardo Soffietti
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Preoperative factors in predicting atypical meningomas
Vino Apok*, Samantha Mills, Calvin Soh, Konstantina Karabatsou
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Prognostic factors for survival in patients with cerebral low-grade glioma
Kazuhiro Tanaka*, Takashi Sasayama, Masamitsu Nishihara, Katsu Mizukawa, Eiji Kohmura
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Prognostic markers and survival in a contemporary series of glioblastomas treated at a single centre
Aliasgar Moiyadi*, Sadhana Kannan, Epari Sridhar, Tejpal Gupta, Prakash Shetty, Rakesh Jalali
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Prognostic value of molecular phenotypes in anaplastic glioma patients with prolonged administration of Temozolomide
Doo-Sik Kong*, Yoon-La Choi, Ho Jun Seol, Jung-Il Lee, Do-Hyun Nam
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Progressive disseminated supratentorial primitive neuroectodermal tumor (SPNET) post- chemoradiation treated with combined chemotherapy and targeted agent
Wafik Zaky*, Adriana Olar, John Stewart, David Sandberg, Lauren Foresman, Leena Ketonen, Soumen Khatua
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Primary brain tumour as second neoplasma in patients with extracranial cancer history
Ondrej Kalita*, Miroslav Vaverka, Lumir Hrabalek, Miloslava Zlevorova, Radek Trojanec, Marian Hajduch, Magdalena Kneblova, Jiri Ehrmann Jr.
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Rab27a confered strong worse prognosis, grade progression association and subtype preference in gliomas
Chuanlu Jiang*, Hongjun Wang
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
RAB34 identified as a progression and prognosis associated biomarker in glioma
Hongjun Wang*, Chuanlu Jiang
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Radiographic response of an incidental meningioma in a patient with glioblastoma on NovoTTF therapy
Lauren Schaff*, Francine Armentano, Cynthia Harrison, Andrew Lassman, Guy McKhann, Fabio Iwamoto
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Radiographically localized biopsies reveal intra-tumoral heterogeneity and peritumoral-specific subtypes in high-grade glioma
Brian Gill*, Jonathon Yun, Hannah Goldstein, Hani Malone, David Pisapia, Adam M. Sonabend, Guy K. Mckhann, Michael B. Sisti, Peter Sims, Peter Canoll, Jeffrey N. Bruce
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Randomized, phase IIIb trial evaluating standard-of-care (SOC) therapy with/without bevacizumab continuation beyond disease progression (PD) in patients with glioblastoma after first-line radiotherapy, temozolomide and bevacizumab (RT/T+BEV): trial rationale and design
Alba A Brandes*, Warren Mason, Josef Pichler, Anna K Nowak, Miguel Gil, Frank Saran, Cedric Revil, Beatrix Lutiger, Antoine F Carpentier
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
RASSF3 candidate tumor suppressor induces apoptosis and G1-S cell cycle arrest via p53, and its depletion contributes to EMT
Takumi Kudo*, Yutaka Hata, Taketoshi Maehara
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Relationship between overall survival and progression-based  endpoints in Bev-included recurrent glioblastoma multiforme trials
Wenting Wu*, Eva Galanis, Patrick Wen, Asha Das, Howard Fine, Tim Cloughesy, Dan Sargent
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Repeated recurrence of pilocytic astrocytomas in adult patients
Wan-Soo Yoon*, Seung-Ho Yang, Dong-Sup Chung, Sin-Soo Jeun, Yong-Kil Hong
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Retrospective study of using carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab
Rifaquat Rahman*, Kelly Hempfling, Andrew Norden, David A. Reardon, Lakshmi Nayak, Mikael Rinne, Lisa Doherty, Sandra Ruland, Arun Rai, Jennifer Rifenburg, Debra LaFrankie, Patrick Wen, Eudocia Lee
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Retrospective study of toxicity profile and survival benefits of intra-arterial carboplatin therapy in recurrent high grade gliomas
Nilanjana Banerji*, Patricia Bruns, Melissa Hoag, Kathryn Gilliland, John Trusheim
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Results of adults treated for metastatic medulloblastoma using the pediatric protocol HIT 2000. A prospective multicenter observational study
André O. von Bueren*, Carsten Friedrich, Katja von Hoff, Robert Kwiecien, Klaus Müller, Torsten Pietsch, Monika Warmuth-Metz, Joachim Kuehl, Rolf-Dieter Kortmann, Stefan Rutkowski
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Risk of seizures following surgical resection of newly diagnosed meningiomas
Mariza Daras*, Meier Hsu, Thomas Kaley, Katherine Panageas, Richard Curry, Edward Avila
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Role of meaning in the patient experience of neurologic cancer
Julie Walker*, Ivo Tremont, Terri Armstrong
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
RTOG 0825: Primary outcome results from a phase III randomized, placebo controlled trial evaluating bevacizumab in newly diagnosed glioblastoma
Mark Gilbert*, Stephanie Pugh, Minhee Won, Deborah Blumenthal, Michael Vogelbaum, Ken Aldape, Howard Colman, Arnab Chakravarti, Robert Jeraj, James Dignam, Terri Armstrong, Jeffrey Wefel, Paul Brown, Kurt Jaeckle, David Schiff, David Brachman, Maria Werner-Wasik, Ivo Tremont-Lukats, Erik Sulman, Minesh Mehta
Friday, November 22, Scientific Meeting:  Plenary Session - Award Winning Abstracts  -  8:15am - 10:15am
Safety analysis of bevacizumab plus NovoTTF-100A in patients with recurrent malignant gliomas
Grace Elzinga, Amy Chung, Eric T Wong*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Safety results from AVAglio, a phase III randomized study of bevacizumab (BEV) plus standard combination temozolomide (TMZ) and radiotherapy (RT) in newly diagnosed glioblastoma (GBM)
Frank Saran*, Olivier L Chinot, Roger Henriksson, Warren Mason, Wolfgang Wick, Ryo Nishikawa, Sunita Dahr, Magalie Hilton, Josep Garcia, Timothy Cloughesy
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Salvage therapy with BRAF inhibitors for recurrent pleomorphic xanthoastrocytoma: a retrospective case series
Marc Chamberlain*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Salvage PCV chemotherapy for recurrent primary central nervous system lymphomas: useful in deferring radiotherapy
Jai Ho Choi*, Yong-Kil Hong
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Sarcoma brain metastases
Rachel Grossman*, Zvi Ram
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Study of chromosome 9q gain, Notch pathway regulators and Tenascin-C in ependymomas
Mehar Sharma*, Rakesh Gupta, Vaishali Suri, Manmohan Singh, Chitra Sarkar
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Seizure control in low-grade glioma patients after treatment with temozolomide
Johan A.F. Koekkoek*, Jaap C. Reijneveld, Linda Dirven, Tjeerd J. Postma, Maaike J. Vos, Jan J. Heimans, Martin J.B. Taphoorn
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Sunitinib in patients with brain metastases from metastatic renal cell carcinoma (mRCC) – final results from a global expanded access trial
Martin Gore*, Subramanian Hariharan, Camillo Porta, Georg Bjarnason, Sergio Bracarda, Robert Hawkins, Stéphane Oudard, Ke Zhang, Kolette Fly, Ewa Matczak, Cezary Szczylik
Friday, November 22, Scientific Meeting:  Concurrent Session 2B - Adult Clinical Studies  -  1:00pm - 3:00pm
Surgery with intra-operative neurophysiological monitoring in the management of thalamic astrocytomas
Giorgio Carrabba*, Giulio Bertani, Filippo Cogiamanian, Gianluca Ardolino, Barbara Zarino, Marco Locatelli, Manuela Caroli, Paolo Rampini
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Survival benefit of levetiracetam in glioblastoma treatment: a prospective, single center, and single arm study
Chae-Yong Kim*, Tackeun Kim, Jung Ho Han, Yu Jung Kim, In Ah Kim, Chang-Ho Yun, Hee Won Jung
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Survival outcomes of patients with recurrent anaplastic glioma treated with bevacizumab
Mohamed Hamza*, Barbara O'Brien, Jacob Mandel, John DeGroot
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Survival outcomes with low-dose bevacizumab compared to standard dose regimens in recurrent glioblastoma
Nicholas Avgeropoulos*, George Avgeropoulos, Garrett Riggs, Christopher Reilly
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Systemic bevacizumab (Bev) for leptomeningeal disease (LMD) from non-small cell lung cancer
Maria Carlo*, Antonio Omuro, Christian Grommes, Mark Kris, Craig Nolan, Elena Pentsova, Maria Pietanza, Thomas Kaley
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Temsirolimus suppresses meningioma growth in mouse models
Doreen Pachow, Nadine Kliese, Elmar Kirches, Christian Mawrin*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Temozolomide followed by high-dose chemotherapy and autologous stem cell transplant (HDC-ASCT) for newly diagnosed anaplastic oligodendroglioma (AO): Can radiotherapy be deferred?
Antonio Omuro*, Lauren Abrey, Jeffrey Raizer, Nina Paleologos, Peter Forsyth, Lisa DeAngelis, Thomas Kaley, David Louis, J. Gregory Cairncross, Matthew Matasar, Jayesh Mehta, Sean Grimm, Craig Moskowitz, Craig Sauter
Friday, November 22, Scientific Meeting:  Concurrent Session 2B - Adult Clinical Studies  -  1:00pm - 3:00pm
Textiloma mimicking recurrent glioblastoma: a case report
Pedro Garciarena*, Mark D. Anderson, Jackson Hamilton, Dawid Schellingerhout, Gregory N. Fuller, Raymond Sawaya, Mark R. Gilbert
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
The effect of field strength on GBM response in patients treated with Novocure-TTF
Scott Turner*, Thomas Gergel, Michel Lacroix, Steven Toms
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
The journey begins:  implementation of a novel survivorship care delivery model at the time of diagnosis for patients with a primary brain tumor
Judy Lima*, Emily Porensky, Robert Cavaliere
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
The Neurologic Assessment in Neuro-Oncology (NANO) Scale: a tool to assess neurologic function for integration in the Radiologic Assessment in Neuro-Oncology (RANO) criteria
Lakshmi Nayak*, Lisa M. DeAngelis, Patrick Y. Wen, Alba A. Brandes, Riccardo Soffietti, David M. Peereboom, Nancy U. Lin, Marc Chamberlain, David Macdonald, Evanthia Galanis, James Perry, Kurt Jaeckle, Minesh Mehta, Roger Stupp, Martin van den Bent, David A. Reardon
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
The role of natural killer (NK) cells in predicting pseudo-progression (PsdPG) vs true progression (TP) in high-grade gliomas
Lisa Sturla*, James J. Culhane, John Donahue, Suriya Jeyapalan
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Thinking outside the box: intractable seizures in the glioma patient, is seizure surgery the answer?
Kathleen Lupica*, Glen Stevens
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Tumor treating fields (TTFields) in recurrent GBM. An updated subgroup analysis of the Phase III data
Andrew A. Kanner*, Eric T. Wong, John L. Villano, Zvi Ram, on behalf of the EF-11 investigators
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Treatment of malignant gliomas with an energy restricted ketogenic diet: case report and literature summary
Kenneth Schwartz*, Howard Chang, Michele Nikolai, Peter Kurniali, Karl Olson, Joseph Pernicone, Charles Sweeley, Mary Noel
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Unconfirmed complete response (CRu) in patients with primary central nervous system lymphoma (PCNSL)
Macarena de la Fuente*, Antonio Omuro, Lisa DeAngelis
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Unusual case of multicentric glioblastoma multiforme with recurrence in the olfactory bulb
Alexandra Flowers*, Brendan Killory
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Use of high-dose methotrexate (HD-MTX) in leptomeningeal metastasis (LM) in patients with breast cancer
Elina Tsyvkin, Paula Rauschkolb, Elena Pentsova*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Using pyrimethamine for reverting high-grade glioma patients’ resistance to bevacizumab
Andrés F. Cardona*, León D. Ortíz, Nícolas Useche, Sonia Bermúdez, Enrique Jiménez, Fernando Hakim, Carlos Yepes, Juan A. Mejía, Laura Bernal-Vaca, Carlos E. Restrepo, Sonia Gómez, Andrés Quintero, Carlos Bartels, Hernán Carranza, Carlos Vargas, Jorge M. Otero
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Visual field defect related to temozolomide
Susanne Koeppen*, Jörg Hense
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Whole Brain Radiotherapy (WBRT) combined with concomitant or sequential intrathecal liposomal Cytarabine (DepoCyte) in the treatment of leptomeningeal metastases - a retrospective safety analysis
Sarah Iglseder*, Martha Nowosielski, Meinhard Nevinny-Stickel, Günther Stockhammer
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
WHO grade II meningioma survival after gross total resection: a 23-year single institution experience.
Heather Leeper*, Derek Johnson
Friday, November 22, Scientific Meeting:  Concurrent Session 2B - Adult Clinical Studies  -  1:00pm - 3:00pm
^Top
 
 
CLIN-Surgical Therapies
5-ALA guided resection of malignant glioma: a single institution experience
Pierandrea Oppido*, Veronica Villani, Antonello Vidiri, Andrea Pace, Alfredo Pompili, Carmine Carapella
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Comparative study of long-term results for intracranial meningeal hemangiopericytoma and malignant meningioma in single institution: focused in survival and local control
Jeong Hoon Kim*, Young Hyun Cho, Chang Jin Kim
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Complete, but not partial resection of recurrent glioblastoma prolongs survival after relapse without impairment of functional outcome
Christine Jungk*, Bernhard Beigel, Vitali Abb, Christel Herold-Mende, Andreas Unterberg
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Diagnostic yield of stereotactic needle-biopsies of sub-cubic centimeter intracranial lesions
Dawn Waters, David Gonda, Hasini Reddy, Ekkehard Kasper, Peter Warnke, Clark Chen*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Endoscopic pituitary tumor surgery: the learning curve
Amjad Anaizi*, Christopher Taylor, Jennifer Kosty, Lee Zimmer, Philip Theodosopoulos
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Endoscopic surgery for intraventricular and paraventricular tumors
Yoshiki Arakawa*, Yoo Kang, Daiki Murata, Ko-ichi Fujimoto, Susumu Miyamoto
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Facial nerve preservation surgery for large vestibular schwannomas: functional and tumor control outcomes
Amjad Anaizi*, Eric Gantwerker, Myles Pensak, Philip Theodosopoulos
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Fluorescence guide surgery in high grade gliomas using a high-definition exoscope system: an alternative to microscope
Jose Piquer*, Jose Luis Llacer, Vicente Rovira, Pedro Riesgo, Antonio Cremades
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Frame-based or frameless stereotactic biopsy: the debate continues
Charlotte Dandurand*, Karin Michaud, Leo Cantin, Silvine Cottin
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Laser Interstitial Thermal Therapy (LITT) as a treatment modality for difficult-to-access high grade gliomas: a multi-center study
Alireza Mohammadi*, Ammar Hawasli, Analiz Rodriguez, Jason Schroeder, Adrian Laxton, Paul Elson, Stephen Tatter, Gene Barnett, Eric Leuthardt
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Long-term outcomes of patients undergoing aggressive surgical management of insular tumors
Neena Marupudi*, Sandeep Mittal
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Low-dose rate Iodine-125 brachytherapy in recurrent malignant gliomas
Christoph Schwartz*, Alexander Romagna, Niklas Thon, Jörg-Christian Tonn, Silke Birgit Schwarz, Friedrich-Wilhelm Kreth
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Male gender is a risk factor for the clinical course of skull-base chordomas
Walter Rachinger, Matthias Simon, Stephan Dützmann, Günther Feigl, Natalia Kremenevskaya, Niklas Thon, Jörg-Christian Tonn*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Management and outcomes in patients with glioma-associated epilepsy
Yoshua Esquenazi*, Jessica Johnson, Nitin Tandon
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Minimally invasive surgical resection of subcortical tumors using the Six Pillars System
Richard Rovin*, Amin Kassam
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
miR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development
Johnny Akers, Valya Ramakrishnan, Ryan Kim, Johan Skog, Ichiro Nakano, Sandeep Pingle, Juliya Kalinina, Santosh Kesari, Xandra Breakfield, Fred Hochberg, Erwin Van Meir, Bob Carter, Clark Chen*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
MRI-based high resolution maps for planning/guiding high precision procedures in brain tumor patients
Yael Mardor*, Ouzi Nissim, Yuval Grober, David Guez, David Last, Dianne Daniels, Chen Hoffmann, Dvora Nass, Alisa Talianski, Roberto Spiegelmann, Zvi Cohen, Leor Zach
Sunday, November 24, Scientific Meeting:  Concurrent Session 8B - Imaging and RANO Update  -  8:15am - 10:05am
Nasal cavity malignancies involving the skull base: is there a role for endoscopy?
Amjad Anaizi*, Sanjeet Grewal, Philip Theodosopoulos, Lee Zimmer
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Orbital metastases as primary clinical manifestation of lung cancer: case report and literature review.
Maria Blagia*, Maurizio Paulis, Giuseppe Orunesu, Salvatore Serra
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phase 1 trial of a retroviral replicating vector (Toca 511) in recurrent high grade glioma patients demonstrates the importance of real-time MRI-guided delivery for dose-related evaluation of safety and efficacy
Manish Aghi*, Michael A. Vogelbaum, Douglas J. Jolly, Joan M. Robbins, Derek Ostertag, Carlos E. Ibañez, Harrry E. Gruber, Noriyuki Kasahara, Krystof Bankiewicz, Timothy F. Cloughesy, Susan M. Chang, Nicholas Butowski, Santosh Kesari, Clark Chen, Tom Mikkelsen, Joseph Landolfi, E. Antonio Chiocca, J. Bradley Elder, Greg Foltz, Dan Pertschuk
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Photodynamic therapy of brain tumors
Harry Whelan*, Mike Kelly, Sachin Jogel, Bruce Kaufmann, Andy Foy, Sean Lew, Brendan Quirk
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phenytoin reduces 5-ala mediated fluorescence in glioblastoma cells
Christopher Steele*, Johnathan Lawrence, Richard Rovin, Robert Winn
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Preoperative nTMS generated motor and language maps: feasibility and outcome
Roger Rotta*, Nicholas Levine, Sujit Prabhu, Raymond Sawaya, Jeffrey Weinberg, Ganesh Rao, Sudhakar Tummala, Catherine Tilley
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Re-operation for recurrent glioblastoma multiforme
Raymund L. Yong*, Tianxia Wu, Nino Mihatov, Michael J. Shen, M. Anthony Brown, Kareem A. Zaghloul, Grace E. Park, John K. Park
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Resection probabilistic maps for quality assessment of glioma surgery: a comparison of two surgical centers using intraoperative stimulation mapping
Philip De Witt Hamer*, Eef Hendriks, Emmanuel Mandonnet, Frederik Barkhof, Koos Zwinderman, Hugues Duffau
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Role of surgery in patients with intracranial non germinomatous germ cell tumors (NGGCT) treated according to SIOP CNS GCT 96 protocol with respect to the site and time of resection
Thomas Czech*, James Nicholson, Didier Frappaz, Rolf-Dieter Kortmann, Claire Alapetite, Maria-Luisa Garré, Umberto Ricardi, Frank Saran, Gabriele Calaminus
Friday, November 22, Scientific Meeting:  Concurrent Session 2B - Adult Clinical Studies  -  1:00pm - 3:00pm
Stereotactic biopsy for deep seated brain tumors using the Leksell stereotactic frame system
Takamitsu Fujimaki*, Masahito Kobayashi, Kenji Wakiya, Miki Ohta, Junichi Adachi, Kohei Fukuoka, Tomonari Suzuki, Takaaki Yanagisawa, Masao Matsutani, Kazuhiko Mishima, Jun Sasaki, Ryo Nishikawa
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Specific treatment considerations and outcome data in elderly glioma patients - a single center experience
Markus Hoffermann*, Lukas Bruckmann, Kariem Mahdy Ali, Martin Asslaber, Franz Payer, Gord von Campe
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Supra-maximal resections for newly diagnosed glioblastoma multiforme
Yoshua Esquenazi*, Elliiot Friedman, Yi Lin, Jay-Jiguang Zhu, Nitin Tandon
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Surgery using a tractography-integrated navigation system and motor evoked potentials for preservation of motor function in patients with malignant glioma
Shiro Ohue*, Shohei Kohno, Akihiro Inoue, Daisuke Yamashita, Yoshiaki Kumon, Takanori Ohnishi
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Surgical resection following primary radiation treatment for vestibular schwannomas: does radiation impact surgical outcomes and extent of resection?
Amjad Anaizi*, Myles Pensak, Philip Theodosopoulos
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
The prognostic significance of extent of resection and residual volume in glioblastoma patients
Daniel Orringer*, Darryl Lau, Yashar Niknafs
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
The role of surgery for anaplastic gliomas with IDH gene mutation
Yukihiko Sonoda*, Ichiyo Shibahara, Ryuta Saito, Masayuki Kanamori, Toshihiro Kumabe, Teiji Tominaga
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Updated therapeutic strategy for adult low-grade glioma stratified by resection, histology, and molecular markers
Masayuki Nitta*, Takashi Maruyama, Hiroshi Iseki, Soko Ikuta, Manabu Tamura, Mikhail Chernov, Saori Okamoto, Yoshikazu Okada, Yoshihiro Muragaki
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Use of 5-aminolevulinic acid for detection of residual meningioma for total removal and avoidance of neurological deficits
Shusuke Moriuchi*, Makoto Dehara, Takanori Fukunaga, Yasushi Hagiwara, Hakao Soda, Masami Imakita
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
^Top
 
 
CLIN-Radiology
A combinatorial radiophenotype stratifies patient survival and associates with invasion/proliferation characteristics in glioblastoma (GBM)
Arvind Rao*, Ganesh Rao, Adam Flanders, TCGA Glioma Phenotype Research Group
Sunday, November 24, Scientific Meeting:  Concurrent Session 8B - Imaging and RANO Update  -  8:15am - 10:05am
Altered functional connectivity of the default mode network in diffuse glioma patients measured with pseudo-resting state functional MRI
Robert Harris*, Susan Bookheimer, Timothy Cloughesy, Hyun Kim, Whitney Pope, Katherine Yang, Albert Lai, Phioanh Nghiemphu, Benjamin Ellingson
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Amide proton transfer MRI of malignant gliomas for detecting active versus inactive tumor
David Wolf*, Xiaobu Ye, Michael Lim, He Zhu, Meiyun Wang, Alfredo Quinones-Hinojosa, Jon Weingart, Alessandro Olivi, Peter van Zijl, John Laterra, Jinyuan Zhou, Jaishri Blakeley
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
An open-label, single arm study to explore whether potential image biomarkers correlate with efficacy of bevacizumab combined with conventional therapy in newly diagnosed glioblastoma
Shuanghu (Tiger) Yuan, Rongjie Tao, Guoren Yang, Zhaoqiu Chen, Dianbin Mu, Shuqiang Zhao, Zheng Fu, Wanhu Li, Jinming Yu*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Analysis of the correlation between malignancy of gliomas and findings on 3D-PRESTO MRI sequence
Kanji Mori*, Reiichi Ishikura, Yusuke Tomogane, Kumiko Ando, Shuichi Izumoto
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Analysis of perfusion and volumetric MRI in progressive glioblastoma patients treated with continuous dose-intense temozolomide
Heinrich Elinzano*, Fatemeh Kadivar, Priyanka O Yadav, Virginia L Breese, Cynthia L Jackson, John E Donahue, Jerrold L Boxerman
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Autopsy and magnetic resonance imaging correlates in two glioblastoma patients on bevacizumab
Peter Pytel, John Collins, Yoon Choi*, Rimas Lukas, Martin Nicholas
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Association between MR imaging measurements and tumor v.s non-tumor image-guided tissue samples in patients with recurrent GBM
Qiuting Wen*, Adam Elkhaled, Emma Essock-Burns, Annette Molinaro, Joanna Phillips, Susan Chang, Soonmee Cha, Sarah Nelson
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Atypical imaging appearance of an intraspinal neurocytoma
Nandita Guha-Thakurta*, Lauren Langford
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Baseline spin-echo echo-planar perfusion nCBV prior to chemoradiation is a strong independent pre-therapy predictor of progression-free and overall survival in newly diagnosed glioblastoma
Rifaquat Rahman*, Ayca Akgoz, Hui You, Alhafidz Hamdan, Ravi Seethamraju, Patrick Wen, Geoffrey Young
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Basic imaging marker depict a regionally increased bevacizumab activity in recurrent glioblastoma associated with substantially prolonged survival
Oliver Bähr*, Patrick N. Harter, Lutz Weise, Se-Jong You, Michael W. Ronellenfitsch, Johannes Rieger, Joachim P. Steinbach, Elke Hattingen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Benefits of using high-field MRI in evaluating the long-term effects of radiation in patients with glioma
Janine Lupo*, Wei Bian, Mekhail Anwar, Suchandrima Banerjee, Christopher Hess, Susan Chang, Sarah Nelson
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Computational imaging features derived from MRI can discriminate the molecular subtypes of glioblastoma multiforme
Payel Ghosh, Ganesh Rao, Juan Martinez, Arvind Rao*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Comparison of multimodal magnetic resonance imaging utilizing 1.5 t and 3.0 t in glioblastoma multiforme at the time of first recurrence
Lara Kunschner Ronan*, Clifford Eskey, Thomas Hampton, Camilo Fadul
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Computerized image analysis of texture descriptors in multi-parametric MRI to distinguish recurrent glioblastoma multiforme from radiation necrosis
Pallavi Tiwari*, Lisa Rogers, Leo Wolansky, Andrew Sloan, Jill Barnholtz-Sloan, Curtis Tatsauka, Mark Cohen, Anant Madabhushi
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Correlation of ADC mean and ADC mean ratio in radiographic pseudoprogression following treatment with ERC 1671 immunotherapy in recurrent glioblastoma
Jose Carrillo*, Daniela Bota, Jason Handwerker, Lydia Min-Ying Su, Thomas Chen, Apostolos Stathopoulos, Hon Yu
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Deformation field morphometry for early detection of malignant transformation in low grade gliomas
Benjamin Ellingson*, Whitney Pope, Albert Lai, Phioanh Nghiemphu, Timothy Cloughesy
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Different spatial distribution between GCB and non-GCB PCNSL revealed by MR group analysis of 100 cases
Manabu Kinoshita*, Takashi Sasayama, Yoshitaka Narita, Atsushi Kawaguchi, Fumio Yamashita, Yasuyoshi Chiba, Naoki Kagawa, Kazuhiro Tanaka, Eiji Kohmura, Hideyuki Arita, Yoshiko Okita, Makoto Ohno, Yasuji Miyakita, Soichiro Shibui, Naoya Hashimoto, Toshiki Yoshimine
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Diffusion and perfusion magnetic resonance imaging in newly diagnosed glioblastoma following treatment with bevacizumab, temozolomide and hypo-fractionated stereotactic radiotherapy (HFSRT)
Mariza Daras*, Sasan Karimi, Lauren Abrey, Juan Sanchez, Kathryn Beal, Philip Gutin, Thomas Kaley, Christian Grommes, Denise Correa, Anne Reiner, Samuel Briggs, Antonio Omuro
Sunday, November 24, Scientific Meeting:  Concurrent Session 8B - Imaging and RANO Update  -  8:15am - 10:05am
Diffusion imaging genomic mapping identifies genomic targets involved in invasion and poor prognosis
Rivka Colen*, Ryan Jafrani, Pascal Zinn
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Functional brain MRI for assessing early activity of ramucirumab and olaratumab in patients with recurrent glioblastoma 
Sarah Nelson*, Frank Lieberman, Janine Lupo, Sana Viziri, L. Burt Nabors, Jason Crane, Patrick Wen, Andre Cote, David Peereboom, Qiuting Wen, Timothy Cloughesy, H. Ian Robins, Joy Fisher, Serena Desideri, Stuart Grossman, Xiaobu Ye, Jaishri Blakeley
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Gliomatosis cerebri: assessment of clinical and radiological response to temozolomide and radiation in 20 patients
Sona Pungavkar*, Prasad Tanawde, Sridhar Epari, Deepak Patkar, Malini Lawande, Aliasgar Moiyadi, Tejpal Gupta, Rakesh Jalali
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Image processing and MRI brain tumor segmentation techniques: a brief review
Ryan Jafrani*, Pascal Zinn, Rivka Colen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Imaging genomic biomarker signature for MGMT promotor methylation identification
Rivka Colen*, Omar Ashour, Pascal Zinn
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Imaging genomic correlation of invasive genomic composition and patient survival demonstrates metabolic dysfunction: a TCGA Glioma Phenotype Research Group project
Rivka Colen*, Mark Vangel, David Gutman, Scott Hwang, Max Wintermark, Rajan Jain, Manal Jilwan-Nicolas, James Chen, Prashant Raghavan, Chad Holder, Daniel Rubin, Eric Huang, Justin Kirby, John Freymann, Carl Jaffe, Adam Flanders, Pascal Zinn
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Imaging genomic IDH-1 biomarker signature
Rivka Colen*, Omar Ashour, Pascal Zinn
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Imaging genomic mapping in brain tumors: an introduction
Ryan Jafrani*, Pascal Zinn, Rivka Colen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Increased [68Ga]-DOTATOC uptake in PET imaging discriminates meningioma and tumorfree tissue
Walter Rachinger, Niklas Thon, Alexander Haug, Ulrich Schüller, Christian Schichor, Jörg-Christian Tonn*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Increased sensitivity to radiochemotherapy in IDH1 mutant glioblastoma as demonstrated by serial quantitative MR volumetry
Anh Tran*, Albert Lai, Sichen Li, Whitney Pope, Stephanie Teixeira, Robert Harris, Davis Woodworth, Phioanh Nghiemphu, Timothy Cloughesy, Benjamin Ellingson
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Intraoperative MRI FLAIR and T2 tumor volumes are underestimated when compared to post-operative corresponding volumes in high and low-grade gliomas
Randy Jensen*, Karen Salzman
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
MRI and medulloblastoma: subtyping at first sight?
Sebastien Perreault*, Kristen Yeom, Vijay Ramaswamy, David Shih, Marc Remke, Betty Luu, Simone Schubert, Paul Fisher, Sonia Partap, Hannes Vogel, Tina Young Poussaint, Michael Taylor, Yoon-Jae Cho
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
MRI changes associated with bevacizumab differ between tumor recurrence and cerebral radiation necrosis
Yoshiki Arakawa*, Ko-ichi Fujimoto, Daiki Murata, Yuji Nakamoto, Tomohisa Okada, Susumu Miyamoto
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
MRI changes associated with bevacizumab differ between tumor recurrence and cerebral radiation necrosis  
Koichi Fujimoto*, Yoshiki Arakawa, Daiki Murata, Yuji Nakamoto, Tomohisa Okada, Susumu Miyamoto
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
New prognostic scoring system for single brain metastasis patients utilizing clinical and radiological factors
Saurabh Dahiya*, Volodymyr Statsevych, Paul Elson, Hao Xie, Samuel Chao, David Peereboom, Glen Stevens, Gene Barnett, Manmeet Ahluwalia
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Potential of MR spectroscopy for assessment of glioma grading
Radim Jancalek*, Martin Bulik, Tomas Kazda
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Perfusion imaging genomic mapping uncovers potential genomic targets involved in angiogenesis and invasion
Rivka Colen*, TCGA Phenotype Group, Pascal Zinn
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
PET guidance for surgery planning in gliomas
Keisuke Miyake*, Daisuke Ogawa, Tetsuhiro Hatakeyama, Nobuyuki Kawai, Takashi Tamiya
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
PET imaging of brain gliomas with C-11 acetate: comparison with F-18 FDG PET
Jong Hee Chang*, Eui Hyun Kim, Se Hoon Kim, Mi Jin Yun
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Predictive value of CT and MR perfusion imaging in patients with high-grade malignant gliomas treated with Bevacizumab
Francesca Piludu*, Andrea Pace, Alessandra Fabi, Vincenzo Anelli, Veronica Villani, Carmine Carapella, Simona Marzi, Antonello Vidiri
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Preoperative grading of diffuse gliomas wih multiparametric imaging: MRI, MRS and [18F]-fluoro-L-thymidine PET
Solene Collet, Samuel Valable, Jean-Marc Constans, Emmanuele Lechapt-Zalcman, Simon Roussel, Nicolas Delcroix, Myriam Bernaudin, Ahmed Abbas, Eziane Ibazizene, Louisa Barre, Jean-Michel Derlon, Jean-Sébastien Guillamo*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Pre-operative MRI diffusion characteristics of the tumour and peritumoral region may predict survival and local recurrence for operated brain metastases
Rasheed Zakaria*, Kumar Das, Vanessa Sluming, Maneesh Bhojak, Carol Walker, Michael D. Jenkinson
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Proliferation rate estimates derived from serial diffusion MRI correlates with 18F-FLT PET SUV values in recurrent glioblastoma treated with bevacizumab
Benjamin Ellingson*, Whitney Pope, Wei Chen, Johannes Czernin, Michael Phelps, Albert Lai, Phioanh Nghiemphu, Linda Liau, Timothy Cloughesy
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Quantitative parametric maps of effective intervoxel contrast agent diffusive flux (Deff) using DCE-MRI as a novel image biomarker in human glioblastoma
Benjamin Ellingson*, Kevin Leu, Anh Tran, Whitney Pope, Albert Lai, Phioanh Nghiemphu, Robert Harris, Davis Woodworth, Timothy Cloughesy
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Quantitative T2-mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival
Oliver Bähr*, Alina Jurcoane, Keivan Daneshvar, Ulrich Pilatus, Michel Mittelbronn, Joachim P. Steinbach, Elke Hattingen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Radiological classification of posterior fossa hemangioblastomas
Tae Hoon Roh*, Eui Hyun Kim, Jong Hee Chang
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Radiological progression types following anti-angiogenic therapy are related to outcome in recurrent glioblastoma patients
Martha Nowosielski*, Benedikt Wiestler, Georg Göbel, Markus Hutterer, Heinz Schlemmer, Günther Stockhammer, Wolfgang Wick, Martin Bendszus, Alexander Radbruch
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Recurrent primary central nervous system lymphoma: apparent diffusion coefficient derived from diffusion weighted imaging is predictive of survival after recurrence
Marc Mabray*, Lorena Sanchez, Francisco Valles, Ramon Barajas, James Rubenstein, Soonmee Cha
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Relation between methionine uptake and molecular markers in glioma
Masahiro Nonaka*, Shin Nakajima, Tomoko Shofuda, Yonehiro Kanemura
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Reliability of quantitative biomarkers of tumor progression based on multispectral MRI in glioblastoma patients
Pamela LaMontagne*, Mikhail Milchenko, Peter Sylvester, Tammie Benzinger, Daniel Marcus, Sarah Jost Fouke
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Spatial correlation between apparent diffusion coefficient and 18F-FDOPA PET in diffuse gliomas
Benjamin Ellingson*, Whitney Pope, Kevin Leu, Wei Chen, Johannes Czernin, Michael Phelps, Albert Lai, Phioanh Nghiemphu, Linda Liau, Timothy Cloughesy
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
T1 rho mapping of brain tumors and tumor-related edema
Javier Villanueva-Meyer*, Ramon Barajas, Marc Mabray, Igor Barani, Weitian Chen, Ajit Shankaranarayanan, Patrick Koon, Soonmee Cha
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The diagnostic accuracy of neuro-imaging to detect infiltrative glioma within the brain: a meta-analysis based on 1598 patients in 58 publications
Niels Verburg, Friso Hoefnagels, Petra Pouwels, Ronald Boellaard, Frederik Barkhof, Otto Hoekstra, Pieter Wesseling, Jaap Reijneveld, Jan Heimans, Peter Vandertop, Koos Zwinderman, Philip De Witt Hamer*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The use of dynamic O-(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of patients with progressive and recurrent glioma
Norbert Galldiks*, Gabriele Stoffels, Christian Filss, Veronika Dunkl, Marion Rapp, Michael Sabel, Maximilian I. Ruge, Roland Goldbrunner, Nadim J. Shah, Gereon R. Fink, Heinz H. Coenen, Karl-Josef Langen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Time delayed contrast enhanced MRI improves detection of brain metastases and apparent treatment volumes
Marina Kushnirsky, Joel Katz, Jonathan Knisely, Michael Schulder*, Jared Steinklein, Lisa Rosen, Craig Warshall, Vinh Nguyen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Tumor perfusion during bevacizumab and irinotecan in recurrent glioblastoma: a multimodal approach
Marica Eoli*, Anna Luisa Di Stefano, Domenico Aquino, Alessandro Scotti, Elena Anghileri, Lucia Cuppini, Elena Prodi, Gaetano Finocchiaro, Maria Grazia Bruzzone
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Tryptophan metabolism in the non-tumoral hemisphere: A PET study of 99 glioma patients
David Kamson*, Tiffany Lee, Kaushik Varadarajan, Natasha Robinette, Otto Muzik, Pulak Chakraborty, Geoffrey Barger, Sandeep Mittal, Csaba Juhász
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Tryptophan PET has a strong prognostic value in post-treatment high-grade gliomas
David Kamson*, Geoffrey Barger, Natasha Robinette, Otto Muzik, Pulak Chakraborty, William Kupsky, Sandeep Mittal, Csaba Juhasz
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Using a Probabilitistic Radiographic Brain Tumor Atlas constructed from 500 glioblastoma patients to predict individual patient "-omic" signatures and treatment responses
Benjamin Ellingson*, Dieter Enzmann, Whitney Pope, Albert Lai, Phioanh Nghiemphu, Linda Liau, Timothy Cloughesy
Sunday, November 24, Scientific Meeting:  Concurrent Session 8B - Imaging and RANO Update  -  8:15am - 10:05am
Volumetric assessment and stratification of patient survival with early post-treatment MRI in patients with recurrent glioblastoma treated with bevacizumab
Raymond Huang*, Rifaquat Rahman, Alhafidz Hamdan, Caroline Kane, Christina Chen, Andrew Norden, David Reardon, Srinivasan Mukundan, Patrick Wen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
^Top
 
 
CLIN-Neuro-cognitive
A descriptive study on the relationship of cognitive function and cognitive reserve in survivors of primary brain tumors
Deborah Allen*, Barbara Carlson
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
A standard neurolinguistic approach to awake brain surgery in the pre-, intra- and postoperative phase
Elke De Witte*, Djaina Satoer, Robert Erik, Henry Colle, Evy Visch-Brink, Peter Mariën
Saturday, November 23, Scientific Meeting:  Concurrent Session 7B - Neurocognitive Outcomes and Quality of Life  -  3:15pm - 5:00pm
APOE genotype and cognitive outcome in patients with brain tumors
Denise Correa*, Jaya Satagopan, Raymond Baser, Kenneth Cheung, Michael Lin, Sasan Karimi, John Lyo, Lisa DeAngelis, Irene Orlow
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Associations between cognitive functioning and health-related quality of life in glioma patients
Florien Boele*, Maaike Zant, Emma Heine, Neil Aaronson, Martin Taphoorn, Jaap Reijneveld, Jan Heimans, Martin Klein
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Atypical language dominance in a right-handed patient: an anatomoclinical study with Direct Electrical Stimulation (DES) and functional Magnetic Resonance Imaging (fMRI)
Elke De Witte*, Peter Mariën
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Cardiopulmonary fitness and neurocognition in newly diagnosed glioblastoma patients treated with bevacizumab and impact on survival
Katherine Peters*, Aarti Kenjale, Miranda West, Whitney Hornsby, James Herndon, Frances McSherry, Annick Desjardins, Henry Friedman, Lee Jones
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Cognitive outcomes among focal low-grade brainstem glioma survivors
Kellie Clark*, Heather Conklin, Thomas Merchant, Paul Klimo, Atmaram Pai Panandiker
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Changes in FDG-PET uptake during a delayed match to sample memory task
Constance Linville*, Akiva Mintz, Robert Hampson, Sam Deadwyler, Ann Peiffer
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Home-based working memory training for pediatric brain tumor survivors
Bonnie Carlson-Green*, Jennifer Puig, Anne Bendel, Yi Lu
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Identifying cognitive reserve in survivors of primary brain tumors:  using proxies of premorbid intelligence, occupation, and education
Deborah Allen*, Barbara Carlson
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Introducing a structured, innovative model of care management developed to meet the needs of a highly complex patient group
Charlotte Lambourn*, Alison Corbett
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Longitudinal analysis of neurocognitive outcomes in patients with glioblastoma (GBM) enrolled in RTOG 0825
Jeffrey Wefel*, Stephanie Pugh, Terri Armstrong, Mark Gilbert, Minhee Won, Merideth Wendland, David Brachman, Paul Brown, Ian Crocker, H. Ian Robins, R. Jeffrey Lee, Minesh Mehta
Saturday, November 23, Scientific Meeting:  Concurrent Session 7B - Neurocognitive Outcomes and Quality of Life  -  3:15pm - 5:00pm
Memory preservation with conformal avoidance of the hippocampus during whole-brain radiotherapy (WBRT) for patients with brain metastases: preliminary results of RTOG 0933
Vinai Gondi*, Minesh Mehta, Stephanie Pugh, Wolfgang Tome, Benjamin Corn, Chip Caine, Andrew Kanner, Howard Rowley, Vijayananda Kundapur, Jeffrey Greenspoon, Andre Konski, Glenn Bauman, Wenyin Shi, Vivek Kavadi, Lisa Kachnic
Friday, November 22, Scientific Meeting:  Plenary Session - Award Winning Abstracts  -  8:15am - 10:15am
Neurocognitive dysfunction in newly diagnosed high-grade glioma patients: utilization of standardized computerized neurocognitive testing
Katherine Peters*, Sarah Woodring, Mary Lou Affronti, Stevie Threatt, Scott Lindhorst, Danijela Levacic, Annick Desjardins, Tulika Ranjan, Gordana Vlahovic, Allan Friedman, Henry Friedman
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Neurocognitive functioning and functional status in patients with glioma of the temporal lobes
Mariana Bradshaw*, Kyle Noll, Mateo Ziu, Jeffrey Weinberg, Crystal Strange, Catherine Turner, Jeffrey Wefel
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Neurocognitive functioning in patients with glioma of the right and left temporal lobes
Mateo Ziu*, Kyle Noll, Jeffrey Weinberg, Ronald Benveniste, Catherine Turner, Crystal Strange, Dima Suki, Jeffrey Wefel
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Pediatric cerebellar tumor survivors with severe posterior fossa syndrome suffer from critical lesions of their fronto-cerebellar tracts
Pablo Hernaiz Driever*, Verena Soelva, Stefan Rueckriegel, Harald Bruhn, Ulrich Thomale
Friday, November 22, Scientific Meeting:  Concurrent Session 3B - Pediatric Clinical  -  3:15pm - 5:00pm
Quality of life, mood, and neurocognitive functioning in patients with temporal lobe glioma
Catherine Turner*, Crystal Strange, Mariana Bradshaw, Kyle Noll, Jeffrey Wefel
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Sustainable benefits following computerized intervention targeting cognitive late effects among childhood cancer survivors: a randomized, single-blind, controlled trial
Heather Conklin*, Jason Ashford, Kellie Clark, Karen Martin-Elbahesh, Kristina Hardy, Thomas Merchant, Robert Ogg, Sima Jeha, Lu Huang, Hui Zhang
Saturday, November 23, Scientific Meeting:  Concurrent Session 7B - Neurocognitive Outcomes and Quality of Life  -  3:15pm - 5:00pm
The development of a web-based application of an evidence-based cognitive rehabilitation program for patients with primary brain tumors
Karin Gehring*, Petra Hoogendoorn, Margriet Sitskoorn
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Validation data for software-based neurocognitive tests for primary brain tumors
Chip Caine*, S Keith Anderson, B.T. Harel, Paul Brown, Jane H. Cerhan
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Verbal learning and encoding strategies in patients with glioma of the right and left temporal lobes
Kyle Noll*, Jeffrey Weinberg, Mateo Ziu, Catherine Turner, Crystal Strange, Jeffrey Wefel
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
When do patient/caregiver report of cognitive symptoms predict neurocognitive dysfunction?
Claudia V. Resendiz*, Terri S. Armstrong, Alvina Acquaye, Elizabeth Vera-Bolanos, Mark Gilbert, Jeffrey S. Wefel
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
^Top
 
 
CLIN-Immunotherapy/ Biologic Therapies
A bispecific antibody redirects regulatory T cells to kill tumor cells through granzyme-dependent cytotoxicity
Bryan Choi*, Patrick Gedeon, James Herndon, Luis Sanchez-Perez, Duane Mitchell, Darell Bigner, John Sampson
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
A dramatic clinical and cytologic response to Ipilimumab in a multi-drug regimen with bevacizumab.
Jeremy Rudnick*, Akshay Ravi, Cherry Sanchez, Derek Ng Tang, Jethro Hu, John Yu, Padmanee Sharma, Keith Black
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
A phase I trial of peptide-based glioma vaccine IMA950 in patients with glioblastoma: study design and preliminary results
Joohee Sul*, Norbert Hilf, Sarah Kutscher, Oliver Schoor, Juha Lindner, Carsten Reinhardt, Teri Kreisl, Fabio Iwamoto, Howard Fine, Harpreet Singh-Jasuja
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
A vaccine targeting mutant IDH1 induces antitumor immunity
Theresa Schumacher, Lukas Bunse, Felix Sahm, Stefan Pusch, Jasmin Quandt, Oliver Menn, Matthias Osswald, Angelika Riemer, Philipp Beckhove, Andreas von Deimling, Wolfgang Wick, Michael Platten*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Autologous dendritic cell vaccine to combat brain tumors in dogs and mice
Ratan Bhardwaj, Madhavi Chakravadhanula*, Victor Ozols, Joey Georges, Elizabeth Carlson, Chris Hampton, William Decker
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Bevacizumab and irinotecan in patients with recurrent glioblastoma: results of a retrospective cohort in Complejo Hospitalario de Navarra, Spain
Lucia Teijeira, Irene Gil-Arnaiz, Berta Hernandez-Marin*, Maite Martinez-Aguillo, Susana de la Cruz Sanchez, Antonio Viudez, Irene Hernandez-Garcia, Maria José Lecumberri, Rosana Grandez, Angela Fernandez de Lascoiti, Ruth Vera Garcia
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Case study of a recurrent anaplastic glioma patient treated with intratumoral adoptive allogeneic T cell immunotherapy
Horacio Soto*, Kate Erickson, Colin Malone, Michelle Hickey, Edward Ha, Emma Young, Benjamin Ellingson, Robert Prins, Linda Liau, Carol Kruse
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Cytotoxic T cell functional responsiveness may predict clinical efficacy of dendritic cell vaccination in glioblastoma patients
Richard Everson*, Richard Jin, Michael Safaee, Dominique Lisiero, Sylvia Odesa, Linda Liau, Robert Prins
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Determination and prognostic significance of the EGFRvIII status in glioblastoma: implications for diagnostic testing and current vaccination trials
Michael Weller*, Kerstin Kaulich, Bettina Hentschel, Jörg Felsberg, Dorothee Gramatzki, Thorsten Pietsch, Matthias Simon, Manfred Westphal, Gabriele Schackert, Joerg C. Tonn, Markus Loeffler, Guido Reifenberger
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Differentiation and generation of microglia-like cells from human induced pluripotent stem cells
Hetal Pandya*, Yong Choi, John Park
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Evidence supporting mechanism of action and drug activity in Phase I trial of patients with recurrent high grade glioma administered Toca 511 at surgical resection followed by Toca FC
Timothy F. Cloughesy*, Linda M. Liau, E. Antonio Chiocca, Douglas J. Jolly, Joan M. Robbins, Derek Ostertag, Carlos E. Ibañez, Harry E. Gruber, Noriyuki Kasahara, Michael A. Vogelbaum, Santosh Kesari, Tom Mikkelsen, Steven Kalkanis, Joseph Landolfi, Stephen Bloomfield, Greg Foltz, Dan Pertschuk
Sunday, November 24, Scientific Meeting:  Concurrent Session 9B - Biologic/Immunologic Therapies  -  10:20am - 12:00pm
Feasibility and safety study of GBM stem cell tumor amplified RNA immunotherapy in recurrent glioblastoma
Gordana Vlahovic*, Annick Desjardins, Katy Peters, Tulika Ranjan, James Herndon, Allan Friedman, Henry Friedman, Darell Bigner, Gerald Archer, Denise Lally-Goss, John Sampson
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Feasibility of lymphocyte harvesting and reinfusion in patients with newly diagnosed high grade gliomas
Jian Campian*, Douglas Gladstone, Prakash Ambady, Xiaobu Ye, Karen King, Ivan Borrello, Silvia Petrik, Marc Golightly, Matthias Holdhoff, Stuart Grossman
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
IL13Rα2-overexpressing malignant glioma cells that are resistant to radiation therapy can be successfully targeted by IL13CAR-expressing T cells
Sadhak Sengupta*, Prakash Sampath
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Immune escape in human malignant gliomas after WT1 peptide vaccination
Yasuyoshi Chiba*, Naoya Hashimoto, Naoki Kagawa, Ryuuichi Hirayama, Akihiro Tsuboi, Yuusuke Oji, Yoshihiro Oka, Haruo Sugiyama, Toshiki Yoshimine
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Long term remission over 5 years in patients with newly diagnosed glioblastoma (GBM) treated with ICT-107 vaccine: a follow up study
Surasak Phuphanich*, Christopher Wheeler, Jeremy Rudnick, Jethro Hu, Mia Mazer, Hong Wang, Miriam Nuno, Almar Guevarra, Cherry Sanchez, Xuemo Fan, Jianfei Ji, Ray Chu, James Bender, Elma Hawkins, Keith Black, John Yu
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
MGMT methylation, BRAF and IDH1/2 mutations and  EGFR variant III detection and their association with bevacizumab treatment
Georgios Rigakos, Olympia Spyri, Flora Stavridi, P Nomikos, Irene Grossi, Ioanna Theodorakopoulou, Avraam Assi, Georgios Kouvatseas, Eirini Papadopoulou, Georgios Nasioulas, Stefanos Labropoulos, Evangelia Razis*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Nimotuzumab containing regimen  for pediatric diffuse intrinsic pontine gliomas: single center study
Rejin Kebudi*, F. Betul Cakir, Omer Gorgun, Fulya Yaman Agaoglu, Emin Darendeliler
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Overcoming brain tumor immune-evasion by disrupting the CD47-SIRPa interaction axis to treat high grade pediatric and adult brain tumors
Sharareh Gholamin*, Siddhartha S Mitra, Chase Elliott Richard, Achal Achrol, Suzana Assad Kahn, Anne Katherin Volkmer, Jens Peter Volkmer, Stephen Willingham, Doosik Kong, Jun Jae Shin, Michelle Monje-Deisseroth, Yoon-Jae Cho, Irving Weissman, Samuel H. Cheshier
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Phase I/II trial of tumor lysate pulsed dendritic cell vaccine with a toll-like receptor 7 (TLR7) agonist for patients with glioblastoma
John Yu*, Jeremy Rudnick, Jethro Hu, Surasak Phuphanich, Mia Mazer, Hongqiang Wang, Minlin Xu, Miriam Nuno, Chirag Patil, Ray Chu, Keith Black, Chris Wheeler
Sunday, November 24, Scientific Meeting:  Concurrent Session 9B - Biologic/Immunologic Therapies  -  10:20am - 12:00pm
Plasma IgE increase during treatment correlates with better outcome of glioblastoma patients
Yi Lin*, Yunjie Wang, Xiaoguang Qiu, Tao Jiang
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Prognostic implications of regulatory T-cells in patients with glioblastoma
Alissa Thomas*, Jan Fisher, Udo Baron, Sven Olek, Harker Rhodes, Jiang Gui, Thomas Hampton, Laura Tafe, Gregory Tsongalis, Joel Lefferts, Heather Wishart, Jonathan Kleen, Michael Miller, Marc Ernstoff, Camilo Fadul
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Prognostic value of cytokines in glioblastoma
Yi Lin*, Yunjie Wang, Tao Jiang, Guozhen Zhang, Jiangfei Wang
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Robust induction of type-1 CD8+ T-cell responses in WHO grade II low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC
Hideho Okada*, Lisa Butterfield, Ronald Hamilton, Jan Drappatz, Johnathan Engh, Nduka Amankulor, Mark Lively, Michael Chan, Andres Salazar, Douglas Potter, Edward Shaw, Frank Lieberman
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
ReACT: a phase II study of rindopepimut vaccine (CDX-110) plus bevacizumab in relapsed glioblastoma
David Reardon*, Gordon Li, Lawrence Recht, Karen Fink, Louis Nabors, David Tran, Annick Desjardins, Nitin Chandramouli, J. Paul Duic, Morris Groves, Anne Clarke, Thomas Hawthorne, Jennifer Green, Michael Yellin, John Sampson
Sunday, November 24, Scientific Meeting:  Concurrent Session 9B - Biologic/Immunologic Therapies  -  10:20am - 12:00pm
Simultaneous immunotherapy targeting IDO, CTLA-4 and PD-L1 increases overall survival in an orthotopic brain tumor model
Derek Wainwright*, Mahua Dey, Alan Chang, Yu Cheng, Yu Han, Maciej Lesniak
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Targeting (KLAKLAK)2, a pro-apoptotic peptide to GBM cells
Young A. Choi*, Hetal Pandya, Denise M. Gibo, Waldemar Debinski
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Targeting IDH1 mutations using peptide vaccines in brain tumors
Elizabeth Reap*, Gerald Archer, Luis Sanchez-Perez, Pamela Norberg, Robert Schmittling, Smita Nair, Xiuyu Cui, David Snyder, Vidya Chandramohan, Bryan Choi, Chien-Tsun Kuan, Duane Mitchell, Darell Bigner, Hai Yan, John Sampson
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Vaccination of dendritic cells loaded by electroporation with autologous tumor lysate for patients with recurrent malignant glioma: evaluation of safety and immune response
Yonehiro Kanemura*, Miho Sumida, Ema Yoshioka, Atsuyo Yamamoto, Daisuke Kanematsu, Ai Takada, Masahiro Nonaka, Shin Nakajima, Shigenori Goto, Takashi Kamigaki, Masashi Takahara, Ryuji Maekawa, Tomoko Shofuda, Shusuke Moriuchi, Mami Yamasaki
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Vaccine site pre-treatment with tetanus-diphtheria toxoid systemically enhances migration and therapeutic effect of dendritic cell vaccines in a randomized clinical trial and preclinical model
Kristin Batich*, Duane Mitchell, David Snyder, Weihua Xie, Elizabeth Reap, Xiuyu Cui, Luis Sanchez-Perez, Gary Archer, Smita Nair, Michael Gunn, John Sampson
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
^Top
 
 
LAB-Radiobiology
Association between diffusion and clinical outcome vary with treatment regimen for patients with newly diagnosed glioblastoma
Qiuting Wen*, Laleh Jalilian, Emma Essock-Burns, Yan Li, Soonmee Cha, Susan Chang, Michael Prados, Nicholas Butowski, Sarah Nelson
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Axitinib radiosensitization of radiosurgery
Shyam Rao*, Chris Thompson, Jin Cheng, Adriana Haimovitz-Friedman, Zvi Fuks, Richard Kolesnick
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Connexin 30 (GJB6) inhibits cell growth in human malignant gliomas but mediates radiation resistance. 
Maria Artesi*, Jerome Kroonen, Manuel Deprez, Markus Bredel, Arnab Chakravarti, Christophe Poulet, Tatjana Seute, Bernard Rogister, Vincent Bours, Pierre Robe
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Differential growth and cell redox levels in response to radiation in two types of glioma cell subpopulations
Chao Ke, Katherine Tran, Anne T. Di Donato, Ning Ru, Mark E. Linskey, Charles Limoli, Yi-Hong Zhou*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Inhibition of recurrences of experimental brain tumors and brain metastases after irradiation by blocking the activity of SDF-1 using the Spiegelmer® NOX-A12.
Shie-Chau Liu, Sophia Chernikova, Milton Merchant, Taichang Jang, Stefan Zöllner, Anna Kruschinski, G-one Ahn, Laurence Recht, Martin Brown*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Preclinical evidence that FGFR1 inhibition radiosensitizes human glioblastoma in vitro and in vivo
Elizabeth Cohen-Jonathan Moyal*, Caroline Delmas, Marion Taurand, Sandrine Mazoyer, Morgane Farge, Christine Toulas
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
^Top
 
 
LAB-Metabolic Pathways
A hexokinase 2 (HK2) associated gene signature identifies the azole class of antifungals as effective drug compounds targeting tumour metabolism in glioblastoma
Sameer Agnihotri*, Kelly Burrell, Sanjay Singh, Alenoush Vartanian, Amparo Wolf, Fredrick Lang, Roel Verhaak, Cynthia Hawkins, Kenneth Aldape, Gelareh Zadeh
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Anatomical distribution of oncometabolites in IDH1 mutant gliomas revealed by in situ high resolution imaging mass spectrometry
Fred Fack, David Bonnel, Guillaume Hochart, Anna C. Navis, Pieter Wesseling, William P.J. Leenders, Jonathan Stauber, Simone P. Niclou*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Evaluation of fatty acid synthase expression as predictive factor for aggressiveness in meningiomas
Keishi Makino*, Hideo Nakamura, Taku-ichiro Hide, Shigetoshi Yano, Jun-ichiro Kuroda, Jun-ichi Kuratsu
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Glioblastoma stem cells require iron for maintaining tumorigenic potential
David Schonberg*, Daniel Lubelski, Jeremy Rich
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Hypoxia and oxygenation induce a metabolic switch between the pentose phosphate pathway and glycolysis in glioma stem-like cells
Annegret Kathagen, Alexander Schulte, Gerd Balcke, Heidi Phillips, Hauke Günther, Manfred Westphal, Katrin Lamszus*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Involvement of the kynurenine pathway in human primary glioma pathophysiology
Seray Adams*, Charles Teo, Kerrie McDonald, Anna Zinger, Sonia Bustamante, Chai K Lim, Nady Braidy, Bruce J Brew, Gilles J Guillemin
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
LDHA silencing in IDH mutant gliomas
Charles Chesnelong*, Myriam Chaumeil, Michael D. Blough, Mohammad Al-Najjar, Owen D. Stechishin, Sabrina Ronen, Samuel Weiss, H. Artee Luchman, J. Gregory Cairncross
Sunday, November 24, Scientific Meeting:  Concurrent Session 8A - Metabolic Pathways/Stem Cells  -  8:15am - 10:05am
Meta-analysis of cancer cell line genomes based on their response to alternating electric fields (TTFields)
Moshe Giladi*, Yoram Wasserman, Noa Urman, Yaara Porat, Rosa Schneiderman, Mijal Munster, Uri Weinberg, Eilon Kirson, Yoram Palti
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Metabolic disruption as a mechanism to potentiate temozolomide therapy in glioblastoma multiforme
Ekokobe Fonkem*, Richard Tobin, Jennifer Griffin, Alex Zuzek, Martha Rogers
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Mechanistic insight into "go or grow" behavior of glioma cells: microRNA-451/AMPK negative feedback loop
Jakub Godlewski*, Agnieszka Bronisz, Khairul Ansari, Daisuke Ogawa, Michal O. Nowicki, E. Antonio Chiocca
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Regulating tumor metabolism and response to therapy with hexokinase II (HKII) inhibition in glioblastoma (GBM)
Alenoush Vartanian, Sanjay K. Singh, Kelly Burrell, Sameer Agnihotri, Nesrin Sabha, Gelareh Zadeh*
Sunday, November 24, Scientific Meeting:  Concurrent Session 8A - Metabolic Pathways/Stem Cells  -  8:15am - 10:05am
The bevacizumab pseudoresponse: disappointment or opportunity?
Jae Mo Park, Taichang Jang, Sonal Josan, Dirk Mayer, Daniel Spielman, Lawrence Recht*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The endogenous tryptophan metabolite and NAD+ precursor quinolinic acid confers resistance of gliomas to oxidative stress
Felix Sahm*, Iris Oezen, Christiane Opitz, Bernhard Radlwimmer, Andreas von Deimling, Helge B Bode, Tilman Ahrendt, Seray Adams, Gilles Guillemin, Wolfgang Wick, Michael Platten
Sunday, November 24, Scientific Meeting:  Concurrent Session 8A - Metabolic Pathways/Stem Cells  -  8:15am - 10:05am
^Top
 
 
LAB-Molecular Epidemiology
POT1 germline mutations may explain a subset of familial glioma: a report from the Gliogene Consortium
Melissa Bondy*, Matthew Bainbridge, Shalini Jhangiani, Ali Jalali, Sharon E. Plon, Georgina Armstrong, Jonine Bernstein, Elizabeth Claus, Faith Davis, Richard Houlston, Dora Il'yasova, Robert Jenkins, Christoffer Johansen, Daniel Lachance, Rose Lai, Ching Lau, Ryan Merrell, Sara Olson, Siegal Sadetzki, Joellen Schildkraut, Sanjay Shete, Jill Barnholtz-Sloan, Margaret Wrensch, The Gliogene Consortium, Beatrice Melin, Richard A. Gibbs
Saturday, November 23, Scientific Meeting:  Plenary Session 5 - Award Winning Abstracts  -  10:45am - 11:30am
Chromosome 17q linkage sequencing in familial glioma: a report from the Gliogene Consortium
Ali Jalali*, Matthew Bainbridge, Shalini Jhangiani, Sharon E. Plon, Georgina Armstrong, Jonine Bernstein, Elizabeth Claus, Faith Davis, Richard Houlston, Dora Il'yasova, Robert Jenkins, Christoffer Johansen, Daniel Lachance, Rose Lai, Ching Lau, Ryan Merrell, Sara H. Olson, Siegal Sadetzki, Joellen Schildkraut, Sanjay Shete, Jill Barnholtz-Sloan, Margaret Wrensch, The Gliogene Consortium, Beatrice Melin, Richard A. Gibbs, Melissa Bondy
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Differences in biomarker expression in GBM patients with early progression after surgery
Joshua Palmer*, Jianliang Li, Lawrence Kenyon, David Andrews, Lyndon Kim, Jon Glass, Maria Werner-Wasik, Wenyin Shi
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Genomic alterations in atypical teratoid/rhabdoid tumors: the Medical University of Vienna experience
Christine Haberler*, Thomas Czech, Monika Chocholous, Christian Dorfer, Irene Slavc
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Glioma risk SNPs in EGFR and CCDC26 are associated with specific tumor expression signatures
Kyle M Walsh*, Paul A Decker, Jeanette E Eckel-Passow, Annette M Molinaro, Helen M Hansen, Terri Rice, Shichun Zheng, Thomas Kollmeyer, Mitchel S Berger, Susan M Chang, Michael D Prados, Amanda Rynearson, Alissa Caron, Matthew L Kosel, Daniel H Lachance, Brian Patrick O'Neill, Caterina Giannini, John K Wiencke, Robert B Jenkins, Margaret R Wrensch
Saturday, November 23, Scientific Meeting:  Concurrent Session 6B - Molecular Epidemiology/Biomarkers  -  1:00pm - 3:00pm
IDH1 mutation specific miRNA signature predicts favorable prognosis in glioblastoma with IDH1 wild-type
Zheng Wang*, Zhaoshi Bao, Tao Jiang
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Integrated genomic analysis of hemangioblastoma in central nervous system
Shunsaku Takayanagi*, Akitake Mukasa, Koki Aihara, Kuniaki Saito, Ryohei Otani, Shota Tanaka, Hirofumi Nakatomi, Hiroyuki Aburatani, Koichi Ichimura, Keisuke Ueki, Nobuhito Saito
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
SOCS3 promoter hypermethylation is a favorable prognosticator and a novel indicator for G-CIMP-positive GBM patients
Zheng Wang*, Zhaoshi Bao, Tao Jiang
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Survey of the prognostic factors in 1p/19q codeleted gliomas
Saeko Hayashi*, Hikaru Sasaki, Tokuhiro Kimura, Takumi Nakamura, Tomoru Miwa, Yuichi Hirose, Kazunari Yoshida
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The frequency of the rs55705857 risk allele is elevated and similar in familial and sporadic glioma patients.
Robert Jenkins*, Margaret Wrensch, Thomas Kollmeyer, Georgina Armstrong, Sara Olson, Rose Lai, Daniel Lachance, Ching Lau, Elizabeth Claus, Jill Barnholtz-Sloan, Dora Il'yasova, Joellen Schildkraut, Richard Houlston, Sanjay Shete, Jonine Bernstein, Faith Davis, Ryan Merrell, Christoffer Johansen, Siegal Sadetzki, The GLIOGENE Consortium, Beatrice Melin, Melissa Bondy
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The promoter methylation of MGMT and IDH mutation are potential marker of secondary GBM patients prognosis
Li Bie*, Yunqian Li, Hongyan Yuan
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
^Top
 
 
LAB-Pediatrics Laboratory Research
Association of the presence of neurospheres in tumor cultures with treatment response and survival of children with astrocytoma
Enrique Lopez, Andrea Ponce de León*, Carolina Sepulveda, Luis Zarate, Jaime Diego-Pérez
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
BRAF-InsT variant in pediatric glioblastoma: case report and in vitro response to BRAF inhibition
Tsun-Wen Yao*, Jie Zhang, Berry Anna, Tilman Brummer, Nalin Gupta, Theodore Nicolaides
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Cell migration in paediatric glioma; characterisation and potential therapeutic targeting
Julia Cockle*, Anke Bruning-Richardson, Susan Picton, Jane Levesley, Elizabeth Ilett, Susan Short, Alan Melcher, Sean Lawler
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Defining the cell type- and brain region-specific determinants underlying KIAA1549:BRAF-induced murine glioma in vitro and in vivo
Aparna Kaul*, Yi-Hsien Chen, Sonika Dahiya, Ryan Emnett, Scott Gianino, David Gutmann
Sunday, November 24, Scientific Meeting:  Concurrent Session 8A - Metabolic Pathways/Stem Cells  -  8:15am - 10:05am
Development of a DIPG orthotopic model in nude mice using an implantable guided-screw system
Miguel Marigil, Patricia Jauregi*, Miguel Angel Idoate, Enric Xipell, Guillermo Aldave, Marisol Gonzalez-Huarriz, Sonia Tejada-Solís, Ricardo Diez-Valle, Angel Montero-Carcaboso, Jaume Mora, Marta M Alonso
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Functions of voltage-gated potassium channel EAG2 in medulloblastoma and mechanism-based therapy using a FDA-approved drug
Xi Huang*, Ye He, Adrian Dubuc, Rintaro Hashizume, Wei Zhang, Samantha Stehbens, Susan Younger, Suzanne Barshow, Sijun Zhu, Xiaochong Wu, Michael Taylor, Sabine Mueller, William Weiss, David James, Marc Shuman, Yuh Nung Jan, Lily Jan
Saturday, November 23, Scientific Meeting:  Concurrent Session 7A - Pediatric Basic and Translational Research  -  3:15pm - 5:00pm
Identifying differential roles for Collapsin Response Mediator Protein4 (CRMP4) variants in medulloblastoma growth and metastasis
Balasubramanian Sivasankaran*, Radhi Praba Velayutham, Isabella R Fraschilla, Kevin J Morris, Tobey J MacDonald, Tracy-Ann Read
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Metastatic recurrent medulloblastoma is highly distinct from its matched primary tumor
Livia Garzia*, Sorana Morrisy, Patryk Skowron, Salomeh Jelveh, Patricia Lindsay, David Largaespada, Lara Collier, Adam Dupuy, Richard Hill, Michael Taylor
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Membrane depolarization is a medulloblastoma tumor suppressor
Livia Garzia*, Adrian Dubuc, Graham Pitcher, Paul Northcott, Adrian Mariampillai, Stephen Mack, Kory Zayne, Tiffany Chan, Patryk Skowron, Xiaochong Wu, Anath Lionel, Sorana Morrisy, Cynthia Hawkins, Paul Kongkham, James Rutka, Annie Huang, Anna Kenney, Victor Yang, Michael Salter, Michael Taylor
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Molecular profiling of CNS-PNETs identifies recurrent hallmark aberrations of various well-defined entities
Dominik Sturm*, Paul Northcott, David Jones, Andrey Korshunov, Daniel Picard, Peter Lichter, Annie Huang, Stefan Pfister, Marcel Kool
Friday, November 22, Scientific Meeting:  Concurrent Session 2A - Pathology/Genomics  -  1:00pm - 3:00pm
Neuro-glial interactions in the pontine microenvironment
Viola Caretti*, Alyssa Noll, Pam Woo, Michelle Monje
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
None or little number of chromosomal aberrations detected by comparative genomic hybridization in fetal brain tumors
Tomoru Miwa*, Shizuo Oi, Yuichiro Nonaka, Hikaru Sasaki, Kazunari Yoshida
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Pediatric GBMs: H3F3A mutations and correlation with methylation profiling and histone code
Chitra Sarkar*, Pankaj Pathak, Prerana Jha, Suvendu Purkait, Vikas Sharma, M.C. Sharma, Vaishali Suri, Mohammed Faruq, Mitali Mukherjee
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Recurrent activating ACVR1/ALK2 mutations in diffuse intrinsic pontine glioma
Katy Taylor, Alan Mackay, Nathalene Truffaux, Olena Morozova, Yaron Butterfield, Cathy Phillipe, Maria Vinci, Carmen de Torres, Ofelia Cruz, Jaume Mora, Darren Hargrave, Michelle Monje, Stephanie Puget, Stephen Yip, Chris Jones*, Jacques Grill
Friday, November 22, Scientific Meeting:  Plenary Session - Award Winning Abstracts  -  8:15am - 10:15am
Small RNA sequencing discloses the Oct4-miR199a/214 pathway contributes in chemoresistance and tumor malignacy of pediatric intracranial germ cell tumors
Tsung-Han Hsieh*, Hsei-Wei Wang, Wei-Chung Cheng, Tai-Tong Wong
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression
Kui-Ming Chan, Dong Fang, Haiyun Gan, Rintaro Hashizume, Chuane Yu, Mark Schroeder, Nalin Gupta, Sabine Mueller, David James, Robert Jenkins, Jann Sarkaria, Zhiguo Zhang*
Saturday, November 23, Scientific Meeting:  Concurrent Session 7A - Pediatric Basic and Translational Research  -  3:15pm - 5:00pm
Whole genome sequencing reveals microglia as key microenvironmental drivers of neurofibromatosis-1 glioma formation and growth
Winnie Pong*, Li Ding, Michael McLellan, Ibrahim Hussain, Ryan Emnett, Scott Gianino, Samantha Higer, Jeffrey Leonard, Abhijit Guha, Elaine Mardis, David Gutmann
Saturday, November 23, Scientific Meeting:  Concurrent Session 7A - Pediatric Basic and Translational Research  -  3:15pm - 5:00pm
^Top
 
 
LAB-Angiogenesis and Invasion
A c-Met-ß1 integrin complex drives invasive resistance to anti-angiogenic therapy
Arman Jahangiri, Michael De Lay, Kan Lu, Catherine Park, Shawn Carbonell, Gabriele Bergers, Manish K. Aghi*
Friday, November 22, Scientific Meeting:  Concurrent Session 3A - Angiogenesis and Invasion  -  3:15pm - 5:00pm
Activation of the prototypical SFK c-Src promotes angiogenesis of human glioblastoma
Eskil Eskilsson*, Krishna M. Talasila, Gro V. Røsland, Lina Leiss, Halala Sdik Saed, Narve Brekkå, Per Øystein Sakariassen, Morten Lund-Johansen, Per Øyvind Enger, Rolf Bjerkvig, Hrvoje Miletic
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
An in situ organotypic slice culture migration model to dissect migrating from non-migrating human brain tumor initiating cells
Verena Gawrisch*, Maike Rüttgers, Patrizia Weigell, Eugen Kerkhoff, Markus Riemenschneider, Ulrich Bogdahn, Arabel Vollmann-Zwerenz, Peter Hau
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Angiopoietins and angiopoietin receptor expression and function in glioblastoma.
Hannah Schneider*, Emese Szabo, Katharina Seystahl, Michael Weller
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Anti-angiogenic efficacy of Bevacizumab alone and in combination with a dual PI3K/mTOR inhibitor in an orthotopic  model of malignant glioma: A multimodal neuro-imaging approach
Philip O'Halloran*, Thomas Viel, Katrin Schwegmann, Lydia Wachsmuth, Stefan Wagner, Klaus Kopka, Patrick Dicker, Cornelius Faber, Monika Jarzabek, Sven Hermann, Michael Schäfers, David O'Brien, Jochen Prehn, Andreas Jacobs, Annette Byrne
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma
Tomotsugu Ichikawa*, Manabu Onishi, Kazuhiko Kurozumi, Tomoko Maruo, Kentaro Fujii, Joji Ishida, Yosuke Shimazu, Tetsuo Oka, E. Antonio Chiocca, Isao Date
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Bone marrow derived immune cells and their role in tumor heterogeneity
Kelly Burrell*, Sanjay Singh, Richard Hill, Gelareh Zadeh
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
CD166/ALCAM is expressed in glioblastoma endothelial cells and is involved in the regulation of glioblastoma angiogenesis through the regulation of interleukin 8
Noriyuki Kijima*, Naoki Hosen, Naoki Kagawa, Naoya Hashimoto, Yasuyoshi Chiba, Manabu Kinoshita, Haruo Sugiyama, Toshiki Yoshimine
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
CD44 expression is correlated with animal survival and cell migration in induced mouse models of glioma
Rebecca Klank*, Stacy Decker, Colleen Forster, Matthew Price, Karen SantaCruz, James McCarthy, John Ohlfest, David Odde
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Differences in internalization of bevacizumab by normal brain endothelial cells and endothelial cells isolated from GBM tumors
Gaelle Muller-Greven*, Cathleen Carlin, Candece Gladson
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Distinct functional roles of wild-type EGFR and its mutant EGFRvIII in glioblastoma development
Gro V. Rosland, Krishna M. Talasila, Eskil Eskilsson, Roza Jahedi, Francisco Azuaje, Daniel Stieber, Sarah Foerster, Jobin Varughese, Christoph Ritter, Simone P. Niclou, Rolf Bjerkvig, Hrvoje Miletic*
Friday, November 22, Scientific Meeting:  Concurrent Session 3A - Angiogenesis and Invasion  -  3:15pm - 5:00pm
EGFR- and Notch pathway blockade reduce the angiogenic- and tumourigenic potential of glioblastoma multiforme stem-like cells
Louise Stobbe Olsen*, Marie Stockhausen, Hans Skovgaard Poulsen
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis
Krishna M. Talasila, Anke Soentgerath, Philipp Euskirchen, Gro V. Rosland, Jian Wang, Peter C. Huszthy, Lars Prestegarden, Kai Ove Skaftnesmo, Per Oystein Sakariassen, Eskil Eskilsson, Daniel Stieber, Olivier Keunen, Janice Nigro, Olav K. Vintermyr, Morten Lund-Johansen, Simone P. Niclou, Sverre Mork, Per Oyvind Enger, Rolf Bjerkvig, Hrvoje Miletic*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Endothelial Angiopoietin-2 links angiogenesis and inflammation in glioblastoma and represents an attractive therapeutic target
Karl H. Plate*, Alexander Scholz, Reinhard Henschler, Peter Baumgarten, Patrick Harter, Michel Mittelbronn, Daniel Dumont, Yvonne Reiss
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Fibulin-3/EFEMP1 activates Notch signaling in brain microvascular endothelial cells and promotes glioma vascularization
Nandhu Mohan-Sobhana*, Bin Hu, Jessica De Jesus, Brynn Hollingsworth, Mariano Viapiano
Friday, November 22, Scientific Meeting:  Concurrent Session 3A - Angiogenesis and Invasion  -  3:15pm - 5:00pm
Functional significance of CCAAT/enhancer binding protein -β (C/EBPβ) isoforms in glioblastoma
Monika Anand*, Carol Tucker-Burden, Jun Kong, Daniel J. Brat
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Gene expression profiling of the anti-glioma effect of Cilengitide
Kazuhiko Kurozumi*, Manabu Onishi, Tomotsugu Ichikawa, Kentaro Fujii, Joji Ishida, Yosuke Shimazu, E.Antonio Chiocca, Balveen Kaur, Isao Date
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Glial-tumor interface in metastatic and primary brain neoplasms
Shervin Rahimpour*, Chunzhang Yang, Jason Frerich, Zhengping Zhuang
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Glioblastoma adaptation to anti-vascular therapy involves an up-regulation of glycolysis where lactate dehydrogenase (LDH) represents a potential therapeutic target
Fred Fack, Heidi Espedal, Nina Obad, Olivier Keunen, Eyal Gotlieb, Per Ø. Sakariassen, Hrvoje Miletic, Simone P. Niclou*, Rolf Bjerkvig
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Glioma angiogenesis, angiogenic switch and perfusion imaging
Rajan Jain*, Brent Griffith, Kamal Khalil, Lisa Scarpace, Tom Mikkelsen, Steve Kalkanis, Lonni Schultz
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Glycogen synthase kinase 3β promotes glioma invasion via the FAK/Rac1/JNK/MMP2 pathway
Mitsutoshi Nakada*, Takuya Furuta, Hemragul Sabit, Yuri Chikano, Yutaka Hayashi, Hiroshi Sato, Toshinari Minamoto, Jun-ichiro Hamada
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Hypomethylated Rab27b identified as a progression associated and prognostic biomarker in glioma via inducing a invasive phenotype
Chuanlu Jiang*, Hongjun Wang
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Identification of a novel VEGF-responsive lincRNA that regulates angiogenesis in glioblastoma
Jenny Wang, Megan Wu, Phil Marsden, Sunit Das*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Identifying different functional mechanisms of invasion from mesenchymal and proneural subtypes of glioblastoma
Michael Berens*, Sungwon Jung, Seungchan Kim, Jeff Kiefer, Jenny Eschbacher, Harshil Dhruv, Kristiina Vuori, Craig Hauser, Robert Oshima, Darren Finlay, Pedro Aza-Blanc, Marina Bessarabova, Yuri Nikolsky, Dorothea Emig
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Increased tumor invasiveness following anti-angiogenic treatment in the GL261 model of glioma
Danielle Renner*, Fang Jin, Ian Parney, Aaron Johnson
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Intratumoral heterogeneity of cellular migration in human glioblastoma
Jonathon Parker, Kalen Dionne, Peter Canoll, BK DeMasters, Allen Waziri*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Microglia and infiltrating monocytes promote invasion, mesenchymal, and stem-like signatures in GBM through paracrine HGF
Kan Lu*, Lee Rivera, Jeffrey Chang, Gabriele Bergers
Friday, November 22, Scientific Meeting:  Concurrent Session 3A - Angiogenesis and Invasion  -  3:15pm - 5:00pm
MicroRNA signature of pediatric glioblastoma invasion: an in vivo study in patient-tumor derived orthotopic xenograft mouse models
Yulun Huang, Qi Lin, Hua Mao, Yue Wang, Mari Kogiso, Patricia Baxter, Chris Man, Zhong Wang, Youxing Zhou, Xiao-Nan Li*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Multimodal anti-glioma mechanisms of cilengitide demonstrated by novel invasive glioma models  
Michiari Umakoshi*, Tomotsugu Ichikawa, Kazuhiko Kurozumi, Manabu Onishi, Kentaro Fujii, Joji Ishida, Yoshuke Shimazu, Tetsuo Oka, E. Antonio Chiocca, Balveen Kaur, Isao Date
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Neutrophils promote the malignant glioma phenotype through S100A4
Ji Liang*, Yuji Piao, John de Groot
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Non-invasive MRI biomarkers of response to anti-angiogenic therapy in glioblastoma multiforme
Shahrzad Jalali*, Caroline Chung, Kelly Burrell, Warren Foltz, Gelareh Zadeh
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas
Tetsuo Oka*, Tomotsugu Ichikawa, Kazuhiko Kurozumi, Satoshi Inoue, Kentaro Fujii, Joji Ishida, Yosuke Shimazu, E. Antonio Chiocca, Isao Date
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Oct-3/4 promotes tumor angiogenesis through VEGF production in glioblastoma
Akihiro Inoue*, Hironobu Harada, Shohei Kohno, Shiro Ohue, Takanori Ohnishi, Hisaaki Takahashi, Junya Tanaka
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Phenotype-specific and species-specific differences in mouse and rat glioblastoma models
Sébastien Bougnaud, Anna Golebiewska, Daniel Stieber, Anais Oudin, Nicolaas H.C. Brons, Rolf Bjerkvig, Simone P. Niclou*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Proteomic analysis of invasion- and angiogenesis-related proteins in malignant gliomas
Yu Takahashi*, Tomotsugu Ichikawa, Tomoko Maruo, Kazuhiko Kurozumi, Manabu Onishi, Mamoru Ouchida, Kentaro Fuji, Yosuke Shimazu, Tetsuo Oka, E. Antonio Chiocca, Isao Date
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Promoter methylation and gene expression microarray analysis reveals PDE4C to be a potential marker of prognosis in human glioma
Hongjun Wang*, Chuanlu Jiang
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Reduced EGFR activity in the brain does not affect glioma growth but reduces tumor invasion and prevents the pro-invasive role of brevican
Hosung Sim, Paul Gruenbacher, Lyn Jakeman, Mariano Viapiano*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
S1P: an alternative anti-angiogenic target in GBM
Hazem Abuhusain*, Azadeh Matin, Qiao Qiao, Han Shen, Benjamin Daniels, Maarit Laaksonen, Charlie Teo, Anthony Don, Kerrie McDonald
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Stromal protein periostin identified as a progression associated and prognostic biomarker in glioma via inducing a invasive and proliferative phenotype
Hongjun Wang*, Chuanlu Jiang
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Targeting the PI3Kinase pathway reduces bevacizumab-induced glioblastoma infiltration
Shannon McDonell*, Ji Liang, Yuji Piao, Verlene Henry, Lindsay Holmes, John de Groot
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Targeting the vascular niche: evolving feedback mechanisms of resistance
Gabriele Bergers*, Kan Lu, Lee Rivera, Jeffrey Chang
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Treatment of GBM xenograft tumors with a thrombospondin mimetic peptide, ABT-898:  comparison to bevacizumab
Eunnyung Bae*, Luke Smith, Gaelle Muller-Greven, Ryosuke Yamada, Mariko Nakano-Okuno, Xi Feng, Dolores Hambardzumyan, Ichiro Nakano, Candece L. Gladson
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Vasculogenic mimicry persistently exists during glioblastoma xenograft growth
Cong Li, Yinsheng Chen, Xin Mei, Ke Sai, Zhongping Chen*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
VEGF independent activation of VEGFR2 in glioblastoma multiforme cells
Signe Regner Michaelsen*, Marie-Thérése Stockhausen, Hans Skovgaard Poulsen
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Why aren’t all medial gliomas bilateral?
Russell Rockne*, Andrea Hawkins-Daarud, Joshua Jacobs, Carly Bridge, Maciej Mrugala, Jason Rockhill, Kristin Swanson
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
^Top
 
 
LAB-Stem Cells
Bone marrow derived human mesenchymal stem cells(hMSCs) localize specifically in the human primary glioblastoma xenografts by intravascular injection and Irradiation drives the homing of hMSCs
Tatsuya Takezaki*, Naoki Shinojima, Jun-ichi Kuratsu, Frederick Lang
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Brain tumor stem cells adapt to restricted nutrition through preferential glucose uptake
William Flavahan, Qiulian Wu, Masahiro Hitomi, Nasiha Rahim, Youngmi Kim, Andrew Sloan, Robert Weil, Ichiro Nakano, Jann Sarkaria, Brett Stringer, Meizhang Li, Justin Lathia, Jeremy Rich, Anita Hjelmeland*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Casein kinase 2 alpha regulates GBM cancer stem cell growth through the Beta-catenin pathway
Ryan Nitta, Siddartha Mitra, Maya Agarwal, Timothy Bui, Gordon Li*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Clonal evolution meets cancer stem cells in glioblastoma
Anna Golebiewska*, Daniel Stieber, Lisa Evers, Elizabeth Lenkiewicz, Nicolaas H.C. Brons, Nathalie Nicot, Anaïs Oudin, Sébastien Bougnaud, Frank Hertel, Rolf Bjerkvig, Mike Barrett, Laurent Vallar, Simone P. Niclou
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Divergent effects of BRafV600E expression and pharmacological inhibition in Ink4a/Arf deficient neural stem and progenitor cells
Robin Lerner*, Amelie Griveau, Yuichiro Ihara, Brian Reichholf, Martin McMahon, David Rowitch, David James, Claudia Petritsch
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
EGFRvIII expression contributes to glioblastoma stem cell properties and its expression is regulated by epigenetic mechanisms
David Emlet*, Catherine Del Vecchio, Puja Gupta, Gordon Li, Steven Skirboll, Albert Wong
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Enhancing retroviral replicating vector-mediated prodrug activator gene therapy with engineered human mesenchymal stem cells in animal models of glioma
Quincy Tam*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme
Bryan Day*, Brett Stringer, Fares Al-Ejeh, Michael Ting, John Wilson, Kathleen Ensbey, Paul Jamieson, Zara Bruce, Yi Chieh Lim, Carolin Offenhauser, Sara Charmsaz, Leanne Cooper, Jennifer Ellacott, Angus Harding, Jason Lickliter, Po Inglis, Brent Reynolds, David Walker, Martin Lackmann, Andrew Boyd
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Establishment of genetically distinct brain tumor stem cells from glioblastoma before and after molecular targeted therapy
Shota Tanaka, Samantha Luk, Clarice Chang, John Iafrate, Daniel Cahill, Robert Martuza, Samuel Rabkin, Andrew Chi, Hiroaki Wakimoto*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Evolution of cancer stem cells in glioma to promote therapy resistant phenotype
Ichiro Nakano*
Sunday, November 24, Scientific Meeting:  Concurrent Session 8A - Metabolic Pathways/Stem Cells  -  8:15am - 10:05am
Expression of AJAP1 in U87MG cells inhibits glioma stem cell maintenance
James Lin*, Cory Adamson
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Gap junction switching maintains the tumor hierarchy in glioblastoma
Masahiro Hitomi, Loic Deleyrolle, Maksim Sinyuk, Meizhang Li, Winston Goan, Balint Otvos, Mark Rohaus, Muna Oli, Vinata Vedam-Mai, David Schonberg, Qiulian Wu, Jeremy Rich, Brent Reynolds, Justin Lathia*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Glioblastoma stem- and progenitor-like cells: size matters
Carlo Cusulin*, Artee Luchman, Sam Weiss
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Glioma stem cell specific microRNA-mRNA interaction network
Sanjay Singh*, Kelly Burrell, Elizabeth Koch, Sameer Agnihotri, Shahrzad Jalali, Alenoush Vartanian, Joy Gumin, Erik Sulman, Frederick Lang, Bradley Wouters, Gelareh Zadeh
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Growth factor-dependent divergence of stem cell identity in glioblastoma
Megan Wu, Nestor Fernandez, Sameer Agnihotri, Roberto Diaz, James Rutka, Markus Bredel, Jason Karamchandani, Sunit Das*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Identification of brain tumour targeting peptides
Xiaoguang Hao*, Jennifer Rahn, Eva Ujack, Xuequing Lun, Greg Cairncross, Sam Weiss, Donna Senger, Stephen Robbins
Sunday, November 24, Scientific Meeting:  Concurrent Session 9A - Preclinical Therapeutics  -  10:20am - 12:00pm
Identification of glioblastoma cancer stem-like cell-binding human antibodies via yeast expression library biopanning
Paul Clark*, Michael Zorniak, Yongku Cho, Xiaobin Zhang, Daniel Walden, Eric Shusta, John Kuo
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Improving radiosensitization of glioblastoma initiating cells with hyperthermia by downregulation of PI3K-AKT
Jianghong Man, Jocelyn Shoemake, Monica Venere, Jeremy Rich, Jennifer Yu*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
In vitro treatment response and epigenetic profiling reveal unexpected differences in glioma stem cells compared to patient-matched non-stem cell cultures
Shaun Fouse*, Jean Nakamura, C. David James, Susan Chang, Joseph Costello
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Increased invasion of glioma cancer stem cells under C5α from glioma stroma mesenchymal stem-like cells by means of pp38 networking
Seok-Gu Kang*, Se-Hoon Kim, Yong-Min Huh, Eui-Hyun Kim, Eun-Kyung Park, Jong Hee Chang, Sun Ho Kim, Yong Kil Hong, Dong Seok Kim, Su-Jae Lee
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Induction of immunogenic cancer testis antigens in tumor-initiating glioma stem cells
Jason M. Frerich*, Shervin Rahimpour, Zhengping Zhuang, John D. Heiss
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Integration of gene and protein expression in thirty-seven glioma stem cell lines
Erik P. Sulman, Qianghu Wang, Ekaterina Mostovenko, Huiling Liu, Cheryl F. Lichti, Alexander Shavkunov, Roger A. Kroes, Joseph R. Moskal, Charles A. Conrad, Frederick F. Lang, Mark R. Emmett, Carol L. Nilsson*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Isolating the pre-malignant neoplatic and normal neural stem cells in human glioblastoma to identify the genomic drivers of tumor initiation
Siddhartha Mitra*, Sharareh Gholamin, Abdullah Feroze, Achal Achrol, Suzana Kahn, Irving Weissman, Samuel Cheshier
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
microRNAs involved in endothelial differentiation of glioblasma stem cells
Soon-Tae Lee*, Kon Chu, So-Hee Kim, Sang Kun Lee, Manho Kim, Jae-Kyu Roh
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Presence of meningioma stromal mesenchymal stem-like cells
Eui Hyun Kim*, Seok Gu Kang
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
PTEN regulates GBM's sensitivity to γ-secretase inhibitors: implicating the need for simultaneous inhibition of PI3K and NOTCH pathways in PTEN mutant GBMs
Norihiko Saito*, Jun Fu, Shuzhen Wang, W. K. Alfred Yung, Dimpy Koul
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Regulation of glioma stem cell gene expression and phenotype by Krüppel-like factor 9 transcription factor
Jessica Tilghman*, Mingyao Ying, John Laterra
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Roles of glioblastoma stem cell-derived vascular pericytes
Lin Cheng, Zhi Huang, Wenchao Zhou, Qiulian Wu, Jeremy Rich, Shideng Bao*
Friday, November 22, Scientific Meeting:  Concurrent Session 3A - Angiogenesis and Invasion  -  3:15pm - 5:00pm
Stem cell-like GBM subpopulations exhibit altered telomere stabilization efficacy, MGMT promoter methylation and drug response pattern
Sabine Spiegl-Kreinecker*, Daniela Loetsch, Magdalena Laaber, Christoph Schrangl, Adelheid Wohrer, Johannes Hainfellner, Christine Marosi, Josef Pichler, Serge Weis, Gabriele Wurm, Georg Widhalm, Engelbert Knosp, Walter Berger
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Semaphorin3A regulates GBM stem cell proliferation
Dominique Higgins*, Mark Schroeder, Bret Ball, Brian Milligan, Fredric Meyer, Jann Sarkaria, John Henley
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Silencing BMI1 eliminates tumor formation of pediatric glioma CD133+ cells not by affecting INK4A and ARF but by down-regulating STAU2, ALDH3A, API5, EIF4G2 and RPS6KA2
Patricia Baxter*, Hua Mao, Xiumei Zhao, Zhigang Liu, Yulun Huang, Horatiu Voicu, Sivashankarappa Gurusiddappa, Jack M Su, Laszlo Perlaky, Robert Dauser, Hon-chiu Eastwood Leung, Karin M Muraszko, Jason A Heth, Xing Fan, Ching C Lau, Tsz-Kwong Man, Murali Chintagumpala, Xiao-Nan Li
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Strong therapeutic potential of γ-secretase inhibitor MRK003 for GBM stem-like cells with high CD44 and low CD133 expression
Shingo Tanaka*, Mitsutoshi Nakada, Daisuke Yamada, Ichiro Nakano, Tomoki Todo, Yutaka Hayashi, Jun-ichiro Hamada, Atsushi Hirao
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Sox2 knockdown in a patient-derived gliosarcoma model prevents the formation of the astrocytic but not of the sarcomatous tumor compartment
Artem Berezovsky, Laila Poisson, Laura Hasselbach, Susan Irtenkauf, Andrea Transou, Tom Mikkelsen, Ana C. deCarvalho*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Targeted therapy of glioma stem cells and tumor non-stem cells using cetuximab-conjugated iron-oxide nanoparticles
Milota Kaluzova*, Simon Platt, Marc Kent, Alexandros Bouras, Revaz Machaidze, Costas Hadjipanayis
Sunday, November 24, Scientific Meeting:  Concurrent Session 9A - Preclinical Therapeutics  -  10:20am - 12:00pm
Targeting glioblastoma cancer stem cells via mitotic kinesins
Monica Venere*, Cathleen Chang, Qiulian Wu, Matthew Summers, Steven Rosenfeld, Jeremy Rich
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Targeting the therapeutic resistance and proneural –mesenchymal shift in GBM using non-toxic modulators of ROS
Renza Spelat, Eric Singer, Lisa Matlaf, Sean McAllister, Liliana Soroceanu*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
TGF-β Mediates Homing of Bone Marrow-Derived Human Mesenchymal Stem Cells to Glioma Stem Cells
Naoki Shinojima*, Anwar Hossain, Tatsuya Takezaki, Juan Fueyo, Joy Gumin, Feng Gao, Felix Nwajei, Frank C. Marini, Michael Andreeff, Jun-Ichi Kuratsu, Frederick F. Lang
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The glioma-enhancing role of mesenchymal stem cell exosomes within the tumor microenvironment
Javier Figueroa*, Tal Shahar, Anwar Hossain, Frederick Lang
Sunday, November 24, Scientific Meeting:  Concurrent Session 8A - Metabolic Pathways/Stem Cells  -  8:15am - 10:05am
The role of IGF1 receptor signaling in adaptive radioprotection of glioma stem cells
Satoru Osuka*, Oltea Sampetrean, Takatsune Shimizu, Isako Saga, Nobuyuki Onishi, Eiji Sugihara, Jun Okubo, Satoshi Fujita, Shingo Takano, Akira Matsumura, Hideyuki Saya
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The role of regional astrocyte identity in astrocytoma genomic heterogeneity
Ralf S Schmid*, David M Irvin, Mark Vitucci, Ryan E Bash, Andrea M Werneke, C Ryan Miller
Friday, November 22, Scientific Meeting:  Concurrent Session 2A - Pathology/Genomics  -  1:00pm - 3:00pm
The SMG1 kinase is required for glioblastoma stem cell growth in hypoxia
Sejuti Sengupta, Surbhi Goel-Bhattacharya, Shreya Kulkarni, Brent Cochran*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Therapeutic efficacy and fate of bimodal engineered stem cells in mice models of malignant brain tumors
Jordi Martinez-Quintanilla*, Sung-Hugh Choi, Deepak Bhere, Pedram Heidari, Derek He, Umar Mahmood, Khalid Shah
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Thymosin β4 gene silencing decreases stemness and invasiveness in glioblastoma
Hans-Georg Wirsching*, Shanmugarajan Krishnan, Karl Frei, Niklaus Krayenbühl, Guido Reifenberger, Michael Weller, Ghazaleh Tabatabai
Sunday, November 24, Scientific Meeting:  Concurrent Session 8A - Metabolic Pathways/Stem Cells  -  8:15am - 10:05am
Treatment effects on stem and progenitor subpopulations in a model of glioblastoma
Julie Harness*, Robin Lerner, Yuichiro Ihara, Raquel Santos, Jacqueline De La Torre, Alex Lu, Tomoko Ozawa, Theodore Nicolaides, David James, Claudia Petritsch
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
^Top
 
 
LAB-Immunology Research
Antigens characteristic of M2 type pro-inflammatory macrophages are present on GBM tumor cells
Waldemar Debinski*, Young A. Choi, Denise M. Gibo
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
B7-H1 silencing increases survival in mice with intracranial glioblastoma
Aaron Clark*, Michael Safaee, Taemin Oh, Michael Ivan, Rajwant Kaur, Matthew Sun, Yu-Jen Lu, Tomoko Ozawa, C David James, Orin Bloch, Andrew Parsa
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
CCR4+ regulatory T cells accumulate within the brain tumor in an experimental model of GBM
Alan Chang*, Derek Wainwright, Mahua Dey, Yu Han, Maciej Lesniak
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Cellular and domain heterogeneity of antigen expression in primary human brain tumor tissues
Michael Barish*, Lihong Weng, Massimo D'Apuzzo, Stephen Forman, Christine Brown
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Combination of agonistic anti-CD40 monoclonal antibody and celecoxib induces potent anti-glioma effects by activation of antigen-presenting cells and T-cells
Akemi Kosaka*, Takayuki Ohkuri, Hideho Okada
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Disruption of cell division within anaphase by tumor treating electric fields (TTFields) leads to immunogenic cell death
Sze Xian Lee, Eric Wong, Kenneth Swanson*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Effect of TLR agonists on dendritic cell maturation and their use in generating alloresponsive cytotoxic T lymphocytes to gliomas
Kate Erickson, Colin Malone, Edward Ha, Horacio Soto, Michelle Hickey, Geoffrey Owens, Linda Liau, Robert Prins, Boris Minev, Carol Kruse*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Enhancing tumor antigen-specific CD8+ T cell responses via picornavirus vaccination promotes tumor regression in a GL261 glioma model
Danielle Renner*, Adam Litterman, Alexis Balgeman, Fang Jin, Lisa Hanson, Jeffrey Gamez, Brett Carlson, Jann Sarkaria, Ian Parney, John Ohlfest, Istvan Pirko, Kevin Pavelko, Aaron Johnson
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Expression of the leukocyte-derived Ecrg4 recruits myeloid cells and induces anti-tumorigenic inflammation in glioma
Jisook Lee*, Xitong Dang, Alexandra Borboa, Raul Coimbra, Andrew Baird, Brian Eliceiri
Sunday, November 24, Scientific Meeting:  Concurrent Session 9B - Biologic/Immunologic Therapies  -  10:20am - 12:00pm
Flow cytometry analysis of tumor-infiltrating cells in a large series of glioblastoma patients: impact of lymphocyte infiltration on survival.
Tony Avril, Elodie Vauleon, Abderhamman Hamlat, Jean Mosser, Veronique Quillien*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Generation of TMZ-resistant, GBM-specific T cells for the immunotherapy of GBM
Kevin Chow*, Joanna Yi, Donald Shaffer, Stephen Gottschalk
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Glioblastoma exosomes induce immune suppressive M2 macrophages by direct nuclear transfer of STAT3
Fei Wang*, Jun Wei, Shuo Xu, Xiaoyang Ling, Nasser Yaghi, Ling-Yuan Kong, Tiffany Doucette, Jeffrey Weinberg, Franco DeMonte, Frederick Lang, Sujit Prabhu, Amy Heimberger
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
High-throughput sequencing of tumor-associated T cell receptors in human and murine glioma
Jennifer Sims*, Boris Grinshpun, Yaping Feng, Benjamin Amendolara, Yufeng Shen, Peter Canoll, Peter Sims, Jeffrey Bruce
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Immature mesenchymal stem cell-like pericytes mediate immunosuppression in human malignant glioma
Katharina Ochs*, Felix Sahm, Christiane A. Opitz, Tobias V. Lanz, Iris Oezen, Pierre-Olivier Couraud, Andreas von Deimling, Wolfgang Wick, Michael Platten
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Immunological characterization of glioblastoma cells for immunotherapy
Tae-Young Jung*, Yoo-Duk Choi, Young-Hee Kim, Je-Jung Lee, Hyung-Seok Kim, Ju-Sun Kim, Sang-Ki Kim, Shin Jung, Duck Cho
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Methylation specific PCR approaches for assessing T-cells and Tregs in human glioma
John Wiencke*, William Accomando, E.Andres Houseman, Heather Nelson, Margaret Wrensch, Joseph Wiemels, Shichun Zheng, George Hsuang, Paige Bracci, Karl Kelsey
Sunday, November 24, Scientific Meeting:  Concurrent Session 9B - Biologic/Immunologic Therapies  -  10:20am - 12:00pm
Oncolytic adenovirus Delta-24-RGD infection activates T-cell immune response against glioma cells
Hong Jiang*, Sarah R. Klein, Sujan Piya, Luis Vence, W.K. Alfred Yung, Raymond Sawaya, Amy Heimberger, Charles Conrad, Frederick Lang, Candelaria Gomez-Manzano, Juan Fueyo
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Role of type I Interferon signaling in the glioma microenvironment
Takayuki Ohkuri*, Arundhati Ghosh, Akemi Kosaka, Jianzhong Zhu, Maki Ikeura, Simon Watkins, Saumendra Sarkar, Hideho Okada
Sunday, November 24, Scientific Meeting:  Concurrent Session 9B - Biologic/Immunologic Therapies  -  10:20am - 12:00pm
Sunitinib suppresses myeloid derived suppressor cells (MDSCs) and induces T cell infiltration into murine gliomas
Baisakhi Raychaudhuri*, Patricia Rayman, Pengjing Huang, Mathew Grabowski, Dolores Hamburdzumyan, Jim Finke, Michael Vogelbaum
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Spontaneous immune responses in GBM patients after complete tumor resection are associated with an improved survival
Christel Herold-Mende*, Jan Mossemann, Christine Jungk, Rezvan Ahmadi, David Capper, Andreas von Deimling, Andreas Unterberg, Philipp Beckhove
Saturday, November 23, Scientific Meeting:  Concurrent Session 6B - Molecular Epidemiology/Biomarkers  -  1:00pm - 3:00pm
Testing and analysis of fluorescent markers panel for T-cells' multifunctionality in glioblastoma multiforme patients.
Idan Ben Horin*, Ilan Volovitz, Zvi Ram
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Th17 cells cooperate with IDO inhibition to promote tumor rejection and increase survival in a mouse model of glioblastoma
Derek Wainwright*, Alan Chang, Mahua Dey, Irina Balyasnikova, Yu Cheng, Yu Han, Maciej Lesniak
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The chemotherapeutic agent temozolomide modulates NK cell frequency and activity in a murine model of glioblastoma
Serena Pellegatta*, Sara Pessina, Gabriele Cantini, Dimos Kapetis, Gaetano Finocchiaro
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The role of PD-1 pathway in chordomas
Dimitrios Mathios*, Michael Lim, Jake Ruzevick, Sarah Nicholas, Magdalene Polanczyk, Christopher Jackson, Janis Taube, Peter Burger, Allison Martin, Haiying Xu
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The role of plasmacytoid dendritic cells in malignant glioma progression
Mahua Dey*, Derek Wainwright, Alan Chang, Yu Han, Maciej Lesniak
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
^Top
 
 
LAB-Tumor Models (In vivo/in vitro)
Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas
Ganesh Rao*, Tiffany Doucette, Yuhui Yang, Gregory Fuller, Arvind Rao
Friday, November 22, Scientific Meeting:  Concurrent Session 3A - Angiogenesis and Invasion  -  3:15pm - 5:00pm
A clinical, biological and transcriptional analysis of 12 cases of intraventricular neurocytomas
Nils Ole Schmidt*, Niklas Humke, Hildegard Meissner, Franz-Josef Mueller, Manfred Westphal
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
A reverse genetic screen for GBM drivers
Barbara R Tschida*, Anita R Lowy, Courtney A Marek, Thomas Ringstrom, Thomas J Beadnell, Stephen M Wiesner, David A Largaespada
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
An in vitro mouse model of GBM with abrupt and predictable onset
Jessica DePetro*, Carmen Binding, Michael Blough, John Kelly, Sam Lawn, Jennifer Chan, Sam Weiss, Gregory Cairncross
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
BarTeL, a genetically versatile and efficient bioluminescent mouse model for medulloblastoma
Gregory Shackleford*, Kimberly Swanson, Xiang-He Shi, Massimo D'Apuzzo, Ignacio Gonzalez-Gomez, Richard Sposto, Robert Seeger, Anat Erdreich-Epstein, Rex Moats
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Cell-cell interactions between glioma cells and bone marrow mesenchymal stem cells determine effects of integrin inhibitors in vitro
Oliver Schnell*, Irene Jaehnert, Valerie Albrecht, Peng Fu, Jörg-Christian Tonn, Christian Schichor
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Critical role for NF-κB inhibitors in meningioma cell death
Scott Plotkin*, Marianne James, Michel Kalamarides, Wen-ning Zhao, James Kim, Anat Stemmer-Rachamimov, Stephen Haggarty, James Gusella, Vijaya Ramesh, Fabio Nunes
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Development of an inducible murine model of medulloblastoma
Katie Picotte*, Li Li, Brian Westerhuis, Haotian Zhao
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Development of appropriate models for assessing effects of protein kinase inhibiton on the tyrosine kinase signalling network in glioblastoma
Nicola Thompson*, Douglas Elder, Kirsten Hopkins, Venkat Iyer, Nicki Cohen, Jeremy Tavare
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Development of resistance in an orthotopic glioblastoma multiforme (GBM) xenograft model and identification of bevacizumab response and resistance mechanisms
Thomas Urup*, Louise Stobbe Olsen, Signe Regner Michaelsen, Mette Kjølhede Nedergaard, Ulrik Lassen, Marie-Thérése Stockhausen, Hans Skovgaard Poulsen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Early tumor detection and characterization of changes in tumor permeability of brain metastases using multimodal imaging
Frits Thorsen*, Brett Fite, Lisa M. Mahakian, Jai W. Seo, Shengping Qin, Victoria Harrison, Terje Sundstrøm, Patrick N. Harter, Sarah Johnson, Elizabeth Ingham, Charles Caskey, Thomas Meade, Kai Ove Skaftnesmo, Katherine W. Ferrara
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Efficient microRNA inhibition in a highly invasive orthotopic glioblastoma model
Bo Halle*, Eric Marcusson, Charlotte Aaberg-Jessen, Stine Skov Jensen, Morten Meyer, Mette Katrine Schulz, Claus Andersen, Bjarne Winther Kristensen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Electric fields for the treatment of glioblastomas: a modeling study
Cornelia Wenger*, Pedro Cavaleiro Miranda, Abeye Mekonnen, Ricardo Salvador, Peter Basser
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Evaluation of efficacy and feasibility of local tumor therapy using convection enhanced delivery with temozolomide as potential treatment strategy for glioblastoma in a rat tumor model
Andrea Eisenbeis*, Roland Goldbrunner, Marco Timmer
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
GDNF mediates glioblastoma-induced microglia attraction but not astrogliosis
Michael Synowitz*, Min-Chi Ku, Susanne A. Wolf, Dorota Respondek, Vitali Matyash, Andreas Pohlmann, Sonia Waiczies, Helmar Waiczies, Thoralf Niendorf, Rainer Glass, Helmut Kettenmann
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
HDAC inhibitors: a synthetic lethal tool for targeted therapy of PLGAs? 
Charles Stiles*, Yu Sun, Shwetal Mehta, Christopher Taylor, John Alberta
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Identification of therapeutic targets in an intracranial xenograft model of pituitary adenoma
Eric Monsalves*, Shahrzad Jalali, Toru Tateno, Shereen Ezzat, Gelareh Zadeh
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
In vivo growth of highly invasive glioblastomas derived from stem-like cultures is inhibited by targeting the IGF-1 receptor
Tobias Martens*, Martin Zamykal, Manfred Westphal, Katrin Lamszus
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Interplay between genetic loss of p53, Nf1 and histone modifications in tumorigenesis of glioblastoma
Fumiharu Ohka*, Atsushi Natsume, Hui Zong, Chong Liu, Akira Hatanaka, Keisuke Katsushima, Keiko Shinjo, Toshihiko Wakabayashi, Yutaka Kondo
Saturday, November 23, Scientific Meeting:  Concurrent Session 6A - Cell Biology and Signaling  -  1:00pm - 3:00pm
Longitudinal 18F-FET MicroPET imaging to evaluate treatment response in human glioblastoma multiforme xenografts.
Mette Kjølhede Nedergaard*, Karina Kristoffersen, Hans Skovgaard Poulsen, Marie-Thérése Stockhausen, Ulrik Lassen, Andreas Kjær
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Modeling tumor microenvironment in vivo: impact of conditional macrophage ablation in glioma progression
Konrad Gabrusiewicz, Nahir Cortes-Santiago, Xuejun Fan, Mohammad B. Hossain, Bozena Kaminska, Amy Heimberger, Ganesh Rao, W.K. Alfred Yung, Frank Marini, Juan Fueyo, Candelaria Gomez-Manzano*
Friday, November 22, Scientific Meeting:  Concurrent Session 3A - Angiogenesis and Invasion  -  3:15pm - 5:00pm
Mesenchymal stem cells within brain tumor provide niche for cancer stem cells
Jonghee Yoon*, Honggeun Shin, Kyungsun Choi, Chulhee Choi
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
NF2 + CDKN2A deficiency is a common and actionable genotype of tumorigenic meningiomas
Rintaro Hashizume*, Yuichiro Ihara, Tomoko Ozawa, Andrew Parsa, Jennifer Clarke, Nicholas Butowski, Michael Prados, Arie Perry, Michael McDermott, David James
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Preliminary studies toward development of a rodent model of post-treatment radiographic imaging changes, so called “pseudoprogression”
Randy Jensen*, David Gillespie
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Quantitative MRI tracking of melanoma brain metastasis improves mouse model predictivity
Terje Sundstrøm*, Ingvild Wendelbo, Inderjit Daphu, Erlend Hodneland, Arvid Lundervold, Heike Immervoll, Kai Ove Skaftnesmo, Michal Babic, Pavla Jendelova, Eva Sykova, Morten Lund-Johansen, Rolf Bjerkvig, Frits Thorsen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Role of microvascular structures in migration and invasion of glioblastoma-derived stem cells
Soyoung Chang*, Junghwa Cha, Kyungsun Choi, Chulhee Choi
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Sulfasalazine sensitizes glioblastoma cells to radiation treatment
Linda Sleire*, Bente Sanvei Skeie, Inger Anne Netland, Jan Heggdal, Paal-Henning Pedersen, Per Øyvind Enger
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The development tumor model: the biological, dynamic, in vivo model to understand and try to defeat glioblastoma
Enrico Brognaro*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Tissue engineered scaffolds for studying glioblastoma invasion in 3D
Rachael W. Sirianni*, John M. Heffernan, Derek J. Overstreet
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
^Top
 
 
LAB-Cell Biology and Signaling
A kinome-wide RNAi screen in Drosophila glia reveals that the RIO kinases mediate cell proliferation and survival through TORC2-Akt signaling in glioblastoma
Renee Read*, Tim Fenton, German Gomez, Jill Wykosky, Scott Vandenberg, Ivan Babic, Akio Iwanami, Huijun Yang, Webster Cavenee, Paul Mischel, Frank Furnari, John Thomas
Saturday, November 23, Scientific Meeting:  Concurrent Session 6A - Cell Biology and Signaling  -  1:00pm - 3:00pm
A new role for PKM2 as a direct regulator of the cell cycle machinery controlling mitotic progression
Joydeep Mukherjee*, Shigeo Obha, Wendy See, Russell Pieper
Saturday, November 23, Scientific Meeting:  Concurrent Session 6A - Cell Biology and Signaling  -  1:00pm - 3:00pm
A role for matrix metalloproteinases in invasive and malignant meningiomas
Shahrzad Jalali*, Sameer Agnihotri, Sanjay Singh, Kelly Burrell, Sidney Croul, Gelareh Zadeh
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Acquired resistance to EGFR inhibitors in Glioblastoma is associated with urokinase-type plasminogen activator-mediated suppression of Bim
Jill Wykosky*, Jingjing Hu, Tiffany Taylor, Genaro R. Villa, German Gomez, Paul S. Mischel, Steven L. Gonias, Webster Cavenee, Frank Furnari
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Activation of the Wnt/β-catenin pathway inhibits glioblastoma stem cells self-renewal
Suzana Assad Kahn*, Sharareh Gholamin, Marie-Pierre Junier, Hervé Chneiweiss, Irving Weissman, Siddhartha Mitra, Samuel Cheshier
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Alternative splicing in glioblastoma: a big new world ahead
Marisol Gonzalez-Huarriz*, Guillermo Aldave, Datta Ravi, Angel Rubio, Ricardo Diez-Valle, Miguel Marigil, Patricia Jauregi, Beatriz Vera, Arlet Acanda de la Rocha, Sonia Tejada-Solís, Marta M Alonso
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
ALK alterations in a series of 62 glioblastoma cases: is there a therapeutic role for ALK inhibitors molecules?
Cristina Carrato, Ana Muñoz-Mármol, Laia Serrano, Lara Pijuán, Cristina Hostalot, Salvador Villa, Aurelio Ariza, Olatz Etxaniz, Carmen Balaña*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
AMP-Kinase activation induces resistance to hypoxia and temozolomide in glioblastoma cells
Michael W. Ronellenfitsch*, Anna L. Thiepold, Patrick N. Harter, Michel Mittelbronn, Joachim P. Steinbach
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
An Ehsp90-Lrp1 axis regulates Epha2 signaling and cell morphology
Udhayakumar Gopal*, Jennifer Isaacs
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Autophagy blockade in GBM improves sensitivity to tyrosine kinase inhibition
Alexandra Sufit*, Tamara Burleson, John P Le, Amy K Keating
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
BAI1 is a novel tumor suppressor in medulloblastoma
Dan Zhu*, Robert C Castellino, Erwin G Van Meir
Saturday, November 23, Scientific Meeting:  Concurrent Session 7A - Pediatric Basic and Translational Research  -  3:15pm - 5:00pm
Brain-specific gene signature of melanoma metastasis
Terje Sundstrøm*, Jobin K. Varughese, Patrick Harter, Lars Prestegarden, Kjell Petersen, Francisco Azuaje, Clifford Tepper, Elizabeth Ingham, Lisa Even, Sarah Johnson, Kai Ove Skaftnesmo, Morten Lund-Johansen, Rolf Bjerkvig, Katherine Ferrara, Frits Thorsen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Cadherin-11 regulates motility in normal cortical neural precursors and glioblastoma.
Jessica Schulte, Maya Srikanth, Sunit Das, Jianing Zhang, Justin Lathia, Lihui Yin, Jeremy Rich, Eric Olson, Jack Kessler, Anjen Chenn*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Cadherin-mediated changes in radiosensitivity and expression of CD133 and LEF-1 in U373 glioblastoma Cells.
Christopher P. Cifarelli*, Robert J. Griffin
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Carnosine and its derivatives as a prospective therapy for glioblastoma multiforme
Yulia Rybakova*, Amanda Kalen, Ehab Sarsour, Prabhat Goswami
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
CDK2-mediated OLIG2 phosphorylation represses p27 expression and promotes brain tumor development
Jun Fu*, Dimpy Koul, Jun Yao, Norihiko Saito, Siyuan Zheng, Roel Verhaak, Zhimin Lu, W. K. Alfred Yung
Friday, November 22, Scientific Meeting:  Plenary Session - Award Winning Abstracts  -  8:15am - 10:15am
Coordinate activation of Shh and PI3 kinase signaling pathways in PTEN-deficient glioblastoma presents new opportunities for targeted therapy
Mariella Gruber-Olipitz*, Sukriti Dabral, Shakti Ramkissoon, Andrew Kung, Ekaterina Pak, Jarom Chung, Matthew Theisen, Yanping Sun, Valerie Monrose, Yoko Franchetti, Yu Sun, David Shulman, Navid Redjal, Barbara Tabak, Rameen Beroukhim, Jean Zhao, Silvia Buonamici, Keith Ligon, Joseph Kelleher, Rosalind Segal
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Differentiation of glioblastoma multiforme stem-like cells leads to down regulation of EGFR and EGFRvIII and decreased tumorigenic and stem-like cell potential
Marie-Thérése Stockhausen*, Karina Kristoffersen, Louise Stobbe Olsen, Hans Skovgaard Poulsen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Down-regulation of MDR by Ad-REIC contributes to augment the chemotherapy by temozolomide
Kohei Nakajima*, Keijiro Hara, Teruyoshi Kageji, Yoshihumi Mizobuchi, Keiko Kitazato, Toshitaka Fujihara, Ryotaro Otsuka, David Kung, Shinji Nagahiro
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
EFEMP1 attenuates EGFR signaling activities and the prognostic effect of EFEMP1depends on the level of EGFR expression in gliomas
Yuanjie Hu*, Chris Vo, Zhenzhi Li, Chao Ke, Ning Ru, Kenneth R Hess, Mark E Linskey, Yi-Hong Zhou
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Effects of EGFR signaling on the mode of division of neural progenitors and glioma precursors
Sandra Gomez Lopez*, Dian Qu, Claudia Petritsch
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
EGFR phosphorylates tumor-derived EGFRvIII, driving STAT3/5 and progression in glioblastoma
Q-W Fan, C Cheng, WC Gustafson, E Charron, P Zipper, RA Wong, J Chen, J Lau, C Knobbe-Thosen, M Weller, N Jura, G Reifenberger, KM Shokat, WA Weiss*
Saturday, November 23, Scientific Meeting:  Concurrent Session 6A - Cell Biology and Signaling  -  1:00pm - 3:00pm
Elucidating the mechanism of receptor tyrosine kinase inhibition by soluble LRIG1 in glioblastoma
Katja Tiemann*, Håkan Hedman, Simone P. Niclou
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Erlotinib resistance in EGFR-amplified glioblastoma cells is mediated by up-regulation of EGFRvIII and PI3K p110δ
Alexander Schulte, Katrin Liffers, Annegret Kathagen, Sabine Riethdorf, Manfred Westphal, Katrin Lamszus*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Evaluation of a novel approach to construct a three-dimensional (3D), all human in vitro model of the blood-brain barrier (B-BB) for brain tumour therapy
Zaynah Maherally*, Adam Thorne, Qian An, Eugen Barbu, Helen Fillmore, Geoff Pilkington
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Expression of human aryl hydrocarbon receptor and ARNT, its nuclear translocator, is upregulated after chemotherapy in recurrent glioblastoma multiforme
Marco Timmer*, Robin Tjiong, Gabriele Röhn, Roland Goldbrunner
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Expression of NDRG2 sensitizes glioblastoma cells to temozolomide via Akt inactivation
Hideo Takeshima*, Shinji Yamashita, Kiyotaka Yokogami, Souhei Mizuguchi, Hideo Nakamura, Junichi Kuratsu, Tsuyoshi Fukushima, Kazuhiro Morishita
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
FGFR4 inhibition impacts on glioblastoma aggressiveness in vitro and in vivo
Daniela Lötsch, Claudia Engelmaier, Sigrid Allerstorfer, Michael Grusch, Josef Pichler, Serge Weis, Johannes Hainfellner, Christine Marosi, Sabine Spiegl-Kreinecker, Walter Berger*
Saturday, November 23, Scientific Meeting:  Concurrent Session 6A - Cell Biology and Signaling  -  1:00pm - 3:00pm
Gamma-glutamyl transferase 7 acts as a tumor suppressor in GBM and correlates with good prognosis
Timothy Bui*, Ryan Nitta, Gordon Li
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Gene expression profiles of Sunitinib-treated but not untreated short-term serum-free cultures predict treatment response of high-grade gliomas in vitro
Sylvia Moeckel*, Katharina Meyer, Petra Leukel, Ulrich Bogdahn, Markus J. Riehmenschneider, Anja Katrin Bosserhoff, Rainer Spang, Peter Hau
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Gene-expression profiling elucidates molecular signaling networks that can be therapeutically targeted in vestibular schwannoma
Sameer Agnihotri, Isabel Gugel, Marc Remke, Antje Bornemann, Georgios Pantazis, Stephen Mack, David Shih, Nesrin Sabha, Michael Taylor, Marcos Tatagiba, Gelareh Zadeh, Boris Krischek*
Sunday, November 24, Scientific Meeting:  Concurrent Session 9A - Preclinical Therapeutics  -  10:20am - 12:00pm
Genome-wide shRNA screen revealed synthetic lethal interaction between Dopamine Receptor D2 (DRD2) and Epidermal Growth Factor Receptor (EGFR) inhibition in glioblastoma
Shan Zhu, David Kozono, Jie Li, Deepa Kushwaha, Bob Carter, Clark Chen*
Saturday, November 23, Scientific Meeting:  Concurrent Session 6A - Cell Biology and Signaling  -  1:00pm - 3:00pm
Glioma-associated IDH mutation induces miR-34a repression and stem cell-like physiology through enhanced PDGF signaling
Joachim Silber*, Girish Harinath, Beatriz Aldaz, Armida W.M. Fabius, Sevin Turcan, Timothy A. Chan, Jason T. Huse
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
HCMV glycoprotein B is expressed in primary human glioblastomas and enhances growth and invasiveness via PDGFRα activation
Lisa Matlaf*, Sabeena Khan, Alex Zider, Eric Singer, Charles Cobbs, Liliana Soroceanu
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Heterogeneity of human gliomas: glutathione-S-transferase gene expression profile during disease progression  
Marco Timmer*, Robin Tjiong, Pantelis Stavrinou, Gabriele Röhn, Moritz Perrech, Roland Goldbrunner
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Homeobox gene HOXA10 is related with temozolomide resistance by regulating homologous recombinant DNA repair pathway in glioblastoma cell lines
Sung Kwon Kim, Jin Wook Kim*, Ji Young Kim, Ja Eun Kim, Seung Hong Choi, Tae Min Kim, Se-Hoon Lee, Seung-Ki Kim, Sung-Hye Park, Il Han Kim, Chul-Kee Park, Hee-Won Jung
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Hypoxia induced ROS production regulates stat3 activation followed by angiogenesis in human glioblastoma.
Shin-Hyuk Kang*, Mi Ok Yu, Na-Hyun Song, Kyung-Jae Park, Sung-Gil Chi, Yong-Gu Chung
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Identification and characterization of a novel microRNA involved in gliomagenesis
Daisuke Yamashita*, Toru Kondo, Hisaaki Takahashi, Akihiro Inoue, Shohei Kohno, Hironobu Harada, Shiro Ohue, Takanori Ohnishi
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Identification of molecular mechanisms of resistance to PI3K pathway inhibition to improve therapeutic targeting of glioblastoma
Shaofang Wu*, Jun Fu, Siyuan Zheng, Dimpy Koul, W. K. Alfred Yung
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Ikaros expression inhibits GBM tumorigenesis and correlates with a positive prognosis
Maya Agarwal*, Ryan Nitta, Sinisa Dovat, Gordon Li
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Integrative miRNA-mRNA genomic analysis identifies dysregulated miRNAs in diffuse intrinsic pontine glioma (DIPG)
Yujie Tang*, Dedeepya Vaka, Spenser Chen, Anitha Ponnuswami, Yoon-Jae Cho, Michelle Monje
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Inter-cellular signals within heterogeneous GBM cells induce tumor cell repopulation after radiation treatment
Mutsuko Minata*, Sunghak Kim, Ping Mao, Jothi Kaushal, Ichiro Nakano
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Influences of different blood-brain barrier (B-BB) basement membrane ECM molecules on brain trans-endothelial electrical resistance
Zaynah Maherally*, Sim Ling Tan, Sophie Tan, Qian An, Helen Fillmore, Geoff Pilkington
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Insights into the molecular mechanism of PID1 growth-inhibitory effects in gliomas
Xiuhai Ren, Hong Zhou, Mathew Schur, Abinav Baweja, Mohan Singh, Anat Erdreich-Epstein*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
JAK2-STAT3 activation is associated with cerebrospinal fluid interleukin-10 (IL-10) in primary central nervous system lymphoma
Takashi Mizowaki*, Takashi Sasayama, Kazuhiro Tanaka, Katsu Mizukawa, Masamitsu Nishihara, Satoshi Nakamizo, Hirotomo Tanaka, Masaaki Kohta, Kohkichi Hosoda, Eiji Kohmura
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Leukotriene-stimulated Nestin expression promotes sonic hedgehog signal activation and tumorigenesis of neuronal progenitors
Peng Li, Jessica Ng, Larra Yuelling, Fang Du, Tom Curran, Zeng-jie Yang*
Saturday, November 23, Scientific Meeting:  Concurrent Session 6A - Cell Biology and Signaling  -  1:00pm - 3:00pm
Mutations of CD79B are common event in primary central nervous system B-cell lymphoma patients and are associated with unfavorable prognosis
Kensuke Tateishi*, Yoshitaka Narita, Taishi Nakamura, Daniel Cahill, Nobutaka Kawahara, Koichi Ichimura
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Mutations in the TERT promoter are highly recurrent and upregulate TERT expression in gliomas
Hideyuki Arita*, Yoshitaka Narita, Shintaro Fukushima, Kensuke Tateishi, Yuko Matsushita, Akihiko Yoshida, Yasuji Miyakita, Makoto Ohno, V. Peter Collins, Nobutaka Kawahara, Soichiro Shibui, Koichi Ichimura
Saturday, November 23, Scientific Meeting:  Concurrent Session 6A - Cell Biology and Signaling  -  1:00pm - 3:00pm
Mutant EGFR suppression of microRNA-9 induces FOXP1 to enhance glioblastoma tumorigenicity
German Gomez, Stefano Volinia, Carlo Croce, Cameron Brennan, Webster Cavenee, Frank Furnari*
Saturday, November 23, Scientific Meeting:  Concurrent Session 6A - Cell Biology and Signaling  -  1:00pm - 3:00pm
Mutant IDH1 suppresses prostate apoptosis response-4 in gliomas
Yinxing Liu, Misty Gilbert, Natasha Kyprianou, Vivek Rangnekar, Craig Horbinski*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Modulating PDGF ligand and receptor signaling in glioblastoma
Anna Wade*, Aaron E Robinson, Joanna J Phillips
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Microglial/brain macrophage ­toll-like-receptor 2 signaling promotes glioma expansion
Feng Hu*, Katyayni Vinnakota, Susanne Wolf, Helmut Kettenmann
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
MicroRNA-1, down-regulated in glioma, modulates the content of exosomes released by glioma cells, mitigating their Pro-oncogenic potential
Agnieszka Bronisz*, Michal O. Nowicki, Yan Wang, Khairul Ansari, E. Antonio Chiocca, Jakub Godlewski
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
MicroRNA-183 upregulates HIF-1α by targeting isocitrate dehydrogenase 2 (IDH2) in glioma cells
Hirotomo Tanaka*, Takashi Sasayama, Kazuhiro Tanaka, Satoshi Nakamizo, Katsu Mizukawa, Eiji Kohmura
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Mir-128 controls the activity of epigenetic regulators PRC1 and PRC2 in neural stem cells: implications of its loss in gliomagenesis
Pierpaolo Peruzzi*, E Antonio Chiocca, Jakub Godlewski
Sunday, November 24, Scientific Meeting:  Concurrent Session 8A - Metabolic Pathways/Stem Cells  -  8:15am - 10:05am
Nuclear Factor I A (NFIA) negatively regulates p53, p21, and PAI1 to promote the malignant behavior of glioblastomas
Jun Sung Lee*, Jiping Xiao, Parita Patel, Jake Schade, Jinhua Wang, Benjamin Deneen, Anat Erdreich-Epstein, Hae-Ri Song
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
New alkylindoles selectively promote apoptosis in GBM cells independent of cannabinoid CB1 and CB2 receptors
Brian Haas*, Dave Canton, Philippe Diaz, John Scott, Nephi Stella
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
NF-κB induced IL-6 ensures STAT3 activation and tumor aggressiveness in glioblastoma
Braden C. McFarland*, Suk W. Hong, Rajani Rajbhandari, George B. Twitty Jr., G. Kenneth Gray, Hao Yu, Etty N. Benveniste, Susan E. Nozell
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Oct 7 is expressed in human gliomas and correlates with malignancy grade
Lina Leiss*, Christiane Gjerde, Halala Saed, Aminur Rahman, Mohammad Lellahi, Per Øyvind Enger
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Patterns of molecular heterogeneity in rodent models of glioblastoma
Richard Leung*, Orlando Gil, Liang Lei, Peter Canoll
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
pDING enhances temozolomide-induced glioblastoma cell growth inhibition via miR-21 down regulation
Markus Bookland, Nune Darbinian*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Proneural phenotype and transcriptional network precedes and selects for genetic alterations during glioma progression
Adam M Sonabend*, Mukesh Bansal, Paolo Guarnieri, Liang Lei, Craig Soderquist, Richard Leung, Jonathan Yun, Benjamin Kennedy, Julia Sisti, Samuel Bruce, Rachel Bruce, Reena Shakya, Thomas Ludwig, Steven Rosenfeld, Peter A Sims, Jeffrey N Bruce, Andrea Califano, Peter Canoll
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Redundant insulin receptor and IGF-1R signaling in glioblastoma
Yuanying Gong, Yufang Ma, Zhixiang Cheng, Reid Thompson, Jialiang Wang*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Regulation of cancer promoting tryptophan catabolism in glioblastoma by the glucocorticoid receptor
Martina Ott*, Ulrike Litzenburger, Katharina Rauschenbach, Lukas Bunse, Stefan Pusch, Katharina Ochs, Felix Sahm, Christiane Opitz, Andreas von Deimling, Wolfgang Wick, Michael Platten
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Regulation of primary human astroglial (HAG) cell proliferation via a brain-enriched, NF-κB-sensitive micro-RNA-125b (miRNA-125b)
Walter J. Lukiw*, Brandon M. Jones, Yuhai Zhao, Surjyadipta Bhattacharjee, Frank Culicchia
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
REIC/Dkk-3, one of Dickkopf (Dkk) family members, contributes to the anti-tumor effects in glioblastoma through regulation of both Wnt signal pathways
Keijiro Hara, Teruyoshi Kageji, Yoshifumi Mizobuchi, Keiko Kitazato, Toshiyuki Okazaki, Toshitaka Fujihara*, Kohei Nakajima, Hideo Mure, Kazuyuki Kuwayama, Tomoyo Hara, Shinji Nagahiro
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Roles of NHE-1 activation in glioblastoma cancer cell migration and survival in combination with temozolomide
Damin Cong*, Wen Zhu, Yejie Shi, Paul Clark, John Kuo, Shaoshan Hu, Dandan Sun
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Subtype-specific differences in the coagulome of glioblastoma suggest a link between EGFR, tissue factor and regulation of tumor angiogenesis, inflammation and dormancy
Nathalie Magnus*, Delphine Garnier, Brian Meehan, Serge McGraw, Maryam Hashemi, Tae Hoon Lee, Chloe Milsom, Noha Gerges, Nada Jabado, Jacquetta Trasler, Rafal Pawlinski, Nigel Mackman, Janusz Rak
Friday, November 22, Scientific Meeting:  Concurrent Session 3A - Angiogenesis and Invasion  -  3:15pm - 5:00pm
Subtype-specific expression of the truncated neurokinin-1 receptor in glioblastoma multiforme
Kristine Brown*, Madan Kwatra
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
S-nitrosylation of the p53 tumor suppressor protein in medulloblastoma
Michael Koldobskiy*, Ishrat Ahmed, Gary Ho, Adele Snowman, Eric Raabe, Charles Eberhart, Solomon Snyder
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Targeting the protein kinase CK2 suppresses pro-survival signaling pathways and growth of glioblastoma
Etty (Tika) Benveniste*, Ying Zheng, Braden McFarland, Denis Drygin, Susan Bellis, Markus Bredel
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Temozolomide-triggered activation of the Na+-K+-2Cl- cotransporter NKCC1 via the WNK1/OSR1 kinase pathway in regulation of glioma migration
Wen Zhu*, Gulnaz Begum, Qiwei Wang, Paul Clark, Sung-Sen Yang, Shih-Hua Lin, Kristopher Kahle, John Kuo, Dandan Sun
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The coupling and function of adhesion receptor GPR124 in glioblastoma multiforme
Allison Cherry*, Brian Haas, Yi Hsing Lin, Shao-En Ong, Nephi Stella
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The glial differentiation factor Nuclear Factor One B (NFIB) induces differentiation and inhibits growth of glioblastoma.
Brett Stringer*, Bryan Day, Guy Barry, Michael Piper, Paul Jamieson, Kathleen Ensbey, Zara Bruce, Linda Richards, Andrew Boyd
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The immunomodulatory effects of Decorin - a novel agent for the treatment of glioblastoma multiforme
Lisa Hill*, Hannah Botfield, Kismet Hossain-Ibrahim, Ann Logan, Garth Cruickshank
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The major vault protein mediates survival and migration competence of human glioblastoma cells via stabilization of the EGFR/PI3K signaling
Daniela Loetsch*, Elisabeth Steiner, Klaus Holzmann, Sabine Spiegl-Kreinecker, Christine Pirker, Juraj Hlavaty, Helga Petznek, Balazs Hegedus, Tamas Garay, Thomas Mohr, Wolfgang Sommergruber, Michael Grusch, Walter Berger
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The microRNA-31/TRADD/NF-κB circuitry is dysregulated in glioblastoma
Rajani Rajbhandari, Tanvi Sinha, Gordon Meares, Etty N. Benveniste, Susan Nozell*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The role of Arhgap36 as a novel driver in high-risk human medulloblastoma
Pauline J Jackson*, Jon D Larson, Dominic A Beckmann, Branden S Moriarity, David A Largaespada
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The role of Twist1 in glioma formation and progression
Mari Tokita*, Svetlana Mikheev, Drew Sellers, Andrei Mikheev, Yoshito Kosai, Robert Rostomily
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Tumor migration of human glioblastoma is modulated by the molecule CD90 (Thy-1)
Tony Avril*, Abderrahmane Hamlat, Pierre-Jean Le Reste, Jean Mosser, Véronique Quillien
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Tumor suppressive role of DACH1 in glioblastoma stem-like cell
Akitake Mukasa*, Akira Watanabe, Hideki Ogiwara, Nobuhito Saito, Hiroyuki Aburatani
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Transcriptional regulation at IGF2 promoters and mechanistic insights on induction of IGF2 downstream of YAP in Shh medulloblastomas
Abhinav Dey*, Mélanie Robitaille, Marc Remke, Damien Faury, Caroline Maier, Anshu Malhotra, Nada Jabado, Michael Taylor, Stéphane Angers, Anna Kenney
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Understanding TGF-beta-mediated Smad1/5/8 signaling in gliomas: a prerequisite for the development of TGF-beta-based therapeutic agents
Isabel Tritschler*, Katharina Seystahl, Judith Johanna Schroeder, Michael Weller
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Up-regulation of the chaperone protein prolyl 4-hydroxylase, beta polypeptide (P4HB), promotes tumour invasion, angiogenesis and growth via EGFR/MAPK (ERK) signaling
Stella Sun, Derek Lee, Amy S.W. Ho, Jenny K.S. Pu, Xiao-qin Zhang, Nikki P. Lee, Philip J.R. Dat, Gilberto K.K. Leung*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Variable expression of the truncated neurokinin-1 receptor in glioblastoma multiforme
Kristine Brown*, Madan Kwatra
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Yes-Associated Protein: A master metabolic regulator in medulloblastoma
Anshu Malhotra*, SunPhil Choi, Chad Potts, David A Ford, Zaher Nahle, Anna Marie Kenney
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
^Top
 
 
LAB-Experimental (pre-clinical) Therapeutics and Pharmacology
A combination of interferon-beta and temozolomide augments anti-tumor effects through p73/YAP-mediated apoptosis by PML in glioblastoma
Yoshihumi Mizobuchi*, Toshiyuki Okazaki, Teruyoshi Kageji, Kazuyuki Kuwayama, Keiko T Kitazato, Hideo Mure, Keijiro Hara, Ryoma Morigaki, Kazuhito Matsuzaki, Kohei Nakajima, Shinji Nagahiro
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
A microdialysis study to assess intracerebral concentrations of irinotecan and eribulin with or without iRGD in an orthotopic glioma rat model
Zeynep Eroglu*, Jana Portnow, Arianne Sacramento, Elizabeth Garcia, Andrew Raubitschek, Timothy Synold
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
A new multi-targeted HDAC inhibitor induces apoptosis in in vitro and in vivo model of glioblastoma by modulating p53 expression
Arabinda Das*, Abhay K. Varma, Gerald C. Wallace IV, Yaenette N Dixon-Mah, W Alex Vandergrift III, Pierre Giglio, Swapan K Ray, Sunil J. Patel, Naren L. Banik
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
ABT-414: an anti-EGFR antibody drug conjugate for the treatment of glioblastoma patients
Andrew Phillips, Erwin Boghaert, Kedar Vaidya, Peter Ansell, David Shalinsky, Yumin Zhang, Martin Voorbach, Sarah Mudd, Kyle Holen, Rod Humerickhouse, Edward Reilly*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Alternating electric fields (TTFields) inhibit DNA damage repair response in cancer cell lines
Moshe Giladi*, Ailon Tichon, Rosa Schneiderman, Yaara Porat, Mijal Munster, Matan Dishon, Uri Weinberg, Eilon Kirson, Yoram Wasserman, Yoram Palti
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
An engineered knottin peptide for non-invasive targeting of intracranial medulloblastoma
Melanie Hayden Gephart*, Sarah Moore, Jamie Bergen, YouRong Sophie Su, Helen Rayburn, Matthew Scott, Jennifer Cochran
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
An engineered peptide for non-invasive optical imaging of brain tumors
Sarah Moore, Melanie Hayden-Gephart, Jamie Bergen, YouRong Su, Helen Rayburn, Michael Edwards, Matthew Scott, Jennifer Cochran*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Analysis of combination of Tumor Treating Fields (TTFields) with radiotherapy in non-small cell lung cancer
Katarzyna Zielinska-Chomej, Vitali Grozman*, Jessica Tu, Kristina Viktorsson, Rolf Lewensohn
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Analysis of combination therapy of the adenovirus vector carrying REIC/Dkk-3 (Ad-REIC) and the integrin antagonist cilengitide
Yosuke Shimazu*, Kazuhiko Kurozumi, Tomotsugu Ichikawa, Kentaro Fujii, Manabu Onishi, Joji Ishida, Tetsuo Oka, Masami Watanabe, Yasutomo Nasu, Hiromi Kumon, Isao Date
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Anti-cancer agent siramesine induces effective tumor cell death in glioblastoma cell lines and tumor stem cell containing spheroids
Stine Skov Jensen, Bjarne Winther Kristensen*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Bcl-2, pChk2, MGMT promoter methylation status and mRNA patterns predictchemo- and radiosensitization effects of HDAC inhibitors in GBM cell cultures.
Lotte Berghauser Pont*, Jenneke Kloezeman, Martin van den Bent, Roland Kanaar, Andreas Kremer, Sigrid Swagemakers, Pim French, Clemens Dirven, Martine Lamfers, Sieger Leenstra
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Brain/brain tumor pharmacokinetics and pharmacodynamics of letrozole
Nimita D. Dave*, Pankaj B. Desai, Gary A. Gudelsky, Lionel M.L. Chow, Kathleen LaSance, Xiaoyang Qi
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic, necroptotic cell death
Brian Hurwitz*, Ji Young Yoo, Chelsea Bolyard, Jun-Ge Yu, Jeffery Wojton, Jianying Zhang, Zachary Bailey, David Eaves, Timothy Cripe, Matthew Old, Balveen Kaur
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
CD317-targeted immunotoxin induces apoptosis in human glioma cells
Dorothee Gramatzki*, Matthias Staudinger, Karl Frei, Matthias Peipp, Michael Weller
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Chlorotoxin modified magnetic nanoparticle for specific targeting of brain tumors and delivery of O6-benzylguanine
Zachary Stephen*, Omid Veiseh, Forrest Kievit, Chen Fang, Matthew Leung, Richard Ellenbogen, John Silber, Miqin Zhang
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Cidofovir: a novel antitumor agent for glioblastoma
Piotr Hadaczek*, Tomoko Ozawa, Liliana Soroceanu, Yasuyuki Yoshida, Lisa Matlaf, Eric Singer, Estefania Fiallos, C. David James, Charles S. Cobbs
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Cilengitide affects meningioma cell survival and motility
Anette Wilisch-Neumann, Doreen Pachow, Elmar Kirches, Christian Mawrin*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Clinical characteristics and treatment of ectopic meningiomas
Zhiguo Liu*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Combination therapy for cancer stem cells isolated from recurrent glioblastoma utilizing oncolytic herpes simplex viruses and transforming growth factor-β inhibitor.
Shinichi Esaki*, Samuel Rabkin, Robert Martuza, Hiroaki Wakimoto
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Combination treatment with Delta24-RGD and temozolomide improves survival and influences immune cell subsets in a murine malignant glioma model
Anne Kleijn*, Erik Haefner, Sieger Leenstra, Clemens Dirven, Martine Lamfers
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Combined anti-angiogenic and anti-invasive treatment of orthotopically engrafted human GBM xenografts
Hilde Elise Førde*, Inger Anne Netland, Linda Sleire, Bente Skeie, Per Øyvind Enger, Dorota Goplen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Combined BRAFV600E and MEK inhibition for BRAFV600E-mutant astrocytomas
Jie Zhang*, Sujatmi Hariono, Tsun-Wen Yao, Angadpreet Sidhu, Rintaro Hashizume, C. David James, William A. Weiss, Theodore P. Nicolaides
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Combining PARP inhibitors with TMZ: Improved efficacy observed in recurrent patient-derived cell lines compared to primary cells
Kyoko Nozue-Okada*, Motoo Nagane, Kerrie L McDonald
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Convection-enhanced delivery of chemotherapeutic agent for brainstem malignant glioma: from bench to bedside
Ryuta Saito*, Yukihiko Sonoda, Masayuki Kanamori, Yoji Yamashita, Toshihiro Kumabe, Teiji Tominaga
Saturday, November 23, Scientific Meeting:  Concurrent Session 7A - Pediatric Basic and Translational Research  -  3:15pm - 5:00pm
Curaxin (CBL0137) significantly increases survival in orthotopic models of glioblastoma multiforme alone and in combination with temozolomide
Tara Barone*, Catherine Burkhart, Andrei Purmal, Andrei Gudkov, Katerina Gurova, Robert Plunkett
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Crossing the blood-brain barrier: brain delivery of unmodified cancer therapeutics via intravenous route mediated by a peptide transporter
Gobinda Sarkar*, Geoffry Curran, Robert Jenkins
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Dual mTORC1/2 blockade with AZD8055 inhibits growth of glioblastoma brain tumor stem cells
H. Artee Luchman*, Owen Stechishin, Stephanie Nguyen, J. Gregory Cairncross, Samuel Weiss
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Dendritic cell therapy against virally delivered target antigens is effective in a murine model of glioblastoma
Rudi Scharnweber*, Yuki Kato, Jeff Lin, Richard Everson, Horacio Soto, Carol Kruse, Noriyuki Kasahara, Linda Liau, Robert Prins
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Development of fluorescent graphene nanosheets with BBB permeation for drug and gene co-delivery in malignant brain tumor treatment
Chiungyin Huang*, Hongwei Yang, Kuochen Wei
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Development of novel thiobarbituric acid derivative compounds for treatment of glioblastomas
Sang Lee*, Srinivasa Ramisetti, Becky Slagle-Webb, Arun Sharma, James Connor
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Discordant sensitizing effects of ABT888 combined with temozolomide in GBM tumor models tested in vitro and in vivo
Shiv Gupta*, Ann Mladek, Katrina Bakken, Brett Carlson, Felix Boakye-Agyeman, Sani Kizilbash, Mark Schroeder, Joel Reid, Jann Sarkaria
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Disulfiram when combined with copper is an effective adjuvant therapy with TMZ for treatment of human glioblastoma
Xueqing Lun*, J. Connor Wells, Xiaoguang Hao, Jun Zhang, Natalie Grinshtein, David Kaplan, Artee Luchman, Samuel Weiss, J. Gregory Cairncross, Donna Senger, Stephen Robbins
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Down-regulation of H-ferritin as an adjuvant therapy in human glioma
Min Pang*, Xiaoli Liu, A.B. Madhankumar, Becky Slagle-Webb, Akshal Patel, Patti Miller, James Connor
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Effect of IFN-ß and levetiracetam on resistant glioma cells to temozolomide
Tatsuya Abe*, Yasutomo Momii, Junko Watanabe, Ikuko Morisaki, Atsushi Natsume, Toshihiko Wakabayashi, Minoru Fujiki
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Effects of Lazaroid U-74389G liposomes in a  glioblastoma mouse model
Fady Ibrahim, Pamela New*, Kemi Cui, Hong Zhao, Diana Chow, Wong Stephen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Enhancement of Cediranib anti-glioma efficacy via combination with autophagy inhibitor Quinacrine
Merryl Lobo*, Sarah Green, Matthias Schabel, Yancey Gillespie, Randall Woltjer, Martin Pike
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Eph receptor A3 is a molecular therapeutic target for the treatment of glioblastoma
Sara Ferluga*, Carla Lema Tome, Waldemar Debinski
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Exploring multiple aspects of stem cell-based therapy for cancer using novel multi-functional molecules
Shawn Hingtgen*, Randa Kasmieh, Irina Nesterenko, Jose-Luiz Figueiredo, Rupesh Dash, Devanand Sarkar, Paul Fisher, Khalid Shah
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Foretinib inhibits invasion, a hallmark of malignancy, in glioblastoma multiforme
Sarah K Nelson*, Kristina H Knubel, Ben M Pernu, Angela M Pierce, Amy K Keating
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
GBM perivascular niche disrupting agents identified through a novel high throughput compound library screen
Rajarshi Sengupta*, Jayne Marassa, David Piwnica-Worms, Joshua Rubin
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Geographic variability of drug penetration into the central nervous system
Katherine Warren*, Cynthia McCully, John Bacher, Thomas Thomas, Robert Murphy, Emilie Steffen-Smith, Rhonda McAllister, Devang Pastakia, Brigitte Widemann
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Genome wide identification of modulators of temozolomide response in glioblastoma
Gaspar Kitange*, Mark Schroeder, Jann Sarkaria
Sunday, November 24, Scientific Meeting:  Concurrent Session 9A - Preclinical Therapeutics  -  10:20am - 12:00pm
Gold nanoparticles as a drug delivery system for malignant brain tumors
Yu Cheng*, Qing Dai, Ramin Morshed, Yu Han, Brenda Auffinger, Derek Wainwright, Lingjiao Zhang, Alex Tobias, Esther Rincón, Bart Thaci, Atique Ahmed, Chuan He, Maciej Lesniak
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
High levels of TIMP-1 can reduce the effect of topoisomerase inhibitors on glioblastoma cells
Charlotte Aaberg-Jessen*, Louise Fogh, Bo Halle, Vibeke Jensen, Nils Brünner, Bjarne W. Kristensen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
High-throughout screening to identify pharmacologics cytotoxic to glioblastoma multiforme cellsthat express wildtype or the vIII mutant epidermal growth factor receptor 
James Driscoll*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
High-throughput in vitro screening of glioma stem cell lines: Evaluation of over 350 tyrosine kinase inhibitors
Shannon McDonell*, Ji Liang, Yuji Piao, Nghi Nguyen, Alfred Yung, Roeland Verhaak, Erik Sulman, Clifford Stephan, Frederick Lang, John de Groot
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Hyperoxia resensitizes chemoresistant glioblastoma cells to temozolomide through prolonged activation of unfolded protein response (UPR)
Stella Sun, Derek Lee, Amy S.W. Ho, Jenny K.S. Pu, Ziao-qin Zhang, Nikki P. Lee, Philip J.R. Day, Gilberto K.K. Leung*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Identification of potent enhancers of the oncolytic adenovirus Delta24-RGD using both rationale based combinations and the NIH clinical compound screen
Lotte Berghauser Pont*, Rutger Balvers, Jenneke Kloezeman, Anne Kleijn, Sean Lawler, Sieger Leenstra, Clemens Dirven, Martine Lamfers
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
In vivo modeling of acquired drug resistance: GBM adaptation to sustained cdk4/6 inhibition
Yu-Jen Lu*, Jacqueline De La Torre, Todd Waldman, Michael Prados, Tomoko Ozawa, David James
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
In vivo synergistic activity of mTOR and BRAF V600E inhibitors leading to survival advantage in pediatric low-grade glioma xenografts is driven by cross talk between Akt and BRAF V600E
Tina Dasgupta*, Aleksandra Olow, Xiaodong Yang, Sabine Mueller, Michael Prados, C. David James, Daphne Haas-Kogan
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Influence of time of treatment on the outcomes for in vivo therapeutic efficacy studies
Tomoko Ozawa*, Yasuyuki Yoshida, Raquel Santos, David James
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Intravenous administration of Toca 511 results in uniform distribution of viral spread within the tumor and increased survival in a syngeneic, orthotopic mouse glioma model
Tiffany Huang, Shraddha Parab, Oscar Diago, Fernando Lopez Espinoza, Bryan Martin, Carlos Ibañez, Noriyuki Kasahara, Harry Gruber, Daniel Pertschuk, Douglas Jolly, Joan Robbins*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Investigating the role of Poly-(ADP-Ribose)-Polymerase as a therapeutic target in pediatric high grade glioma
Yev Chornenkyy*, Sameer Agnihotri, Pawel Buczkowicz, Patricia Rakopoulos, Andrew Morrison, Mark Barszczyk, Oren Becher, Cynthia Hawkins
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Liposomes for the drug delivery of Carboranes
Temidayo Olusanya*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
MerTK inhibition as a novel therapeutic approach to glioblastoma multiforme
Kristina Knubel*, Ben M Pernu, Alexandra Sufit, Angela M Pierce, Sarah K Nelson, Amy K Keating
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
MiR-655 enhances the sensitivity of glioblastoma to Temozolomide therapy
Daisuke Ogawa*, EA Chiocca, Jakub Godlewski
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Nanovehicle-mediated delivery of anti-Ape1 siRNA sensitizes pediatric brain tumor cells to the DNA damaging effects of radiation therapy
Forrest Kievit*, Zachary Stephen, Kui Wang, Douglas Kolstoe, John Silber, Richard Ellenbogen, Miqin Zhang
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Nucleus-targeted doxorubicin as a potential therapy for glioblastoma
Young A. Choi*, Hetal Pandya, Denise M. Gibo, Isabela Fokt, Waldemar Priebe, Waldemar Debinski
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Noninvasive synergistic treatment of gliomas in mice by targeted chemotherapeutic delivery and amplified hyperthermia
Kuochen Wei*, Hungwei Yang, Chiungyin Huang, Pinyuan Chen, Muyi Hua, Haoli Liu
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
NOTCH pathway activation and response to NOTCH inhibition therapy is heterogeneous in human glioblastoma
Wen-Shin Lee*, Cecile Maire, Michael Kluk, Jon C. Aster, Keith Ligon
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Novel EGFR/DNA binary targeting molecule ZRBA1 potentiates radiation response in glioblastoma tumor model
Slawomir Kumala, Mitra Heravi, Slobodan Devic, Thierry Muanza*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Novel EGFRvIII-selective TRAIL fusion protein for treatment of glioma
Irina V. Balyasnikova*, Melanie S. Prasol, Deepak K. Kanoija, Karen S. Aboody, Maciej S. Lesniak
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
OMX-4.80, an engineered oxygen carrying protein, oxygenates hypoxic tumors and increases the efficacy of radiotherapy in orthotopic models of glioblastoma
Laura Serwer, Yasuyuki Yoshida, Natacha Le Moan, Raquel Santos, Sarah Ng, Nicholas Butowski, Ana Krtolica, Tomoko Ozawa, Stephen P.L. Cary, C. David James*
Sunday, November 24, Scientific Meeting:  Concurrent Session 9A - Preclinical Therapeutics  -  10:20am - 12:00pm
Overcoming cell size escape from tumor treating fields using a varying frequency treatment paradigm in-vitro
Moshe Giladi*, Yaara Porat, Rosa Schneiderman, Mijal Munster, Uri Weinberg, Eilon Kirson, Yoram Palti
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Pathogen-inspired drug delivery to the brain
Rachael W. Sirianni*, Rebecca L. McCall
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
PD-0332991, a CDK4/6 inhibitor, significantly prolongs survival in a genetically engineered mouse model of brainstem glioma
Kelly Barton*, Katie Misuraca, Francisco Cordero, Elena Dobrikova, Hooney Min, Matthias Gromeier, David Kirsch, Oren Becher
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
PENAO, a novel mitochondria-targeted agent, synergizes with dichloroacetate to target aberrant glucose metabolism in glioblastoma
Han Shen*, Stephanie Decollogne, Pierre Dilda, Sylvia Chung, Peter Luk, Philip Hogg, Kerrie McDonald
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Potential synergistic effect of terameprocol given by convection-enhanced delivery and temozolomide in treating orthotopic glioblastoma xenograft
Pin-Yuan Chen*, Chiung-Yin Huang, Kuo-Chen Wei
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Prodrug activator gene therapy with a non-lytic retroviral replicating vector (Toca 511) radiosensitizes glioma cells after intracellular generation of 5-fluorouracil
Masamichi Takahashi*, Gilmer Valdes, Akihito Inagaki, Shuichi Kamijima, Kei Hiraoka, Ewa Micewicz, William H. McBride, Keisuke S. Iwamoto, Harry E. Gruber, Joan M. Robbins, Douglas J. Jolly, Noriyuki Kasahara
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Preclinical evaluation of NT-113, a novel ERBB inhibitor optimized for CNS biodistribution
Yasuyuki Yoshida*, Tomoko Ozawa, Nicholas Butowski, Wang Shen, Dennis Brown, Harry Pedersen, David James
Sunday, November 24, Scientific Meeting:  Concurrent Session 9A - Preclinical Therapeutics  -  10:20am - 12:00pm
Preclinical evaluation of PENAO: a potent mitochondrial specific, arsenical-based inhibitor for glioblastoma
Sylvia Chung*, Stéphanie Decollogne, Peter Luk, Han Shen, Wendy Ha, Bryan Day, Brett Stringer, Philip Hogg, Pierre Dilda, Kerrie McDonald
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Preclinical high-dose acetaminophen with N-acetylcysteine rescue enhances the efficacy of cisplatin chemotherapy in atypical teratoid rhabdoid tumors
Alexander Neuwelt*, Tam Nguyen, Y. Jeffrey Wu, Andrew Donson, Rajeev Vibhakar, Sujatha Venkatamaran, Vladimir Amani, Edward Neuwelt, Louis Rapkin, Nicholas Foreman
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Preclinical investigation of concurrent vs. sequential radiation + cdk4/6 inhibitor therapy reveals heightened anti-tumor effect from inhibitor administration following completion of radiation
Rintaro Hashizume*, Maxwell Tom, Yuichiro Ihara, Tomoko Ozawa, Raquel Santos, Jacquelin De La Torre, Edgar Lepe, Todd Waldman, Michael Prados, David James
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Pre-clinical refinement of a highly-penetrative polymeric nanoparticle drug delivery system for the treatment of glioblastoma multiforme
Garth Strohbehn*, Komli-Kofi Atsina, Toral Patel, Joseph Piepmeier, Jiangbing Zhou, W Mark Saltzman
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Preferential accumulation of a multimeric H-NOX oxygen carrier protein in multiple intracranial glioblastoma models
Laura Serwer*, Gregory T. Kapp, Natacha Le Moan, Yasuyuki Yoshida, Jamie M. Romero, Sarah Ng, Andrew Davis, Tomoko Ozawa, Ana Krtolica, C. David James, Stephen P.L. Cary
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Promiscuous transactivation of multiple receptor tyrosine kinases by EGFRvIII: mechanism and therapeutic significance
Terrance Johns*, Sameer Greenall, Jacqueline Donoghue, Timothy Adams
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Small molecules kill proliferating and non-proliferating glioma cells by altering the intracellular trafficking of PAI-1:uPA protein complexes
Nagarekha Pasupuleti*, Fredric Gorin, Anthony Valenzuela, Leonardo Leon, Kermit Carraway
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Synergistic antiglioma effect of temozolomide and triptolide through inhibition of NF-kappaB pathway
Ke Sai*, Wen-yu Li, Wei-ping Li, Zhong-ping Chen
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Synergistic effect of supercritical extracts of Curcuma species with cancer drugs in glioma cell lines
Chepapil Ramachandran*, Smitha Nair, Karl-W Quirrin, Ziad Khatib, Enrique Escalon, Steven Melnick
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Targeted liposomes for the treatment of peripheral nerve sheath tumors
Achuthamangalam Madhankumar*, Becky Slagle-Webb, Elias Rizk, Russell Payne, Annie Park, Min Pang, Kimberly Harbaugh, James Connor
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Targeted MRI contrast agent alongside of drug: Interleukin-13-Gadolinium-DTPA-Doxorubicin-Liposomes in image-guided drug delivery for detection and treatment of glioma
Xiaoli Liu*, Achuthamangalam B. Madhankumar, Patti Miller, Becky Webb, James R. Connor, Qing X. Yang
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Targeting the histone H3.3-K27M mutation for the treatment of diffuse intrinsic pontine gliomas
Rintaro Hashizume*, Yuichiro Ihara, Xi Huang, Lu Yu-Jen, Maxwell Tom, Sabine Mueller, Nalin Gupta, David Solomon, Todd Waldman, Zhiguo Zhang, David James
Saturday, November 23, Scientific Meeting:  Plenary Session 5 - Award Winning Abstracts  -  10:45am - 11:30am
Targeting hypoxia in glioblastoma multiforme with a novel oxygen carrier protein
Natacha Le Moan*, Laura Serwer, Yasuyuki Yoshida, Sarah Ng, Tina Davis, Raquel Santos, Andrew Davis, Kevin Tanaka, Tim Keating, Jennifer Getz, Gregory T. Kapp, Jamie M. Romero, Tomoko Ozawa, C. David James, Ana Krtolica, Stephen P.L. Cary
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Targeting Notch and mTOR in glioblastoma: crosstalk in a new direction
Samantha Semenkow*, Qian Chu, Charles Eberhart
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Toca 511 gene transfer in combination with temozolomide appears safe and demonstrates synergistic therapeutic efficacy in a mouse glioblastoma model
Tiffany Huang*, Juraj Hlavaty, Derek Ostertag, Fernando Lopez Espinoza, Bryan Martin, Helga Petznek, Maria Rodriguez-Aguirre, Carlos Ibanez, Noriyuki Kasahara, Walter Gunzburg, Harry Gruber, Daniel Pertschuk, Doug Jolly, Joan Robbins
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The anti-tumor effect of the fibrin glue mixed with temozolomide against malignant glioma, an in vivo model
Shigeo Anai*, Takuichiro Hide, Hideo Nakamura, Keishi Makino, Shigetoshi Yano, Jun-ichi Kuratsu
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The brain microenvironment negatively regulates miRNA-768-3pin lung cancer to induce KRAS and promote metastasis  
James Driscoll*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The brain-penetrant anti-HER2 mAb, ANG4043, targets HER2+ brain tumors and increases survival in mice with intracranial BT-474 cell tumors.
Jean Lachowicz*, Michel Demeule, Anthony Regina, Sasmita Tripathy, Jean-Christophe Curry, Tran Nguyen, Jean-Paul Castaigne
Sunday, November 24, Scientific Meeting:  Concurrent Session 9A - Preclinical Therapeutics  -  10:20am - 12:00pm
The CXCR7 inhibitor CCX650 significantly prolongs survival in the C6 rat model of glioblastoma
Karen Ebsworth*, Matthew J. Walters, Linda S. Ertl, Yu Wang, Robert D. Berahovic, Jeff McMahon, Jay P. Powers, Juan C. Jaen, Thomas J. Schall
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The therapeutic evaluation of integrin αvβ3-specific disintegrin on brain tumor using MRI
Chiao-Chi Chen, Nai-Wei Yao, Woei-Jer Chuang, Chen Chang*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The immunohistological and radiological survey on temozolomide-induced cytotoxicity enhanced by cdk inhibitor in vivo
Takuro Hayashi*, Kazuhide Adachi, Shinya Nagahisa, Mitsuhiro Hasegawa, Yuichi Hirose
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
The ketogenic diet alters angiogenic processes and edema in a mouse model of malignant glioma
Eric C. Woolf*, Mohammed G. Abdelwahab, Kathryn E. Fenton, Qingwei Liu, Greg Turner, Mark C. Preul, Adrienne C. Scheck
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Therapeutic targeting of XPO1/CRM1 in adult and pediatric high-grade glioma
Adam L. Green*, Shakti Ramkissoon, Dilara McCauley, Kristen Jones, Jennifer A. Perry, Lori Ramkissoon, Cecile Maire, Sharon Shacham, Keith L. Ligon, Andrew L. Kung
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Therapeutic opportunities in diffuse intrinsic pontine gliomas determined by functional chemical screens and mutational profiling
Catherine Grasso*, Lining Liu, Oren Becher, Noah Berlow, Lara Davis, Maryam Fouladi, Amar Gajjar, Cynthia Hawkins, Elaine Huang, Esther Hulleman, Marianne Hutt, Charles Keller, Xiao-Nan Li, Paul Meltzer, Martha Quezado, Michael Quist, Eric Raabe, Paul Spellman, Nathalene Truffaux, Dannis van Vuurden, Nicholas Wang, Katherine Warren, Ranadip Pal, Jacques Grill, Michelle Monje
Friday, November 22, Scientific Meeting:  Concurrent Session 3B - Pediatric Clinical  -  3:15pm - 5:00pm
Therapeutically targeting ATRX deficiency in lower-grade astrocytoma
Beatriz Aldaz*, Armida W.M. Fabius, Joachim Silber, Girish Harinath, Timothy A. Chan, Jason T. Huse
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Third generation ST-drugs have an increased potency in proliferative classical glioblastoma subtype
Eric Horne*, Philippe Diaz, Nephi Stella
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Tumor derived mutations of protein tyrosine phosphatase receptor type K affect its function and alter sensitivity tochemotherapeutics in glioma
Timothy Ryken*, Supreet Agarwal, Maha Al-Keilani, Mohammad Alqudah, Zita Sibenaller, Mahfoud Assemolt
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
TRAIL in combination with proteasome inhibition shows synergistic cytotoxicity in glioblastoma subsets defined by RNA expression profiling
Jochem Spoor*, Marielle van der Kaaij, Jenneke Kloezeman, Mieke Geurtjens, Clemens Dirven, Martine Lamfers, Sieger Leenstra
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Very low-dose temozolomide and cisplatin treatments cause time and dose dependent dendritic spine damage in cultured hippocampal neurons
Xing Gong, Adrienne Andres, Joseph Hanson, Johnny Delashaw, Daniela Bota*
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
Zinc enhances TMZ cytotoxicity in  glioblastoma multiforme model system
Ruty Shai*, Tatyana Pismenyuk, Itai Moshe, Tamar Fisher, Shani Freedman, Amos Simon, Ninette Amariglio, Gideon Rechavi, Amos Toren, Michal Yalon
Saturday, November 23, Scientific Meeting:  Poster session  -  5:00pm - 7:00pm
^Top
 
 
LAB--omics and Prognostic Markers
A telomerase-based assay detects circulating tumor cells in the peripheral blood of primary brain tumor patients
Kelly MacArthur, Stephen Hahn, Gary Kao, Robert Lustig, Michelle Alonso-Basanta, Sanjay Chandrasekaran, E. Paul Wileyto, Emigdio Reyes, Jay Dorsey*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A five gene signature to predict outcome of TRC-102 and temozolomide treatment in glioblastoma
Shwetal Mehta*, Brock Armstrong, Sen Peng, Aditi Bapat, Michael Berens
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A molecular predictor of response to bevacizumab based on analysis of RTOG 0825, a phase III trial comparing chemoradiation with and without bevacizumab in patients with newly diagnosed glioblastoma
Erik Sulman*, Minhee Won, Ravesanker Ezhilarasan, Peng Sun, Deborah Blumenthal, Michael Vogelbaum, Howard Colman, Robert Jenkins, Arnab Chakravarti, Robert Jeraj, Paul Brown, Kurt Jaeckle, David Schiff, James Dignam, James Atkins, David Brachman, Maria Werner-Wasik, Mark Gilbert, Minesh Mehta, Ken Aldape
Saturday, November 23, Scientific Meeting:  Concurrent Session 6B - Molecular Epidemiology/Biomarkers  -  1:00pm - 3:00pm
A radiogenomic analysis of the TCGA glioblastoma data set
David Gutman*, Chad Holder, Rivka Colen, William Dunn, Rajan Jain, Lee Cooper, Scott Hwang, Adam Flanders, Daniel Brat
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A retrospective review of the influence of quantitative MGMT methylation on survival after chemoradiotherapy for patients with glioblastoma
Charlene Crosby, Claire Faulkner, Thomas Smye-Rumsby, Kathreena Kurian, Maggie Williams, Kirsten Hopkins*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A subset of the periostin gene network is related to survival and recurrence in gliomas
Andrew Trister*, Mari Tokita, Svetlana Mikheeva, Andrei Mikheev, Stephen Friend, Robert Rostomily
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A survey of intragenic breakpoints in GBM identifies a distinct subset associated with poor survival
Siyuan Zheng*, Jun Fu, Rahulsimham Vegesna, Yong Mao, Lindsey Heathcock, Wandaliz Torres-Garcia, Ravesanker Ezhilarasan, Shuzhen Wang, Aaron McKenna, Lynda Chin, Cameron Brennan, W. K. Alfred Yung, John Weinstein, Kenneth Aldape, Erik Sulman, Ken Chen, Dimpy Koul, Roel G. W. Verhaak
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
A whole-genome methylation study in meningiomas reveals patterns of aberrant hypermethylation associated with clinical and molecular aggressivity
Barbara Melendez*, Manuela Mollejo, Pilar Mur, Teresa Hernandez-Iglesias, Concepción Fiaño, Juan Ruiz, Juan A. Rey
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Adult gliomas display different DNA copy number alterations, prognostic factors, and gender association depending on grade and IDH status
Adam L. Cohen*, Mariko Sato, Kenneth D. Aldape, Clint Mason, Kristen Diefes, Lindsey Heathcock, Lisa Abegglen, Dennis Shrieve, William Couldwell, Joshua D. Schiffman, Howard Colman
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
An integrated genomic analysis of individual patients with glioblastoma reveals previously unrecognised levels of intra-tumour heterogeneity that reflects cancer evolutionary dynamics
Colin Watts*, Andrea Sottoriva, Inmaculada Spiteri, Sara Piccirillo, Anestis Touloumis, Peter Collins, John Marioni, Christina Curtis, Simon Tavaré
Friday, November 22, Scientific Meeting:  Plenary Session - Award Winning Abstracts  -  8:15am - 10:15am
Analysis of IDH1 mut expression in human astrocytomas by RT-PCR
Moritz Perrech*, Lena Dreher, Gabriele Röhn, Roland Goldbrunner, Marco Timmer
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Biomarkers indicative of tendency to recur on meningiomas: an immunohistochemical and molecular study related to clinical data and follow up
Bianca Pollo*, Veronica Palumbo, Chiara Calatozzolo, Monica Patanè, Raffaele Nunziata, Mariangela Farinotti, Antonio Silvani, Sandro Lodrini, Gaetano Finocchiaro
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Cancer stem cell transcriptional subtyping of glioblastoma multiforme correlates with clinically relevant molecular and imaging phenotypes
Olivier Gevaert*, Achal Achrol, Sharareh Gholamin, Siddhartha Mitra, Erick Westbroek, Joshua Loya, Lex Mitchell, Steven Chang, Gary Steinberg, Sylvia Plevritis, Samuel Cheshier
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Chromosomal imbalance and survival in patients with astrocytoma
Enrique Lopez, Ana Rioscovian, Ruth Ruiz, Georgina Siordia, Andrea Ponce de León*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Clonal evolution in a highly recurrent astroblastoma of childhood
Sergey Popov, Alan Mackay, Wendy Ingram, Anna Burford, Alexa Jury, Mara Vinci, Chris Jones*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Clonal expansions and evolving subpopulations in glioblastoma multiforme
Noemi Andor*, Julie Harness, Sandra Gomez Lopez, Tang Ling Fung, Hans W. Mewes, Claudia Petritsch
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Comprehensive MGMT and mismatch repair analysis in paired primary and recurrent gliomas reveals evolutionary and temozolomide-induced changes during tumor progression
HF van Thuijl*, T Mazor, BE Johnson, SD Fouse, JJ Heimans, P Wesseling, B Ylstra, JC Reijneveld, BS Taylor, MS Berger, SM Chang, JF Costello
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Control of SOCS1 and SOCS3 methylation, and relationship with MGMT as effectiveness factor of treatment in glioblastoma
Wilver Federico Carbonel Luyo*, Michel Herranz Carnero, María Elena Padín Iruegas, Alvaro Ruibal Morell, Manuel Constenla Figueiras, Rafael López López, Concepcion Fiaño Valverde
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Consideration of relationships between genetic abnormality and clinical picture inglioma without +7 and -1p/19q
Kazuhide Adachi*, Hikaru Sasaki, Shinya Nagahisa, Kouichiro Yoshida, Natsuki Hattori, Yuya Nishiyama, Tsukasa Kawase, Mitsuhiro Hasegawa, Masato Abe, Yuichi Hirose
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Creating a radiogenomics map of multi-omics and quantitative image features in glioblastoma multiforme
Olivier Gevaert*, Lex Mitchell, Achal Achrol, Jiajing Xu, Gary Steinberg, Samuel Cheshier, Sandy Napel, Greg Zaharchuk, Sylvia Plevritis
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Deciphering a molecular signature of glioma progression using microRNA expression data
Josie Hayes*, Alastair Droop, Helene Thygesen, Marjorie Boissinot, David Westhead, Susan Short, Sean Lawler
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Development of receptor targeted quantum dots as in vitro and in vivo diagnostic agent for GBM
Achuthamangalam Madhankumar*, Cody Weston, Becky Slagle-Webb, Jonas Sheehan, Akshal Patel, Michael Glantz, James Connor
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Distinguishing responders from non-responders to Bevacizumab using CT Perfusion
Timothy Pok Chi Yeung*, Baraa Al-Khazraji, Laura Morrison, Lisa Hoffman, Dwayne Jackson, Ting-Yim Lee, Slav Yartsev, Glenn Bauman
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
EGFR and EGFRvIII expression in glioblastoma
Claire Faulkner, Abigail Palmer, Hannah Williams, Chris Wragg, Harry R Haynes, Maggie Williams, Kirsten Hopkins*, Kathreena M Kurian
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Exome sequencing of CNS germ cell tumors reveals frequent mutations in KIT and KRAS pathways and JMJD genes
Ching Lau*, Linghua Wang, Keita Terashima, Shigeru Yamaguchi, Matthew Burstein, Jiayi Sun, Tomonari Suzuki, Ryo Nishikawa, Hideo Nakamura, Atsushi Natsume, Syunsuke Terasaka, Ho-Keung Ng, Donna Muzny, Richard Gibbs, David Wheeler
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Expression and prognostic significance of cysteine-rich protein 61 in glioblastoma
Joji Ishida*, Kazuhiko Kurozumi, Tomotsugu Ichikawa, Manabu Onishi, Kentaro Fujii, Yosuke Shimazu, Tetsuo Oka, Isao Date
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Expression of brachyury in chordomas: association with malignancy
Ryohei Otani*, Akitake Mukasa, Shunsaku Takayanagi, Kuniaki Saito, Shota Tanaka, Masahiro Shin, Nobuhito Saito
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients
Satoshi Nakamizo*, Takashi Sasayama, Hirotomo Tanaka, Kazuhiro Tanaka, Katsu Mizukawa, Masaru Yoshida, Eiji Kohmura
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Genetic mutations in epigenomically-defined promoters and enhancersin glioblastoma
Robert Bell*, Robin Kang, Chibo Hong, Jun Song, Joseph Costello
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Genome-wide CNV analysis identifies loci putatively associated with delayed time to first recurrence in IDH-mutant low-grade astrocytomas
Tim Lautenschlaeger*, Tareq A Juratli, Joseph McElroy, Wei Meng, Alexander Huebner, Kathrin D Geiger, Dietmer Krex, Gabriele Schackert, Arnab Chakravarti
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Genomic analysis of TRAF7-only mutant meningiomas reveals novel driver mutations
Victoria Clark*, Zeynep Erson Omay, Akdes Serin, Jennifer Günel, Bulent Omay, Conor Grady, Mark Youngblood, Kaya Bilgüvar, Joachim Baehring, Joseph Piepmeier, Philip Gutin, Alexander Vortmeyer, Cameron Brennan, M. Necmettin Pamir, Türker Kilic, Boris Krischek, Matthias Simon, Katsuhito Yasuno, Murat Günel
Friday, November 22, Scientific Meeting:  Concurrent Session 2A - Pathology/Genomics  -  1:00pm - 3:00pm
Genomic characterization of spatial and temporal heterogeneity of glioblastoma multiforme
Hoon Kim, Siyuan Zheng, Tom Mikkelsen, Daniel J. Brat, Selene Virk, Saman Amini, Carrie Sougnez, Lynda Chin, Jill Barnholtz-Sloan, Roel G.W. Verhaak*
Friday, November 22, Scientific Meeting:  Concurrent Session 2A - Pathology/Genomics  -  1:00pm - 3:00pm
Global analysis of histone modification states in primary medulloblastomas reveals subgroup-specific patterns of gene regulation
Paul Northcott*, Volker Hovestadt, David Jones, Marcel Kool, Andrey Korshunov, Peter Lichter, Stefan Pfister
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Glioma patient tissue biomarkers for hypoxia and vascularity taken from specific intratumoral regions correlate with preoperative perfusion MRI and are predictive of patient outcome
Randy Jensen*, Karen Salzman, Mattias Schabel, David Gillespie, Michael Mumert
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
GLIOMETH: A novel DNA methylation signature predicts overall survival in glioblastoma multiforme
Olivier Gevaert*, Achal Achrol, Steven Chang, Griffith Harsh, Gary Steinberg, Samuel Cheshier, Sylvia Plevritis
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma
Tatsuya Ozawa*, Markus Riester, Yu-Kang Cheng, Jason Huse, Karim Helmy, Nikki Charles, Massimo Squatrito, Franziska Michor, Eric Holland
Sunday, November 24, Scientific Meeting:  Concurrent Session 8A - Metabolic Pathways/Stem Cells  -  8:15am - 10:05am
Hyperpolarized [1 - 13C] α-Ketoglutarate: a novel DNP probe for non-invasive assessment of IDH1 mutational status in glioma
Myriam Chaumeil*, Peder Larson, Hikari Yoshihara, Daniel Vigneron, Sarah Nelson, Russell Pieper, Joanna Phillips, Sabrina Ronen
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Identification of a gene signature distinctive of primary glioblastomas with spatial relationship to the subventricular zone
Christine Jungk*, Andreas Mock, Christoph Geisenberger, Rolf Warta, Sara Friauf, Andreas Unterberg, Christel Herold-Mende
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Identification of anaplastic oligodendroglioma patients benefitting from adjuvant PCV chemotherapy using the Illumina platform: a further report from EORTC study 26951
Martin van den Bent*, Lale Erdem, Thierry Gorlia, Martin Taphoorn, Johan Kros, Pieter Wesseling, Hendrik Dubbink, Ahmed Ibdaih, Marc Sanson, Pim French
Saturday, November 23, Scientific Meeting:  Concurrent Session 6B - Molecular Epidemiology/Biomarkers  -  1:00pm - 3:00pm
Identification of candidate genes associated with malignant transformation of IDH-mutated low-grade astrocytomas using genome-wide copy number variation analysis
Tareq A Juratli*, Joseph McElroy, Wei Meng, Alexander Huebner, Kathrin D Geiger, Dietmer Krex, Gabriele Schackert, Arnab Chakravarti, Tim Lautenschlaeger
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Identification of differentially regulated miRNA in the blood of short- and long-term PCNSL survivors by Next Generation Sequencing
Patrick Roth*, Andreas Keller, Jörg Hoheisel, Paula Codo, Andrea Bauer, Christina Backes, Petra Leidinger, Eckart Meese, Eckhard Thiel, Agnieszka Korfel, Michael Weller
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Identification of distinct subgroup of glioma and novel genes related to malignant progression by genome-wide methylation analysis
Kuniaki Saito*, Akitake Mukasa, Genta Nagae, Motoo Nagane, Koki Aihara, Shunsaku Takayanagi, Shota Tanaka, Hiroyuki Aburatani, Nobuhito Saito
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Identification of prognostic serum-antibodies against glioblastoma-associated antigens
Andreas Mock*, Volker Stadler, Alexander Schulte, Katrin Lamszus, Christian Schichor, Manfred Westphal, Jörg-Christian Tonn, Andreas Unterberg, Christel Herold-Mende
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
IDH1 status as a diagnostic and prognostic marker for malignant astrocytomas with limited histological specimen: the role of surgical resection, pathological analysis and molecular testing
Betty YS Kim*, Wen Jiang, Jason Beiko, Sujit Prabhu, Franco DeMonte, Frederick Lang, Mark Gilbert, Kenneth Aldape, Raymond Sawaya, Daniel Cahill, Ian McCutcheon
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Image-guided metabolomic analysis of 2-hydroxyglutarate in IDH-mutant gliomas
Llewellyn Jalbert*, Adam Elkhaled, Joanna Phillips, Susan Chang, Sarah Nelson
Sunday, November 24, Scientific Meeting:  Concurrent Session 8B - Imaging and RANO Update  -  8:15am - 10:05am
Integrative epigenomics to identify driver epimutations in GBM
Robert Bell*, Raman Nagarajan, Bo Zhang, Aaron Diaz, Ting Wang, Jun Song, Joseph Costello
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Landscape of chromosomal copy number aberrations (CNAs) in glioneuronal tumors (GNTs): relatively frequent gain of chromosome 5 and/or 7; chromothripsis in subset of cases
A Prabowo, HF van Thuijl*, I Scheinin, HF van Essen, WGM Spliet, C Ferrier, PC van Rijen, TJ Veersema, M Thom, AYN Schouten-van Meeteren, JC Reijneveld, B Ylstra, P Wesseling, E Aronica
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Longitudinal epigenomics of low-grade gliomas during malignant progression
Tali Mazor*, Brett Johnson, Chibo Hong, Michael Barnes, Llewellyn E. Jalbert, Sarah J. Nelson, Andrew W. Bollen, Ivan V. Smirnov, Jun S. Song, Adam B. Olshen, Mitchel S. Berger, Susan M. Chang, Barry S. Taylor, Joseph F. Costello
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors
Aden Ka-Yin Chan*, Jesse Chung-Sean Pang, Nellie Yuk-Fei Chung, Kay Ka-Wai Li, Wai Sang Poon, Danny Tat-Ming Chan, Yin Wang, Ho-Keung Ng
Saturday, November 23, Scientific Meeting:  Concurrent Session 6B - Molecular Epidemiology/Biomarkers  -  1:00pm - 3:00pm
Low levels of human cytomegalovirus infection in glioblastoma multiforme associates with patient survival; a prospective study
Giuseppe Stragliotto*, Afsar Rahbar, Cecilia Söderberg-Naucler
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
MGMT promoter methylation is present in low grade glioma (WHO Grade II/III) and glioblastoma multiforme in the absence of IDH mutations
Harry R Haynes, Charlene Crosby, Hannah Williams, Paul White, Kirsten Hopkins*, Maggie Williams, Kathreena M Kurian
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
microRNA 371-373 and 302A in cerebrospinal fluid are potential tumor-derived biomarkers for intracranial germ cell tumors
Keita Terashima*, Jianhe Shen, Joseph Luan, Alexander Yu, Tomonari Suzuki, Ryo Nishikawa, Masao Matsutani, Yu Liang, Tsz-Kwong Man, Ching Lau
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
MicroRNA promoter methylation and expression in anaplastic glioma
Maximilian Schliesser*, Christiane Grimm, Elisa Weiss, Rainer Claus, Dieter Weichenhan, Markus Weiler, Thomas Hielscher, Felix Sahm, Benedikt Wiestler, Ann-Catherine Klein, Jonas Blaes, Michael Weller, Christoph Plass, Wolfgang Wick
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Molecular characterization of 11p-deleted diffuse low-grade gliomas
Agusti Alentorn*, Yannick Marie, Sylvie Poggioli, Hussa Alshehhi, Blandine Boisselier, Catherine Carpentier, Karima Mokhtari, Laurent Capelle, Dominique Figarella-Branger, Khê Hoang-Xuan, Marc Sanson, Jean-Yves Delattre, Ahmed Idbaih
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Molecular features of adult patients with gangliogliomas
Shlomit Yust-Katz, Mark Anderson*, Adriana Olar, Agda Eterovic, Nader Ezzeddine, Ken Chen, Hao Zhao, Gregory Fuller, Kenneth Aldape, John de Groot
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Multi-focal glioblastoma: insights from an integrated genomic analysis
Zhao-Shi Bao, Ji-Dong Lang, Hui-Ping Lu, Bang-Rong Cao, Chuan-Bao Zhang, Peng-Fei Song, Xiao-Guang Qiu, Shou-Wei Li, Kun Yao, Yu-Ling Yang, Wen-Bin Li, Chun-Sheng Kang, Yong-Ping You, Geng TIan, Kai-Tai Zhang, Clark Chen*, Shu-Jun Cheng, Tao Jiang
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Novel genes and Gene signature in prognostication of glioblastoma: potential targets and pathway identification.
Arimappamagan Arivazhagan*, Kumaravel Somasundaram, Kandavel Thennarasu, Paritosh Pandey, B Anandh, Vani Santosh, BA Chandramouli, AS Hegde, Paturu Kondaiah, MRS Rao
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
O6-methylguanine-DNA methyltransferase (MGMT) activity in anaplastic oligodendroglial tumors:  Associations with alkylating agent response, 1p19q deletion and MGMT promoter methylation
Clifford Rostomily*, Robert Rostomily, Daniel Silbergeld, Douglas Kolstoe, Marc Chamberlain, John Silber
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Omics analysis of the anti-glioma effect by combination therapy of vasculostatin expressing oncolytic virus and cilengitide
Kentaro Fujii*, Kazuhiko Kurozumi, Tomotsugu Ichikawa, Manabu Onishi, Joji Ishida, Yosuke Shimazu, Balveen Kaur, E.Antonio Chiocca, Isao Date
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Pathway signature analysis (PSA) of glioblastoma molecular subtypes
Zack Taich, Goyal Amit, Gonda David, Jiang Tao, Bob Carter, Clark Chen*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Peroxiredoxin 1: a prognostic marker in anaplastic glioma with proinvasive and chemoresistant properties
Elisa Weiss*, Christiane Grimm, Maximilian Schliesser, Thomas Hielscher, Rainer Claus, Felix Sahm, Benedikt Wiestler, Ann-Catherine Klein, Jonas Blaes, Björn Tews, Markus Weiler, Dieter Weichenhan, Christian Hartmann, Michael Weller, Christoph Plass, Wolfgang Wick
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Poly-omic profiling of glioblastoma long-term survivors reveals a novel chemotherapy-refractory, slow-cycling subgroup
Christoph Geisenberger*, Andreas Mock, Rolf Warta, Christian Schwager, Christian Hartmann, Andreas von Deimling, Amir Abdollahi, Christel Herold-Mende
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Precise reconstruction of amplified regions in glioblastoma multiforme using high-throughput sequencing data from the Cancer Genome Atlas reveals oncogenic double minute chromosomes
Sofie Salama*, J. Zachary Sanborn, Mia Grifford, Cameron Brennan, Tom Mikkelsen, Suresh Jhanwar, Lynda Chin, David Haussler
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Predictors of progression-free survival and overall survival in IDH1-mutant glioma patients
Franziska Loebel*, William T. Curry, Fred G. Barker, Nina Lelic, Andrew S. Chi, Daniel P. Cahill
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Prognostic and predictive role of VEGF-A and of the diffusible isoform VEGF-121 in patients with glioblastoma
Quintino Giorgio D'Alessandris*, Tonia Cenci, Maurizio Martini, Lucia Ricci-Vitiani, Ruggero De Maria, Luigi Maria Larocca, Roberto Pallini
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Prognostic values of long non-coding RNA signatures in glioblastoma multiforme
Xiao-qin Zhang, Stella Sun, Kwok-fai Lam, Karrie M.Y. Kiang, Jenny K.S. Pu, Amy S.W. Ho, Gilberto K.K. Leung*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Quantification of tumor-specific DNA as a predict marker for meningiomas
Li Bie*, Yunqian Li, Yiping Li, Haiyu Liu
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Receptor/RAS/PI3K/Akt/mTOR variations in Akt pathway subtypes suggest therapeutic alternatives
Anna Joy*, Ivan Smirnov, Mark Reiser, William Shapiro, Gordon Mills, Seungchan Kim, Burt Feuerstein
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Single cell sequencing resolves clonal and subclonal alterations in glioblastoma
Cecile Maire*, Joshua Francis, Cheng-Zhong Zhang, Joonil Jung, Veronica Manzo, Viktor Adalsteinsson, Heather Homer, Brendan Blumenstiel, Chandra Sekhar Pedamallu, Elizabeth Nickerson, Azra Ligon, Christopher Love, Matthew Meyerson, Keith Ligon
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
The combination of interleukin-10 and beta2-microglobulin in cerebrospinal fluid is a useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL)
Takashi Sasayama*, Kazuhiro Tanaka, Satoshi Nakamizo, Masamitsu Nishihara, Hirotomo Tanaka, Katsu Mizukawa, Eiji Kohmura
Saturday, November 23, Scientific Meeting:  Concurrent Session 6B - Molecular Epidemiology/Biomarkers  -  1:00pm - 3:00pm
The genetic and epigenetic context of MGMT methylation in glioma may impact the predictive and prognostic value
Pierre Bady, Sebastian Kurscheid, Mauro Delorenzi, Monika E. Hegi*
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
The medulloblastoma methylome reveals new epigenetic regulatory mechanisms
David T. W. Jones*, Volker Hovestadt, Simone Picelli, Wei Wang, Paul A. Northcott, Marcel Kool, Guido Reifenberger, Torsten Pietsch, Marc Sultan, Hans Lehrach, Marie-Laure Yaspo, Arndt Borkhardt, Pablo Landgraf, Roland Eils, Andrey Korshunov, Marc Zapatka, Bernhard Radlwimmer, Stefan M. Pfister, Peter Lichter
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
The PROACTIVE-Glioma Program at MD Anderson: gateway to personalized medicine trials for glioma
John de Groot*, Brett Theeler, Kenneth Aldape, Frederick Lang, Ganesh Rao, Mark Gilbert, Erik Sulman, Raja Luthra, Karina Eterovic, Ken Chen, Mark Routbort, Roeland Verhaak, Gordon Mills, John Mendelsohn, Funda Meric-Bernstam, Alfred Yung
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Therapy-induced evolution of low-grade glioma genomes during malignant progression
Brett Johnson*, Tali Mazor, Chibo Hong, Michael Barnes, Shogo Yamamoto, Hiroki Ueda, Kenji Tatsuno, Koki Aihara, Llewellyn Jalbert, Sarah Nelson, Andrew Bollen, Martin Hirst, Marco Marra, Akitake Mukasa, Nobuhito Saito, Hiroyuki Aburatani, Mitchel Berger, Susan Chang, Barry Taylor, Joseph Costello
Friday, November 22, Scientific Meeting:  Concurrent Session 2A - Pathology/Genomics  -  1:00pm - 3:00pm
Tumor specific epigenetic activation of alternative promoters in the body of oncogenes
Raman Nagarajan*, Bo Zhang, Brett Johnson, Robert Bell, Adam Olshen, Shaun Fouse, Aaron Diaz, Ivan Smirnov, Robin Kang, Ting Wang, Joseph Costello
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
Transcript rearrangements involving cancer driver genes in adult lower-grade gliomas
Olena Morozova*, Solomon Katzman, Mia Grifford, Sofie Salama, David Haussler
Friday, November 22, Scientific Meeting:  Concurrent Session 2A - Pathology/Genomics  -  1:00pm - 3:00pm
Whole exome sequencing of paired GBM specimens from patients treated with chemoradiotherapy
Dan Lu*, Julia Yin, Charlie Teo, Kerrie McDonald
Friday, November 22, Scientific Meeting:  Poster session  -  7pm - 9:00pm
^Top
 
 
Late-Breaking Research
A phase 1 study of AZD6244 in pediatric patients with recurrent or refractory low grade gliomas:  a report from the Pediatric Brain Tumor Consortium.
Anuradha Banerjee*, Regina Jakacki, Arzu Onar-Thomas, Shengjie Wu, Theodore Nicolaides, Clinton Stewart, Stacye Richardson, Michael Prados, Roger Packer, Ibrahim Qaddoumi, Sridharan Gururangan, Stewart Goldman, Ian Pollack, Austin Doyle, James Boyette, Larry Kun, Maryam Fouladi
Friday, November 22, Scientific Meeting:  Concurrent Session 3B - Pediatric Clinical  -  3:15pm - 5:00pm
Health Related Quality of Life results from temozolomide chemotherapy vs. radiotherapy in molecularly characterized (1p loss) low-grade glioma. A randomized phase III Intergroup study by the EORTC/NCIC-CTG/TROG/MRC-CTU (EORTC22033-26033)
J.C. Reijneveld*, Andrew Bottomley, Martin Taphoorn, Corneel Coens, Martin van den Bent, Warren Mason, Khe Hoang-Xuan, Alba Brandes, Roger Stupp, Guy Kantor, Mohamed Ben Hassel, Gail Ryan, Wolfgang Wick, Brian Theissen, Denis Lacombe, Thierry Gorlia, Brigitta Baumert
Saturday, November 23, Scientific Meeting:  Concurrent Session 7B - Neurocognitive Outcomes and Quality of Life  -  3:15pm - 5:00pm
The association of acquired TERT promoter mutations in glioma with germline polymorphisms in the TERT and RTEL1 regions.
Thomas Kollmeyer, Kyle Walsh*, Gobinda Sarkar, Shichun Zheng, Alissa Caron, Terri Rice, Paul Decker, Matthew Kosel, Jeanette Eckel-Passow, Hugues Sicotte, Lucie McCoy, Ivan Smirnov, Tarik Tihan, Helen Hansen, Joseph Patoka, Daniel Lachance, Joseph Wiemels, John Wiencke, Margaret Wrensch, Robert Jenkins
Saturday, November 23, Scientific Meeting:  Concurrent Session 6B - Molecular Epidemiology/Biomarkers  -  1:00pm - 3:00pm
^Top